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Abstract 
Evaluation of next generation sequencing for epidemiological investigation of 
nosocomial pathogens 
 
 Rapid and accurate typing of pathogens is crucial for effective surveillance and outbreak 
investigation. Although classical typing methods are still well implemented in clinical 
microbiology laboratories, whole genome sequencing (WGS) is emerging as a powerful molecular 
typing tool with considerable power of discrimination between outbreak and non-outbreak 
isolates. This technique has been used to study the epidemiology of important pathogens, such as 
Pseudomonas aeruginosa and Staphylococcus aureus. 
 An increase in P. aeruginosa incidence was observed in the intensive care units (ICUs) of 
the University Hospital of Lausanne. Double locus sequence typing (DLST) detected the presence 
of three major genotypes during the study period with different epidemiological behaviours. One 
of the projects developed during this doctoral thesis aimed to use WGS to further investigate these 
three DLST types. A standard methodology was defined by incorporating open access 
bioinformatic methods for SNPs analysis using P. aeruginosa PA14 as the reference. Results 
showed an unexpected high number of SNP differences between isolates suspected to be part of 
an outbreak. The original methodology was altered by adding additional steps of stricter quality 
filtering which resulted in a more accurate number of SNP differences found. Using a closer 
reference to each DLST type gave similar SNP differences to when the adapted methodology was 
used. Changing specific mapping and site coverage thresholds resulted in minor changes in SNPs 
between isolates. When a definitive methodology was finally chosen, WGS was able to 
differentiate between outbreak (< 10 SNPs) and non-outbreak isolates, to confirm suspected 
epidemiological links, and infer relatedness between isolates/environment that were not 
epidemiologically linked. Combining DLST with the discriminatory power of WGS efficiently 
elucidated on the P. aeruginosa epidemiology in our ICUs. 
 Genomic data is mainly exploited by SNP analysis or by gene-by-gene methods. The 
objective of this doctoral thesis’ second project was to assess the performance of these 
genomic methods by using a previously published ST228 Methicillin-resistant 
Staphylococcus aureus (MRSA) dataset. Original published results were compared to the 
ones obtained with the whole genome SNPs (wgSNPs) and whole genome MLST 
(wgMLST) tools implemented in BioNumerics. Clustering of isolates was identical 
between the three analysis and distances were similar between wgSNPs and wgMLST. 
The advantages of using the BioNumerics wgMLST tool for real-time outbreak 
 investigation, i.e. no need for a close reference, high interlaboratory reproducibility, and 
almost no bioinformatic skills needed, turn this method into a simple and easy alternative 
to other analysis approaches.  
  
 
 
 
 
Résumé  
Évaluation du séquençage de nouvelle-génération pour l'investigation 
épidémiologique d'agents pathogènes nosocomiaux 
 
Le typage rapide et précis des agents pathogènes est essentiel pour assurer une 
surveillance ou une investigation d'épidémie efficaces. Bien que les méthodes classiques de typage 
soient encore bien utilisées dans les laboratoires de microbiologie clinique, le séquençage du 
génome entier (whole genome sequencing, WGS) est en train de devenir un puissant outil de 
typage moléculaire avec un pouvoir considérable de discrimination permettant de différencier les 
isolats épidémiques et non- épidémiques. Cette technique a été utilisée pour étudier 
l’épidémiologie d’agents pathogènes importants comme Pseudomonas aeruginosa et 
Staphylococcus aureus. 
Une augmentation de l’incidence de P. aeruginosa a été observée dans les services de soins 
intensifs (intensive care units, ICUs) du Centre Hospitalier Universitaire Vaudois.  
Le typage par la méthode du “Double locus sequence typing” (DLST) a permis de détecter 
la présence de trois génotypes majeurs pendant la période d’étude qui avaient des comportements 
épidémiologiques différents. Un des projets développés pendant cette thèse de doctorat a eu pour 
but d’utiliser le séquençage du génome entier afin d’examiner plus profondément ces trois types 
de DLST. Une méthodologie standard a été définie en incorporant des méthodes bio-informatique 
en libre accès pour l’analyse de SNPs utilisant le génome de P. aeruginosa PA14 comme référence. 
Les résultats ont montré un nombre élevé inattendu de différences de “single nucleotide 
polymorphisms” (SNPs)  entre les isolats suspectés de faire partie d’une épidémie. La 
méthodologie originale a été altérée en utilisant les étapes supplémentaires de filtrage de qualité 
plus stricts, qui a abouti à un nombre plus précis de différences de SNP trouvées. Utiliser une 
référence plus proche à chaque type de DLST a donné des différences de SNP semblables à celles 
trouvées lors de l’utilisation de la méthodologie adaptée. Le changement des seuils spécifique de 
mapping et de couverture de site ont abouti à des changements mineurs de SNP entre les isolats. 
Quand une méthodologie définitive a été finalement choisie, le séquençage du génome entier a 
permis de différencier les isolats de l’épidémie (10 SNPs) de ceux qui ne font pas partie de 
l’épidemie, a ainsi confirmé des liens épidémiologiques soupçonnés et déduit la liaison entre 
isolats/environnement qui n'étaient pas lié de façon épidémiologique. En combinant le DLST avec 
le pouvoir discriminant du WGS, cela nous a permis d’élucider efficacement l’épidémiologie de P. 
aeruginosa dans nos services de soins intensifs. 
Les données génomiques sont principalement exploitées par l’analyse de SNP ou par des 
méthodes de comparaison de gène-à-gène. L'objectif du deuxième projet de cette thèse de 
 doctorat était d'évaluer la performance de ces méthodes génomiques en utilisant un dataset 
d’isolats de S. aureus résistant à la méticilline (MRSA) du ST228 précédemment publié. Les 
résultats publiés originaux ont été comparés à ceux obtenus avec les SNPs de génomes entiers 
(wgSNPs) et la méthode du “whole genome MLST” (wgMLST), des outils disponible dans le 
programme commercial BioNumerics. Le groupement des isolats étaient identiques entre les trois 
analyses et les distances étaient semblables entre wgSNPs et wgMLST. Les avantages d’utiliser 
l’outil wgMLST de BioNumerics pour les enquêtes en temps réel sur les épidémies, est qu’il n’est 
pas nécessaire d’avoir une référence génétiquement proche, une grande reproductibilité inter 
laboratoire et presque aucune compétence en bio-informatique, . Cette méthode est donc une 
alternative simple pour l’investigation d’épidémies. 
  
 
 
 
 
Résumé large public 
Évaluation du séquençage de nouvelle-génération pour l'investigation 
épidémiologique d'agents pathogènes nosocomiaux 
 
Les infections acquis à l’hôpital, ou nosocomial, affectent approximativement 30% des 
patients dans les unités de soins intensifs et sont associées à une morbidité et une mortalité 
substantielles. Pseudomonas aeruginosa et Staphylococcus aureus sont parmi les pathogènes 
nosocomiaux les plus fréquement rapportés. Si une augmentation de l’incidence de ces 
pathogènes est observée, une investigation doit être entreprise pour comprendre cette 
augmentation et identifier une épidémie potentielle. Cette investigation doit combiner autant les 
données épidémiologiques que microbiologiques afin d'évaluer les possibles transmissions de 
patient à patient et/ou la possibilité d'une source commune. 
Le typage des souches bactériennes permet de mesurer la similarité génétique entre elles. 
Si des souches sont génétiquement très similaires, on suspecte fortement qu'elles appartiennent 
à la même chaîne de transmission. Les méthodes de typage conventionnelles examinent 
généralement une fraction du matériel génétique de ces bactéries. Récemment, avec le 
développement du séquençage de nouvelle génération, le génome entier peut être analysé, 
augmentant fortement le pouvoir discriminant de la méthode. 
L’objectif de cette thèse de doctorat était d’évaluer le séquençage complet de génomes 
pour l’investigation épidémiologique des pathogènes nosocomiaux P. aeruginosa et S. aureus.  
Suite à une augmentation de l'incidence de P. aeruginosa aux soins intensifs, le typage moléculaire 
a mis en évidence 3 groupes principaux de patients qui étaient tous infectés par les mêmes 
génotypes. Notre avons utilisé le séquençage complet de génome sur les souches de ces 3 groupes 
pour mieux comprendre s'il y a eu transmissions ou pas. Après une importante phase 
d'optimisation de la méthode d’analyse des données de séquençage complet de génome, les 
résultats ont montré que les souches qui étaient génétiquement très similaires avaient 
effectivement des liens épidémiologiques entre elles (transmissions potentielles). En plus de 
révéler les avantages évidents de l’utilisation de cette méthode pour les enquêtes d'épidémies, 
cette étude a attiré l’attention sur l'influence des programmes bio-informatiques et des 
paramètres utilisés sur les résultats obtenus. 
Il existe deux approches différentes pour analyser les données de séquençage de nouvelle 
génération: l'analyse des mutations ponctuelles (SNP, "single nucleotide polymorphism") ou la 
comparaison gène par gène (wgMLST, "whole genome Multi Locus Sequence Typing"). Nous avons 
voulu évaluer si ces deux méthodes produisaient des résultats identiques. Pour ce faire, nous 
avons utilisé une collection de souches d'une épidémie bien décrite de S. aureus résistant à la 
 méticilline (SARM). Les résultats ont montré des résultats très similaires, confirmant que les deux 
approches peuvent être utilisées pour l'investigation d'épidémies. D'autre part, l’analyse gène-
par-gène, disponible dans le programme commercial BioNumerics, a été simple et rapide sans 
qu’il soit nécessaire d’acquérir de grandes connaissances en bio-informatique. 
En conclusion, cette étude montre comment le séquençage complet de génomes peut être 
une valeur ajoutée aux méthodes classiques utilisées pour les investigations d’épidémies. Il met 
également en évidence les limites de ces méthodes ainsi que leurs avantages et inconvénients. 
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CHAPTER 1. 
General Introduction 
 
1.1. Typing of nosocomial pathogens 
 The main role of bacterial typing is to unveil clonal relatedness between different 
strains within a species (3). Isolates relatedness enables the assessment of the sources 
and routes of infection, confirms or rules out outbreaks, determines cross-transmission 
of nosocomial pathogens, recognizes virulent strains and evaluates the effectiveness of 
the surveillance systems (4, 5). Typing of microorganisms relies on the fact that bacterial 
genomes are constantly undergoing alterations by genetic mechanisms such as point 
mutations, recombination, gene loss or acquisition and horizontal gene transfer (6, 7). 
This genetic diversity within bacterial species leads to the creation of new phenotypes, 
which may have selective advantages in specific ecological niches (8). 
 Choosing a molecular typing method will depend on the need of resolution, on the 
epidemiological context, as well as on the time and geographical scale it is going to be 
applied (3). The method should have intra- and inter-laboratory reproducibility, 
interlaboratory portability, and unequivocal interpretation of results, high throughput 
and appropriateness. In terms of convenience, it must be user-friendly, with low cost, 
rapid and affordable (9, 10). 
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1.1.1. Molecular typing methods 
For many years, traditional typing strategies based on phenotypes have been 
applied in clinical microbiology laboratories. The development of molecular typing 
methods has enabled the introduction of new tools for efficient surveillance and outbreak 
detection. As a result, more efficient infection control programmes and distribution of 
resources were implemented across Europe (3). Several molecular typing methods are 
commonly used to subtype different pathogens, each one with advantages/disadvantages. 
PCR-based methods with high discriminatory power, such as multiplelocus VNTR 
fingerprinting (MLVF) (11), can work rapidly in characterizing isolates to contain local 
outbreaks. If the outbreak has disseminated to various geographical locations, a robust 
typing method like Pulsed-field gel electrophoresis (PFGE) would be more suitable. Due 
to its discriminatory power and applicability to different bacteria , PFGE was considered 
the gold standard method for molecular typing (12). More recent methods, such as 
multilocus VNTR analysis (MLVA), Single locus sequence typing (SLST) (13), multilocus 
sequence typing (MLST) (14), SNP or DNA microarray analysis, allow the typing of isolates 
with a comparable efficiency to PFGE with the advantage that urgent results can be 
acquired rapidly. Since different typing methods are based on the detection of different 
genomic target sequences, variations found with one approach may not be detected when 
applying another typing method. In these cases, combining several different typing 
techniques can add more precise discrimination of bacterial isolates than using solely one 
typing approach (3, 15). Whole genome sequencing (WGS) permits a completely 
unambiguous typing of different bacterial isolates as it can resolve single base differences 
between two genomes. This confers high resolution to genomic epidemiological 
investigation and makes WGS a promising ultimate method for bacterial typing. 
Nonetheless, WGS is still time consuming and expensive in comparison to other 
conventional typing methods. 
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1.1.1.1.  Double locus sequence typing (DLST) 
 Double locus sequence typing is a DNA sequence-based method that relies on 
partial sequencing of two highly variable loci, and it has been successfully used to 
investigate the epidemiology of Staphylococcus aureus and Pseudomonas aeruginosa (16-
19). Similarly to other sequence-based methods, it gives unambiguous definition of types, 
allowing inter laboratory comparisons and high reproducibility. In addition, the use of 96-
well microtiter plates greatly reduces costs and handling time.  
 For such reasons, this method can be incorporated into long term routine surveillance 
programs (16, 17). In the case of P. aeruginosa, the two hypervariable loci consist in ms172 
(partial sequencing of 400 base pairs), and ms217 (350 base pairs) (18). A simple 
representation of both loci is present in Figure 2. For both loci, an arbitrary number is 
assigned to each allele that has a distinct sequence. Hence, the final result consists in two 
numbers that correspond to the DLST type (18). 
 
 
Figure 1. Hypervariable loci ms172 (400 base pairs) and ms217 (350 base pairs) used in the typing of P. 
aeruginosa with DLST. (Adapted from (18)). 
 
 A study comparing DLST and PFGE showed that, although DLST can be valuable as 
a first-line typing tool in the investigation of P. aeruginosa outbreaks due to its simplicity, 
its complementation with more discriminatory methods, such as PFGE or WGS, would 
result in an efficient typing strategy for outbreak investigation (20).  
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1.1.1.2. Whole genome sequencing (WGS) 
 In the past decade, DNA sequencing technologies have made important 
improvements, both quantitatively and qualitatively, increasing accessibility of this 
technology to research and clinical laboratories worldwide. After the completion of the 
first human genome sequence (21), different projects aiming to create new cheaper and 
faster sequencing methods resulted in the development of next generation sequencing 
(NGS) methods (22).  
Advances in the NGS technology resulted in the amelioration of Whole Genome 
Sequencing (WGS). WGS of bacterial isolates is revolutionizing clinical and public health 
microbiology with its increased accessibility, decrease sequencing costs, and optimisation 
of the ‘wet laboratory’ components of NGS (quality and throughput of DNA extraction, 
library preparation and sequencing reactions) (23). It enables accurate and rapid species 
identification, inference of resistome and virulome, and high resolution subtyping 
without the need for multiple diagnostic steps, which currently involve traditional and 
molecular methods (24). However, this technology is still far from being universal. 
 
 WGS enables a single base-pair resolution between isolates, making it an ultimate 
molecular typing technique to study bacteria. Sequencing of bacterial genomes is 
nowadays almost exclusively conducted by Illumina sequencers. Short read sequencing 
performed with Illumina is based on the principle of sequencing-by-synthesis, resulting in 
read sizes of up to 300 base pairs, and in coverage between 30 and 100 reads per base for 
a bacterial genome. Longer reads can be produced by other sequencing technologies, such 
as Pacific Biosciences (PacBio) or Oxford Nanopore’s MinION, allowing the complete 
assembly of bacterial genomes (2). A typical WGS workflow applied to clinical 
microbiology is represented in Figure 2.   
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 Nowadays, with advances in obtaining high quality sequencing data, the major 
problems associated with the implementation of WGS for clinical purposes are focused on 
post-sequencing data analysis (25). Robust, standardized, portable and scalable methods 
are needed for the treatment of WGS results in epidemiological investigations. 
Nevertheless, the existence of an array of bioinformatic tools and approaches for bacterial 
WGS hinders the harmonization between surveillance and investigation (26). These 
bioinformatic tools are used to analyse sequencing data with the assistance of computer-
based algorithms. Open-source and commercially available bioinformatic programs have 
been developed for their use in clinical settings by personnel with few knowledge in 
bioinformatics (27, 28). However, several tools are not able to batch analytical processes 
on large datasets or customize the analysis pipelines according to the difficulties 
encountered during the investigation. Bioinformatic software based on text-based 
command-line in UNIX or Linux operating systems can overcome these disadvantages as 
Figure 2.WGS workflow applied to clinical microbiology. 1)DNA extraction from microbial 
samples. 2) WGS using different next-generation sequencers, Illumina MiSeq and Pacific 
Biosciences RS II. 3) SNP calling from read mapping to a reference. Reads can also be de novo 
assembled into longer contiguous sequences (contigs), and orientated and aligned to form 
scaffolds. 4) The resulting de novo assemblies can be used for further analyses such as typing and 
resistance detection, or can be further finished into a completed or closed genome. 5) Data 
analysis for outbreak investigation, typing, or resistance detection. Closed annotated genomes 
can be used as reference genomes for comparison, or can be analysed in further detai(2). 
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it allows custom programming scripts and pipelines to automate WGS data analysis in a 
single step (25). When choosing the bioinformatic tools that best suit the WGS analysis 
approach for the isolate collection, several factors have to be considered, and they are 
listed in Table 1. 
 Investigation of outbreak isolates can be performed by calling variants based on 
analysis of single nucleotide polymorphisms (SNPs), which offers the highest resolution 
and discrimination, although it is difficult to standardize. Other approaches based on 
gene-by-gene analysis, referred to as core genome (cg) or whole genome (wg) MLST, may 
be advantageous as standardization is easier between laboratories using the same 
scheme. Nevertheless, there is not yet a consensus on the best WGS data analyses 
methodology, as well as on the cut-offs to determine closely related isolates in an outbreak 
(2). 
 
1.2. Nosocomial pathogens 
1.2.1. Pseudomonas aeruginosa 
Pseudomonas aeruginosa is the best-known and studied member of the genus 
Pseudomonas. Members of this genus are gram-negative, rod-shaped, motile bacteria (29) 
and they possess a remarkable metabolic versatility which allows them to colonize very 
different ecological niches, from the environment to the interaction with different hosts 
(30). They are found in water and soil, and on plants, including fruits and vegetables (31). 
Besides colonizing humans, animals and plants, P. aeruginosa is a ubiquitous organism, 
highly disseminated through the environment, mostly in moist and wet niches (32). A 
variety of carbon/energy sources are exploited for growth by P. aeruginosa, such as 
carbohydrates, amino acids, fatty acids and, by preference, tricarboxylic acid 
intermediates (33, 34). 
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Table 1. Criteria to be considered when choosing bioinformatic tools for WGS data analysis. (Adapted from (25)). 
Criteria Explanation 
Usability 
Linux-based tools able to easily customize WGS analyses. Tools operated through a Graphical User Interface (GUI) 
will be preferred by users with little bioinformatics knowledge 
Automation 
Linux-based pipelines capable of ‘batching’ or sequential running of several processes on multiple genomes with 
a single command, compared with running each component individually 
Speed 
Bioinformatic tools able to analyse multiple samples at the same time and perform computer multithreading or 
hyperthreading (split large complex processes into smaller processes running in parallel) 
Accuracy and detail 
While research pursuits require accurate and detailed analyses, the additional resolution from this level of detail is 
not always required for clinical decisions. For example, Bayesian methods have become popular in estimating a 
phylogenetic tree. However, while faster neighbour-joining methods may not produce as accurate an evolutionary 
tree, the resolution is sufficient and rapid analysing a public health outbreak in real time 
Cost 
Free publicly available software for bioinformatic analysis tends to be command line based with low adaptability 
across different sequencing platforms. GUI-based software that can be used with relatively little experience is 
available but at a financial, speed, and sometimes detail, cost 
Documentation and support 
 
Commercial software offers user manuals and professional support for troubleshooting. In open-source software, 
while there is usually some documentation for use but limited support available from open-source software 
developers, many issues require local computing expertise for implementation and troubleshooting 
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Additionally, this bacteria can reduce of nitrogen-containing compounds (35). Its 
ubiquitous growth capacity combined with a high intrinsic resistance against antibiotics 
and disinfectants, as well as the ability to readily acquire resistance mechanisms makes 
P. aeruginosa an important pathogen for humans (36).  
P. aeruginosa population structure is consensually believed to be panmictic-epidemic 
(37-39), i.e. a superficially clonal structure with frequent recombination that creates new 
strains with unique genetic characteristics, in which occasionally highly successful 
epidemic clones arise. In addition, clinical isolates are indistinguishable from 
environmental isolates; and there are no specific clones related to a specific habitat 
selection (39). 
 
1.2.1.1. Genome 
In 2000, Stover et al. published the first complete genome sequence of P. 
aeruginosa (40). This discovery brought new insights on the bacterium as a pathogen, as 
well as on the relationship between genome size, genetic complexity and ecological 
versatility. P. aeruginosa is currently known to have a very large genome varying from 
5.5 to 7 million base pairs that can encode more than 5500 genes. Of this set, more than 
500 are involved in gene regulation, allowing the bacterium to switch on/off phenotypes 
required in specific ecological niches (40, 41). 
P. aeruginosa has a mosaic structure consisting of accessory genomic segments inserted 
in the chromosome at so called “regions of genome plasticity” (RPG) (42). An early 
comparative genomic study done on five genomes showed that approximately 90 % of 
the P. aeruginosa genome is highly conserved with low sequence diversity (0.5-0.7 %). 
However, discrepancies are still observed in the core genome size and the genes that it 
incorporates (43). In combination with deletions, rearrangements and mutations, the 
horizontal gene transfer of accessory genes plays an important role in the evolution of P. 
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aeruginosa genome. Integrative and conjugative elements (ICEs), replacement islands, 
prophages and phage-like elements, transposons, insertion sequences, integrons and, in 
the same strains, extra-chromosomal plasmids compose a great part of the P. aeruginosa 
accessory genome (44). This accessory genome is rich in virulence and in antibiotic 
resistance genes, which contribute to its importance in healthcare settings (45). Large 
inversions and recombination events were observed between different P. aeruginosa 
strains, highlighting the high plasticity of P. aeruginosa chromosome (42). 
 
1.2.1.2. Pathogenesis and virulence factors 
 The opportunistic pathogen P. aeruginosa disseminates from its reservoirs and 
infects animals and humans. In the latter case, it can cause infections in both community 
and hospital settings (39). Community-acquired P. aeruginosa infections can cause 
ulcerative keratitis, external otitis, and skin and soft tissue infections (46). P. aeruginosa 
nosocomial infections are responsible for severe and invasive diseases in critically ill and 
immunocompromised patients (47). This bacterium is the main cause of hospital-
acquired pneumonia in ventilated patients (48). It can cause chronic airway infections in 
patients with bronchiestasis, chronic obstructive bronchopulmonary disease, and cystic 
fibrosis (CF) (41, 49). Bacteraemia caused by P. aeruginosa can occur in neutropenic 
patients undergoing chemotherapy (46, 50). This pathogen is considered the third 
leading cause of nosocomial urinary tract infections (UTIs), which can happen through 
ascending and descending routes, and usually after catheterization or surgery (51, 52). It 
is extremely probable that a burned patient, or patients with toxic epidermal necrolysis, 
will be exposed to P. aeruginosa during the healing process, due to its presence in the 
environment (53). 
 P. aeruginosa capacity to infect several sites, and its persistence in hostile 
environments, is enabled by the different virulence factors and regulatory mechanisms 
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encoded in this pathogen’s genome. The most common virulence factors are represented 
in Figure 3. 
 
Figure 3. Pseudomonas aeruginosa virulence factors (54). 
 
Virulence factors associated with the bacterial surface are flagella, pili, 
lipopolysaccharides (LPS), components enabling toxin secretion, biofilm formation and 
quorum sensing (QS) (54, 55). The P. aeruginosa cell possesses a single flagellum at the 
pole where shorter pili are also localized (Figure 3). The flagellum is related to this 
bacterium swimming motility in aqueous environments, but it is also involved in biofilm 
dispersal and adhesion to host cells (56, 57). Type IV pili are important adhesins enabling 
the “twitching motility”, which consists of retractile movements that pull bacteria along 
solid surfaces(58). Additionally, pilli can lead to bacterial aggregation forming 
microcolonies in specific tissues, and consequently protecting the pathogen from the 
immune system and antimicrobial treatment (59). LPS is a virulence factor located on the 
outer bacterial membrane. Its detection generates a strong immune defense, triggering 
the inflammatory response, exclusion of external molecules, and enabling interactions 
with antimicrobial agents (60, 61). 
Quorum sensing allows bacteria to regulate their population density and their gene 
expression accordingly (Figure 1). Approximately 6% of the P. aeruginosa genome 
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undergoes regulation by QS systems, which play an important role in biofilm formation 
and toxin production (62, 63). Biofilms consist of highly organized and structured 
microbial communities attached to the surface. These communities are encased in 
extracellular polymeric substances (EPS), which are polymers of polysaccharides, nucleic 
acids, lipids, and proteins that make up to 90 % of the biofilm volume and confer physical 
and chemical robustness to the structure (64, 65). Such composition permits the growth 
of bacteria in a protected mode and allows them to survive in hostile environments (66). 
P. aeruginosa recurs to the type III secretion system (T3SS; Figure 1), a complex pilus-like 
structure, to translocate effector proteins from bacteria, through bacterial membranes 
and into the host cytoplasm using a needle-like appendage that forms a pore in the 
eukaryotic membrane (67). Only four P. aeruginosa effector proteins or toxins have been 
characterized so far: ExoY, ExoS, ExoT, and ExoU (68). The expression of this secretion 
system usually leads to acute invasive infections, resulting in high mortality rates (69). 
Secretion of the exopolysaccharide alginate at the cell surface enhances the adhesion 
capacity and anchor P. aeruginosa to the colonized respiratory epithelium, as in the case 
of respiratory infections (70). Pyocyanin, pyoverdine, alkaline protease, protease IV, 
elastase, phospholipase and exotoxin A, are other examples of secreted proteins that play 
an important role in P. aeruginosa virulence (61).  
 
1.2.1.3. Antimicrobial resistance 
 The problem of P. aeruginosa resistant strains deserves special attention in many 
hospitals worldwide, since they are related with a three-fold higher rate of mortality, a 
nine-fold higher rate of secondary bacteraemia, a two-fold increase in the length of 
hospital stay, and consequently, a real burden in healthcare costs (71, 72). The complete 
sequencing of the P. aeruginosa PAO1 wild strain brought great knowledge on this 
microorganism’s inherent resistance. Due to this bacteria genome’s flexibility, 
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“pathogenicity islands” are capable of easily acquire large mobile genetic elements that 
encode for resistance genes (40). P. aeruginosa genome complexity and versatility 
confers it the capacity to resist a wide variety of antimicrobial agents, posing a serious 
problem in the choice of therapeutic strategies for serious infections (73). 
 P. aeruginosa is intrinsically resistant to most antibiotics due to specific 
mechanisms such as low outer membrane permeability, the presence of multidrug efflux 
transporters, and endogenous antimicrobial inactivation (74, 75). Additionally, 
resistance to antimicrobials can be increased due to acquisition of inheritable traits. Such 
acquired resistance occurs via chromosomal mutations and horizontal transfer of genetic 
elements, such as plasmids, transposons, integrons, prophages, and resistance islands. A 
third type of resistance is known as adaptive resistance and it depends on the adaptation 
of the bacteria to a new antibiotic or environmental stimulus (76). A number of triggering 
factors are responsible for the induction of this type of resistance, including antibiotics, 
biocides, polyamines, pH, anaerobiosis, cations and carbon sources, as well as 
mechanisms like biofilm formation and swarming (77). 
 
 The main classes of anti-pseudomonal agents include ß-lactams, fluoroquinolones 
and aminoglycosides (52, 75, 78). Resistance to ß-lactams involves ß-lactamases, 
chromosomally encoded efflux mechanisms that lead to antibiotic expulsion, and a 
decrease of porins in the outer membrane, which reduce the uptake of the drug (79-81). 
Resistance to fluoroquinolones (ciprofloxacin in particular) involves mutations in the 
DNA gyrase and topoisomerase IV genes (82, 83). Aminoglycosides, as amikacin and 
tobramycin, are used as treatment for patients with CF suffering pulmonary infections 
caused by P. aeruginosa (84). However, due to acquired aminoglycoside-modifying 
enzymes, rRNA methylases and endogenous efflux mechanisms, this class of anti-
pseudomonal antibiotics is associated with high resistance occurrence (85).  
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 In 2015, the European Antimicrobial Resistance Surveillance Network (EARS-Net) 
reported the currently active antimicrobial groups against P. aeruginosa. The list included 
some fluoroquinolones (e.g. ciprofloxacin and levofloxacin), aminoglycosides (e.g. 
gentamicin, tobramycin and amikacin), some beta-lactams (piperacillin + tazobactam, 
ceftazidime, cefepime, imipenem, doripenem, meropenem and the new ceftolozane-
tazobactam) and polymyxins (polymyxin B and colistin) (86). In addition, this report 
showed that most of the countries had resistance percentages above 10% for all 
antimicrobial groups under surveillance (piperacillin-tazobactam, ceftazidime, 
fluoroquinolones, aminoglycosides, and carbapenems), suggesting that antimicrobial 
resistance in P. aeruginosa is common in Europe; the previously observed (2011-2014) 
decreasing trends for fluoroquinolone and aminoglycoside resistance and increasing 
trend for piperacillin + tazobactam resistance in P. aeruginosa continued in 2015; lastly, 
13.7% of the P. aeruginosa isolates (N= 12711) were resistant to at least three 
antimicrobial groups, and 5.5% were resistant to all five examined antimicrobial groups 
(86).  
 
1.2.1.4. Molecular typing of P. aeruginosa  
 P. aeruginosa possesses a very complex ecology. For that reason, only powerful 
typing methods can give insight on the relatedness of strains, and consequently on the 
routes of colonization and/or infection (87). Different molecular typing methods have 
been used to investigate this pathogen’s epidemiology. 
 The high discriminatory power of PFGE gave it the connotation of “gold standard” 
for DNA fingerprinting of many microorganisms, as in the case of P. aeruginosa (88-90). 
However, this method as several disadvantages, like long analysis time, the use of 
expensive and specialized equipment, and is labor-intensive which make it not the 
optimal method to be used in a large investigation (90, 91). Multiple-locus variable 
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number tandem repeat (MLVA), which characterizes each isolate by the number of 
repeats in several loci, has also been applied in different P. aeruginosa typing schemes 
(92, 93). Nevertheless, the definition of types is ambiguous thus hindering inter-
laboratory standardization (94). Multi-locus sequence typing (MLST) relies on partial 
sequencing of seven genes of the core genome and showed to be efficient in the study of 
the global population structure of P. aeruginosa (95). Several studies on P. aeruginosa 
population genetics were performed using this technique, but it was not discriminatory 
enough to investigate local epidemiology (96). More recent studies on the P. aeruginosa 
evolution and dissemination in hospital settings have been conducted by recurring to 
whole genome sequencing (WGS) (97-99).  
 
1.2.1.5. Epidemiology of P. aeruginosa in the Intensive Care Units (ICUs) 
 Pseudomonas aeruginosa accounts for 11 – 14% of nosocomial infections. These 
values reach even higher percentages, 13 – 23%, when the infection is acquired in ICUs 
(100, 101). Upon admission in ICUs, approximately 2 – 13% of individuals are colonized 
with P. aeruginosa, and 1% is already infected with this pathogen (102). Although its 
incidence may vary from unit to unit, and from study to study, P. aeruginosa is commonly 
identified as the most frequent microorganism in burn units, being the cause of a large 
number of wound infections, bacteraemia and ventilator-associated pneumonia in these 
units (103, 104).  
 
 A general overview of the P. aeruginosa epidemiology in the ICU suggests that 
colonization is a crucial aspect to be taken into account, since it represents the true 
bacterial load within ICUs (105). Outbreak occurrence in ICUs was thought to be mainly 
caused by environmental sources. Thus, after implementation of control measures, 
several studies showed a reduction of outbreaks (106, 107). In addition to environmental 
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reservoirs, P. aeruginosa was also found to be part of the endogenous microbiota of 2.6 
to 24% of the hospitalized patients (32, 108).  
 
1.2.1.6. P. aeruginosa in the University Hospital of Lausanne 
 In 1998, a molecular epidemiological investigation on P. aeruginosa possible 
sources and transmission was performed in the University Hospital of Lausanne (109). It 
reported that the acquisition of P. aeruginosa from faucets as an exogenous source was 
an important cause of infection and colonization in ICU patients, during a nonepidemic 
period. Infection control measures were implemented and consequently decreased the 
incidence of P. aeruginosa infection and colonization in patients hospitalized in the ICU, 
showing its efficiency in the presence of an environmental reservoir and patient to 
patient transmission (110).  
 Another study conducted in the same hospital investigated whether P. aeruginosa 
infections in ICU patients were due to endogenous or exogenous sources (111). This 
study covered a longitudinal period of 10 years, from 1998 to 2007, and used the 
molecular typing techniques PFGE (1998-2004) and DDSL (2007). The authors 
concluded that the relative contribution of endogenous and exogenous reservoirs to the 
colonization and infection of ICU patients with this bacterium varies over time.  
 More recently, an unexplained increase in P. aeruginosa incidence was observed 
in this hospital’s ICUs over a two-year period (112). Clinical and environmental isolates 
retrieved during the study period were typed using DLST. Several DLST types were found 
among the isolates. The largest cluster, DLST cluster 1-18, comprised the highest number 
of patients hospitalized mainly in the burn unit during overlapping periods of time.  This 
DLST type was also found in the environment of the hydrotherapy room. In conclusion, 
the use of a novel molecular typing method, DLST, lead to the identification of the 
environmental source of a large burn unit outbreak, which was successfully eradicated 
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after implementation of a continuous surveillance of DLST type 1-18 P. aeruginosa in the 
ICUs 
 
1.2.2. Staphylococcus aureus 
Staphylococcus aureus is a Gram-positive, coagulase-positive pathogen belonging 
to the family Staphylococcaceae. This bacterium is spherical, approximately 1 μm in 
diameter and forming grape-like clusters (113). S. aureus is considered a commensal 
bacterium normally present asymptomatically on skin, skin glands, and mucous 
membranes, as well as on the nasopharynx, throat, and intestinal tract in 30% of humans 
(113, 114). This colonization facilitates the acquisition of infections, normally by the S. 
aureus strain the affected individual carries as commensal (115). S. aureus is the most 
clinically important staphylococcal species being responsible for a variety of diseases and 
clinical outcomes (114). Some of the disease manifestations of this pathogen are 
bloodstream, skin, soft tissue and lower respiratory tract infections, but it can also cause 
infections related to medical devices and severe deep-seated infections, such as 
endocarditis and osteomyelitis (116). S. aureus is capable of causing disease in diverse 
physical settings. Clones of S. aureus causing both health-care and community acquired 
infections have emerged in the past years. These clones transport specific traits 
responsible for S. aureus adaptability to diverse environments with different selective 
pressures (117). Additionally, S. aureus colonizes and causes opportunistic infections in 
a variety of animal species apart from humans, e.g. livestock-associated infections (118). 
This capacity of adapting to different environmental and anatomical niches in several 
host species classifies S. aureus as an exceptionally versatile pathogen.  
Studies on the population structure of S. aureus, using techniques such as PFGE or 
MLST, have demonstrated the high clonality of this bacterium’s population (119). Such 
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findings are consistent with the perspective that S. aureus is not naturally transformable, 
as opposed to other recombining species (120, 121)  
 
1.2.2.1. Genome 
Whole genome sequencing was used to investigate the resistance and virulence 
mechanisms of S. aureus. Methicillin-resistant Staphylococcus aureus (MRSA) strains 
N315 and Mu50 were the first staphylococcal genomes to be sequenced (122) followed 
by a number of other strains (123-125). The S. aureus genome is approximately 2.8 Mbp 
in size and have a relatively low G+C content. Most regions of the staphylococcal genome 
are well conserved while several blocks demonstrate high variability, probably due to 
horizontal acquisition of these genomic islands. Integration of these islands must have, at 
least initially, required DNA recombination (integrase) genes (126). However, it has been 
reported that variation from point mutation was 15-fold more frequent than 
recombination, suggesting that the latter is not the major contributor for genetic 
variation in S. aureus (119). The above-mentioned variable blocks normally carry 
virulence and antibiotic resistance determinants implicated in the development of 
staphylococcal diseases, such as as prophages, pathogenicity islands, or staphylococcal 
cassette chromosomes.  
 
1.2.2.2. Pathogenesis and virulence factors 
 When S. aureus is initially exposed to host tissues beyond the mucosal surface or 
skin, an upregulation of virulence genes occurs (127). On the other hand, host phagocytes 
and epithelial cells in the skin and mucosal tissue respond to bacterial products or tissue 
injury by immune system activation. S. aureus  α-toxin, β-toxin, and PVL are implicated in 
pneumonia and lung injury. Both α-toxin and Panton-Valentine leukocidin (PVL) 
produced by S. aureus are pore-forming toxins, which exaggerate the host inflammatory 
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response by inducing the expression of proinflammatory cytokines and lysing 
inflammatory cells to release additional inflammatory mediators (128). S. aureus can 
overcome opsonisation by complement and antibodies through the expression of a 
capsule, clumping factor A, protein A, and several complement inhibitors on its surface. 
All of these will prevent host opsonins from binding or targeting the bacterium for 
destruction(129).  
 In addition to host immune defence evasion, bacterial survival within the host 
relies on the successful acquisition of nutrients, such as iron. S. aureus is able to secrete 
aureochelin and staphyloferrin during iron starvation, which are high affinity iron-
binding particles(130) . 
 Another virulence mechanism of clinical significance is biofilm formation which 
allows S. aureus to persist on plastics and resist host defences or antibiotics (131). Small 
colony variants aid S. aureus to survive in a metabolically inactive state under harsh 
conditions. This virulence factor has been implicated in chronic infections, e.g. 
osteomyelitis (132). 
 
 Methicillin-resistant S. aureus (MRSA) deserves special consideration when 
discussing S. aureus pathogenesis as it possesses a distinct epidemiology particularly 
marked by morbidity and mortality (129). In 2005, invasive diseases and deaths 
attributable to MRSA were 94,360 and 18,650, respectively, in the United States, 
overcoming mortality rates attributed to HIV (133). Hospital- and community-acquired 
MRSA are two genotypically different groups of MRSA that target different but 
overlapping populations and cause different diseases. HA-MRSA became increasingly 
problematic in the 1990’s especially in intensive care unit settings where it became a 
major cause of nosocomial infections (134). This pathogen’s chromosome contains large 
staphylococcal cassettes (SCCmec types I-III), which encodes one (SCCmec type I) or 
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multiple antibiotic resistance genes (SCCmec type II and III). Such high resistance to 
antibiotics probably was the cause for this bacterium’s survival in an environment where 
antibiotic use is frequent (129).  
 
1.2.2.3. Molecular typing of S. aureus 
 Phenotypic methods, like phage typing and protein profiling, were used in 
variation investigations of S. aureus populations. Early Staphylococcus taxonomists 
helped to define staphylococcal biotypes but they correlated loosely with their host 
species association based on phenotypic markers like coagulation of human and bovine 
plasma, production of fibrinolysin, crystal violet reaction type, beta haemolytic activity, 
and phage susceptibility(135). From there after, the development of molecular typing 
techniques provided increasing resolution for distinguishing S. aureus isolates and 
understanding its population structure. With multilocus enzyme electrophoresis (MLEE) 
it was possible to infer allelic variation among S. aureus strains based on electrophoresis 
of housekeeping enzymes with varying charge(136). PFGE was considered by several 
authors as the gold standard for outbreak investigation (90). DNA-based molecular 
approaches such as multilocus sequence typing (MLST) allowed the investigation of 
genetic diversity between strains of the same species (14). Combination of allelic variants 
is used to assign a sequence type (ST), and S. aures STs that share alleles at ≥5 loci are 
considered to belong to the same clonal complex (CC) (137). Due to the availability and 
affordability of DNA sequence technology, several sequenced-based typing methods are 
now widely used, such as MLST and spa typing (138), which are the most frequently used 
for S. aureus. Characterization of S. aureus isolates is now done though combination of 
different techniques (including the SCCmec type for the characterization of MRSA 
strains). Nonetheless, the amount of sequencing MLST requires and the high number of 
primers needed to identify SCCmec types as new types impede the combination of these 
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methods for clonal characterization due to cost-related reasons. Consequently, SeqNet 
(http://www.seqnet.org), the European Network of Laboratories for Sequence Based 
Typing of Microbial Pathogens, suggested spa typing as the primary sequence-based 
method for determining genetic relatedness of S. aureus isolates (137).  
 Improvement of the WGS technology in recent years has affected the typing of 
several pathogens, including S. aureus. Figure 4 shows the increasing number of studies 
on general S. aureus population biology along with nosocomial investigations using WGS 
(137)  
 
Figure 4. Chronology of different studies on S. aureus population biology(137). 
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CHAPTER 2. 
Use of open-access bioinformatic 
tools to investigate P. aeruginosa 
 
2.1. Objectives 
 An unexplained increase in P. aeruginosa incidence was observed in the ICUs of 
the University Hospital of Lausanne from 2010 to 2014. During this period, the retrieved 
clinical and environmental isolates were typed by the double locus sequence typing 
(DLST) method. Numerous DLST clusters were identified, from which three harboured 
the highest number of patients: cluster 1-18 (N= 24), 6-7 (N= 22), and 1-21 (N= 16). DLST 
cluster 1-18 isolates were believed to be part of an outbreak in the burn unit (ICU 3), as 
it was epidemiologically well described before (112). The remaining two DLST types 
showed sporadic occurrence with only few cases of possible transmission between 
patients. . The principal objective of this project is to further investigate these three major 
DLST clusters using the higher discriminatory power of whole genome sequencing. 
Therefore, the following tasks will be executed: 
 
 Construction of the P. aeruginosa isolates phylogeny for each DLST cluster; 
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 When a definite and accurate phylogenetic tree is achieved, environment-to-
patient and patient-to-patient transmission events suspected by epidemiological 
data will be confirmed/ruled out; 
 Genetic characterization of each cluster 
 
2.2. Material and Methods 
2.2.1. Bacterial isolates and molecular typing  
P. aeruginosa isolates were collected from patients hospitalized in the five ICUs of 
the University Hospital of Lausanne over a five-year period. From 2010 to 2014, clinical 
and environmental isolates were typed by the double locus sequence typing (DLST) 
method previously developed by our group(18). Three major DLST clusters, i.e. clusters 
with the highest number of patients, were further analysed in this study: DLST cluster 1-
18 (24 patients), 6-7 (22 patients), and 1-21 (16 patients). At least one isolate per patient 
was included. If several isolates were collected from one patient, only isolates sampled 
15 days apart were selected, unless they belonged from different sample types. All 
environmental isolates from the three DLST clusters (mainly from sink traps) were 
considered. A total of 74 DLST 1-18 isolates (55 clinical and 19 environmental), 50 DLST 
6-7 isolates (38 clinical and 12 environmental), and 31 DLST 1-21 isolates (18 clinical 
and 13 environmental) were selected for whole genome sequencing. 
 
2.2.2. Epidemiological investigation 
Epidemiological data (unit and room of hospitalization, dates of ICU admission and 
discharge, and clinical diagnosis) was retrieved from the hospital databases and used to 
construct epidemiological maps and annotate the phylogenetic trees. Epidemiological 
links between patients or environment were identified as: (i) patients hospitalized during 
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overlapping periods in the same ICU, or (ii) patients showing an identical DLST type with 
an environmental sample isolated in the same unit during the period of the study. 
 
2.2.3. DNA extraction and whole genome sequencing 
We extracted genomic DNA from a 5ml Lysogenic Broth (LB) culture, acquired 
from single colonies and incubated to reach an early exponential phase, using the 
GenElute bacterial genomic DNA kit (SIGMA-ALDRICH, St. Louis, MO, USA). Whole 
genome sequencing was performed on 155 P. aeruginosa clinical and environmental 
isolates by the Lausanne Genomic Technologies Facility (GTF, University of Lausanne). 
The sequencing libraries were prepared using the Nextera DNA Library Preparation Kit 
(Illumina, Inc., San Diego, CA, USA) for 100-bp paired-end sequencing runs on Illumina 
HiSeq 2500, aiming for a 100-fold coverage. 
 
2.2.4. Analysis of WGS data 
 WGS was performed on 155 clinical and environmental DLST 1-18 (94), DLST 1-
21 (31), and DLST 6-7(50) isolates, retrieved from 2004-2014, using Illumina HiSeq. 
Reads quality metrics were assessed with FastQC. Isolates’ sequence type (ST) was 
assigned from the short reads data by the Short Read Sequence Typing 2 (SRST2) 
software (139). It defined DLST cluster 1-18, 1-21, and 6-7 as ST1076, ST253, and ST17, 
respectively. Two methodologies based on mapping raw reads against a reference, SNPs 
analysis, and phylogeny construction were used in this project. No complete reference 
genomes belonging to ST1076 or ST17 were published thus far, hence we used a well-
known ST253 reference strain, P. aeruginosa UCBPP-PA14 (accession number: 
NC_008463; (140)), for the “mapping against a reference” step in both methodologies. 
Additionally, the mapping step in the two procedures was performed against a complete 
reference genome for each ST created by combining both PacBio (Pacific Biosciences) and 
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Illumina HiSeq sequencing of the index case of each DLST cluster (Patient 2 isolate for 
DLST 1-18). These three reference genomes were submitted to Microbiology Resource 
Announcements, from the American Society for Microbiology journal and the genome 
announcement is currently under revision (Chapter 3). 
 
2.2.4.1. Standard methodology 
The bioinformatic analysis of our sequenced data was defined according to a 
thorough literature search on outbreak investigation of several nosocomial pathogens 
(141-143). The chosen scheme included essentially open access programs which were 
responsible each for several steps of the methodology (Figure 5).  
 
Figure 5. Schematic representation of the different steps included in the standard methodology. 
 
Genome alignment of each DLST cluster isolates was acquired with Snippy 
(https://github.com/tseemann/snippy) by mapping against the two reference genomes 
previously mentioned under default parameters (minimum mapping quality of 60, 
minimum coverage of variant site of 10, and minimum proportion for variant evidence of 
0.9). Putative phages present in the reference genomes were searched with PHASTER 
(144) and repeat regions were identified with a homemade script (developed by Dr. 
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Benoit Valot, University of Franche-Comté, France) and afterwards masked from 
the genome alignment. The final single nucleotide polymorphisms (SNPs) alignment was 
obtained by excluding regions of high SNPs density indicative of recombination. Gubbins 
(145) was the software used for that purpose by applying the default parameters: 
minimum of three SNPs to be considered a recombination block, maximum window of 
1000, and a minimum window of 100. A maximum likelihood tree was constructed from 
the final SNPs alignment using the PhyML algorithm implemented in Seaview version 4.7 
(146). Tree visualization was done with FigTree version 1.4.3.  
 
2.2.4.2. Adapted methodology 
 The basis of both methodologies is very similar, yet there are differences in 
relation to the programs used and the quality filtering applied. A scheme of the second 
procedure used to analyse the P. aeruginosa sequences is present in Figure 6 and the 
addition of two steps in highlighted in red. 
 
 
Figure 6. . Schematic representation of the different steps included in the adapted methodology. 
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A first step of subsampling the number of raw reads to reach the lower read depth 
observed (70x) was added to provide comparable accuracy in the posterior analysis, as 
well as to reduce mapping time (147). The subsampled reads were then mapped against 
their respective complete reference genome with BWA-MEM. Variant calling was 
performed with FreeBayes with a minimum mapping quality of 60 and a minimum 
proportion for variant evidence of 0.9. A series of other in-house scripts was applied to 
the variant call format (VCF) file (lists each position where a SNP is detected along with 
several characteristics associated with this SNP, e.g. nucleotide change, quality value, or 
the applied filtering) acquired after SNP calling with FreeBayes. An in-house script was 
used for identification of recombination regions: it determines a threshold for SNP 
density according to the data being analysed and lists the regions of high SNP density to 
be masked above this threshold. A probability to remove regions of high SNP density of 
0.001 and a window size of 2000 was used for recombination detection. Additionally, an 
in-house script performed repeat region identification. Putative phages found with 
PHASTER (144) along with repeat regions and potential recombination regions were 
excluded from the genome alignment. The VCF file was then filtered with other in-house 
scripts applying the following parameter thresholds: minimum quality of base 
assignement of 100 and a minimum read by allele to report a SNP of 20. A maximum 
likelihood tree was constructed from the final core SNPs alignment using the PhyML 
algorithm implemented in Seaview version 4.7 (146). Tree visualization was done with 
FigTree version 1.4.3.  
 
2.2.4.3. Visualization of SNP differences data 
 The SNPs sequence alignment in FASTA acquired with both methodologies was 
converted to a pairwise SNP distance matrix using a script deposited in GitHub 
(https://github.com/tseemann/snp-dists). A heatmap was constructed from the 
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pairwise SNP distance matrix using the heatmap.2 function present in the gplots package 
implemented in R (http://www.R-project.org.). Using the same pairwise matrix as input, 
the ggplot2 package in R was applied to plot the frequency of the number of SNP 
differences observed in the dataset. 
 
2.3. Results 
2.3.1. Different epidemiology of the three DLST clusters 
To infer possible epidemiological links between patients of the same DLST cluster 
and/or between patients and environmental isolates, the hospitalization period, the ICU 
where the hospitalization occurred, and the ICUs environmental sampling of P. 
aeruginosa were investigated and are schematically represented in Figure7. DLST cluster 
1-18 was previously considered responsible for an outbreak in the burn unit from 2010 
to 2012 (112). From the 24 patients harboring this DLST type, 18 were hospitalized in 
the burn unit (ICU 3), and six in other ICUs. Several epidemiological links were found 
between the patients hospitalized in the burn unit which shared the same hydrotherapy 
shower room, during overlapping hospitalization periods. The first patient observed 
harbouring this DLST type was hospitalized in ICU5 and was not epidemiologically linked 
to other patients infected with the same type. Links between environmental isolates, 
mainly from the shower room and sink traps, and patients hospitalized in the same ICU 
were also found. 
Only two epidemiological links were identified for DLST cluster 1-21; one between 
two patients hospitalized in the same ICU (ICU 2), and one between those patients and an 
environmental sample retrieved from a sink trap in the same ICU. The remaining patients 
were dispersed through the six ICUs during the study period, except in 2013 when no 
patient was found to be colonized or infected with this DLST type (Figure 7). Such 
behaviour suggests DLST cluster 1-21 was not considered to be the cause of an outbreak.  
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Three epidemiological links were found between DLST cluster 6-7 patients 
hospitalized in the burn unit, in 2010. Thereafter, no epidemiological links were 
suspected as patients were not hospitalized in the same ICU during overlapping periods 
of time, and no epidemiological links between patients and environmental sources were 
observed. Similarly to DLST cluster 1-21, this DLST type occurred sporadically 
throughout the study period and was not responsible for an outbreak. 
 
 
 
Figure 7. Epidemiological maps of the three different DLST types. The first panel corresponds to patients 
harbouring DLST 1-18 (N=24), the second to DLST 1-21 (N=16), and the third to DLST 6-7 (N=22). Each 
line represents the hospitalization period of each patient from 2010 to 2014. Units where patients were 
hospitalized are differentiated by colors. Stars represent the first isolation of P. aeruginosa for each 
patient. 
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2.3.2. Different DLST clusters belonged to different sequence types 
Among the different genotyes, DLST cluster 1-18, 1-21, and 6-7 comprised the 
highest number of patients and were chosen for posterior analysis with WGS. Although 
DLST allows inter laboratory comparison of genotypes (17), the universal standard of 
MLST is still widely used for strain comparison. Therefore, the Illumina HiSeq raw reads 
were used to identify the STs present in the isolate collection. MLST results defined DLST 
1-18, 1-21, and 6-7 isolates as STs 1076, 253, and 17, respectively. 
 
2.3.3. Standard methodology with mapping against P. aeruginosa PA14 
A bioinformatic pipeline was created by resorting to open access tools selected 
according to previously published studies on outbreak investigation using WGS. Although 
the basic steps of this methodology have been used for WGS data analysis of P. aeruginosa 
isolates, the combination of programs used in this study was only reported for the 
investigation of other pathogens (2, 148) 
 
DLST 1-18 phylogeny was divided in two clades (definition of clade being a group 
of all the descendants from a common ancestor): one clade subdivided in two subclades 
and the other in three, each one with both clinical and environmental isolates (Figure 8). 
Most of DLST 1-18 isolates were distanced by 20 to 100 SNPs. Patient 1 (Figure 9), which 
was not hospitalized in the burn unit and had no epidemiological link with the outbreak, 
clustered within one of the subclades at the tip of a long branch representative of 100 to 
200 SNP differences in relation to other isolates. Isolates retrieved from the same patient 
also exhibited and unexpected high number of SNPs between them. Patient 4 isolates 
sampled less than one week apart were located in different subclades of the phylogenetic 
tree (Figure 8, in pink). Three isolates from 
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Figure 8. DLST 1-18 maximum likelihood tree based on the SNPs alignment obtained with the standard methodology, mapping against P. aeruginosa PA14. Non-outbreak 
isolates belonging to Patient 1 are highlighted in grey, and clustered apart from the remaining isolates. Isolates from Patient 4 and 23 are highlighted in pink and blue, 
respectively.  
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Patient 21_R | 22.04.2012 | ICU4 
Patient 8 | 28.02.2011 | ICU3 
Patient 20 | 18.03.2012 | ICU3 
Patient 17_R | 11.12.2011 | ICU3 
Env. 6 | 23.03.2012 | ICU3 
Patient 16 | 30.01.2012 | ICU3 
Patient 17_R | 18.02.2012 | ICU3 
Patient 17_R | 01.02.2012 | ICU3 
Patient 24 | 04.12.2012 | ICU3 
Patient 18_R | 03.01.2012 | ICU3 
Patient 16 | 01.02.2012 | ICU3 
Patient 16 | 01.03.2012 | ICU3 
Patient 8 | 13.03.2011 | ICU3 
Patient 4 | 13.04.2011 | ICU3 
Patient 20 | 13.04.2012 | ICU3 
Patient 15_R | 16.10.2011 | ICU3 
Patient 20 | 16.03.2012 | ICU3 
Patient 2_R | 28.05.2010 | ICU3 
Patient 13_R | 26.07.2011 | ICU3 
Patient 4 | 10.05.2011 | ICU3 
Patient 11_R | 06.06.2011 | ICU4 
Env. 10 | 27.07.2012 | ICU 4/5 
Patient 12_R | 25.07.2011 | ICU4 
Patient 4 | 01.03.2011 | ICU3 
Patient 4 | 18.04.2011 | ICU3 
Patient 19_R | 13.03.2012 | ICU3 
Env. 5 | 23.03.2012 | ICU3 
Patient 3_R | 28.08.2010 | ICU3 
Env. 2 | 23.03.2012 | ICU3 
Env. 18 | 25.01.2013 | ICU3 
Patient 4 | 03.04.2011 | ICU3 
Patient 9 | 18.05.2011 | ICU3 
Env. 11 | 24.10.2012 | ICU3 
Patient 16 | 08.12.2012 | ICU3 
Env. 12 | 25.01.2013 | ICU3 
Env. 14 | 25.01.2013 | ICU3 
Patient 9 | 04.04.2011 | ICU3 
Patient 9 | 08.06.2011 | ICU3 
Env. 9 | 17.07.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Patient 23_RR | 18.10.2012 | ICU3 
Env. 1 | 10.10.2011 | ICU3 
Patient 16 | 15.02.2012 | ICU3 
Env. 15 | 25.01.2013 | ICU3 
Env. 13 | 25.01.2013 | ICU3 
Env. 17 | 25.01.2013 | ICU3 
Patient 9 | 01.07.2011 | ICU3 
Env. 7 | 23.03.2012 | ICU3 
Patient 5_R | 24.01.2011 | ICU3 
Patient 20 | 22.03.2012 | ICU3 
Env. 16_R | 25.01.2013 | ICU3 
Patient 13_R | 14.07.2011 | ICU3 
Patient 8_R | 22.02.2011 | ICU3 
Patient 22_R | 25.06.2012 | ICU3 
Patient 19_R | 27.02.2012 | ICU3 
Patient 21_R | 03.05.2012 | ICU4 
Patient 21_R | 25.04.2012 | ICU4 
Env. 8 | 27.04.2012 | ICU4 
Patient 6_R | 30.01.2011 | ICU3 
Patient 12_R | 26.06.2011 | ICU4 
Patient 4 | 13.01.2011 | ICU3 
Patient 20 | 04.03.2012 | ICU3 
Patient 14 | 10.10.2011 | ICU ped 
Patient 9 | 21.03.2011 | ICU3 
Patient 7 | 01.02.2011 | ICU1 
Patient 16 | 07.12.2011 | ICU3 
Patient 3 | 15.08.2010 | ICU3 
Patient 10_R | 02.05.2011 | ICU3 
Patient 11 | 11.06.2011 | ICU4 
Patient 23 | 18.10.2012 | ICU3 
Patient 1_R | 31.03.2010 | ICU5 
Patient 1_R | 24.04.2010 | ICU5 
Patient 23 | 25.10.2012 | ICU3 
Figure 9. DLST 1-18 color heatmap showing pairwise genomic distances obtained with the standard methodology, mapping against P. 
aeruginosa PA14. Number of SNP differences between pairs of isolates are displayed in each square. Each line corresponds to an isolate. 
Isolate’s identification on the columns from left to right: Patient 23 (first isolate) to Patient 21 (last isolate). Different colors represent 
different SNP differences’ limits:10, 20, 50, 100, 150, 200, and 300. A white line on the color legend plot pictures the frequency of each 
number of SNP differences. 
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Patient 23 belonged to the same subclade with a high number of SNP differences (80-121 
SNPs). Interestingly, two Patient 23 isolates collected seven days apart clustered together 
with 121 SNPs between them. In spite of being considered responsible for an outbreak, 
DLST 1-18 demonstrated a minimum number of 24 SNPs between two isolates from 
different patients and a maximum number of 206. Plotting the frequency of observed 
SNPs in this isolate collection helped visualize a pique around 40 SNPs, which afterwards 
decreased to a smaller count of an increasingly higher number of SNPs (Figure 10). 
DLST 1-21 phylogeny was divided in numerous clades and subclades (Figure 12) 
distantly related to each other with a high number of SNPs among them supporting the 
assumption that this cluster was not responsible for an outbreak (Figure 11). Patient 8 
hospitalized in the paediatric ICU clustered apart from the remaining isolates with 81 to 
114 SNP differences (Figure 11 and 12). The previously suspected epidemiological link 
between isolates from three patients and the environment (Figure 12, in blue) was 
confirmed as no SNP differences were found between them. Two isolates retrieved two 
years apart, from two patients hospitalized in different ICUs, shared only nine SNP 
differences. Interestingly, a low number of SNPs (<15 SNPs) was observed between 
environmental isolates retrieved ten years apart (Figure 12, in orange). Eight 
environmental isolates collected from different sink traps in the burn unit (ICU3) were 
closely related mostly with less than 10 SNP differences, except for environmental sample 
13 retrieved in May 2013 which showed a slightly higher number of differences (<15 
SNPs). Isolates belonging to the same patient, from Patient 2 and Patient 6, showed 4 and 
5 SNP differences between them, respectively. The count of number of SNP differences 
observed between DLST 1-21 isolates depicted a low frequency of a highly variable 
number of SNPs, with a maximum of 114 SNPs (Figure 10). 
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(B) 
(C) 
(A) 
Figure 10. Frequency of number of SNP differences obtained with the standard 
methodology, mapping against P. aeruginosa PA14, for (A) DLST 1-18, (B) DLST 1-21, and 
(C) DLST 6-7. 
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Env. 2_R | 23.12.2004 | ICU ped 
Env. 12 | 07.03.2013 | ICU5 
Env. 1_R | 18.05.2004 | ICU ped 
Patient 16 | 01.09.2014 | ICU5 
Patient 10 | 31.03.2012 | ICU2 
Env. 5 | 02.04.2012 | ICU2 
Patient 11 | 10.04.2012 | ICU2 
Patient 12 | 07.11.2012 | ICU4 
Patient 5 | 27.10.2010 | ICU2 
Patient 4 | 02.09.2010 | ICU4 
Patient 1 | 08.01.2010 | ICU5 
Patient 3 | 18.05.2010 | ICU1 
Patient 13 | 04.12.2012 | ICU1 
Patient 6  | 31.12.2011 | ICU5 
Patient 6  | 28.02.2011 | ICU5 
Patient 9 | 13.03.2012 | ICU5 
Patient 15 | 08.08.2014 | ICU5 
Env. 6 | 27.04.2012 | ICU5 
Patient 7 | 03.04.2011 | ICU2 
Patient 14 | 02.02.2013 | ICU ped 
Patient 2 | 29.04.2010 | ICU5 
Patient 2 | 03.05.2010 | ICU5 
Env. 8 | 07.12.2012 | ICU3 
Env. 10 | 25.01.2013 | ICU3 
Env. 7 | 13.11.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Env. 9 | 25.01.2013 | ICU3 
Env. 11 | 25.01.2013 | ICU3 
Env. 13 | 29.05.2013 | ICU3 
Patient 8 | 08.12.2011 | ICU ped 
Figure 11. DLST 1-21 color heatmap showing pairwise genomic distances obtained with the standard methodology, mapping against P. aeruginosa PA14. 
Number of SNP differences between pairs of isolates are displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns 
from left to right: Env. 13 (first isolate) to Env.2_R (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. The 
frequency of each number of SNP differences is pictured by a white line on the color legend plot. 
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Figure 12. DLST 1-21 maximum likelihood tree based on the SNPs alignment obtained with the standard methodology, mapping against P. aeruginosa PA14. Three 
environmental isolates retrieved between 2004 and 2013 are highlighted in orange; isolates from two patients and an environmental sample collected from ICU2 are 
highlighted in blue; subclade of environmental isolates from the burn unit are highlighted in green.  
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DLST 6-7 results showed that Patient 22 was distantly related to the remaining 
isolates with more than 800 SNP differences (Figure 13 and 14). One of the subclades 
represented in the phylogenetic tree (Figure 14) was composed in majority by isolates 
retrieved from the burn unit (Figure 14, in green). These isolates belonged to patients 
hospitalized during the same period in the burn unit. However, a high number of SNPs 
was still observed between them (>50 SNPs). Patient 11 and environmental isolates all 
retrieved from ICU2 clustered together in the phylogenetic tree (Figure 2.7, in blue), 
nonetheless with a high number of SNPs as observed before (>50 SNPs). One isolate from 
Patient 4 comprised in this subclade was associated with a long branch representative of 
more than 200 SNPs in relation to the remaining isolates. Another subclade harbouring 
five environmental isolates retrieved from both ICU3 and ICU4 clustered with the burn 
unit subclade with also more than 50 SNP differences. Isolates from the same patient 
retrieved less than two weeks apart had a high number of SNP differences between them, 
e.g. Patient 12 (85-124 SNPs). Two long branches respective to environmental samples 1 
and 11 were detected (>200 SNPs). Figure 10 shows an elevated frequency of 
approximately 125 SNPs and in a smaller proportion from 750 to 1000 SNPs, suggesting 
most of the isolates were not closely related.  
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Patient 11 | 18.11.2011 | ICU2 
Patient 11 | 07.11.2011 | ICU2 
Env 10 | 07.11.2012 | ICU2 
Env 15 | 04.03.2014 | ICU2 
Patient 20 | 26.04.2014 | ICU2 
Patient 11 | 06.12.2011 | ICU2 
Env 9 | 30.07.2012 | ICU2 
Env 14 | 20.03.2013 | ICU2 
Env 3 | 02.04.2012 | ICU2 
Patient 18 | 11.10.2013 | Not ICU - Ped 
Patient 21 | 13.10.2014 | ICU2 
Patient 14 | 07.10.2012 | ICU1 
Patient 14 | 26.09.2012 | ICU1 
Patient 7 | 21.05.2011 | ICU1 
Patient 7 | 04.05.2011 | ICU1 
Patient 7 | 19.04.2011 | ICU1 
Patient 12 | 09.04.2013 | ICU1 
Patient 12 | 21.03.2013 | ICU1 
Patient 9 | 30.07.2011 | ICU4 
Patient 13 | 04.05.2012 | ICU5 
Patient 10 | 26.08.2011 | ICU1 
Patient 16 | 17.05.2013 | ICU3  
Patient 5 | 10.09.2010 | ICU3  
Patient 2 | 20.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 3 | 25.07.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 4 | 30.08.2010 | ICU3  
Patient 2 | 10.07.2010 | ICU3  
Patient 5 | 15.08.2010 | ICU3  
Patient 1 | 06.04.2010 | ICU3  
Patient 2 | 02.06.2010 | ICU3  
Env 4 | 03.04.2012 | ICU4 
Env 2 | 10.10.2011 | ICU3  
Env 12 | 08.11.2012 | ICU4 
Env 8 | 17.07.2012 | ICU3  
Env 5 | 27.04.2012 | ICU4 
Patient 17 | 30.05.2013 | ICU1 
Patient 12 | 15.04.2012 | ICU1 
Patient 19 | 10.01.2014 | ICU2 
Patient 15 | 12.12.2012 | ICU ped 
Env 6 | 27.04.2012 | ICU4 
Patient 8 | 21.07.2011 | ICU ped 
Patient 6 | 16.09.2010 | ICU2 
Env 7 | 17.07.2012 | ICU3  
Env 13 | 11.12.2012 | ICU3 
Env 1 | 10.10.2011 | ICU2 
Env 11 | 07.11.2012 | ICU2 
Patient 4 | 03.08.2010 | ICU3  
Patient 22 | 15.10.2014 | ICU5 
Figure 13. DLST 6-7 color heatmap showing pairwise genomic distances obtained with the standard methodology, mapping against P. aeruginosa PA14. 
Number of SNP differences between pairs of isolates are displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the 
columns from left to right: Patient 22 (first isolate) to Patient 11 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, 
150, 200, 400, and 1000. The frequency of each number of SNP differences is pictured by a white line on the color legend plot.   
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Figure 14. DLST 6-7 maximum likelihood tree based on the SNPs alignment obtained with the standard methodology, mapping against P. aeruginosa PA14. Patient 22 
clustered apart from the remaining isolates. A subclade of isolates from the burn unit suspected to be epidemiologically linked are highlighted in green. Another subclade, 
in blue, is composed of isolates from Patient 11 and environmental isolates retrieved from ICU2. An example of isolates belonging to the same patient, Patient 12, is 
highlighted in green. Two long branches belonging to Env. 1 and Env. 11 are highlighted in red. 
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2.3.4. Adapted methodology with mapping against P. aeruginosa PA14 
 To understand if the odd number of SNPs observed in clusters 1-18 and 6-
7 with the standard bioinformatic methodology was an accurate representation of our 
data or if it was due to artefacts, we decided to deconstruct the original methodology and 
complement it with additional steps. Only the isolates mentioned in the previous results 
for the first methodology will be used as example for a comparison measure between 
different methodologies. This information is summarized for each DLST type in Tables 2 
to 4.  
A drastic decrease in SNP differences was found for DLST 1-18 when analysed with 
the adapted methodology (Table 2).  
Table 2. SNP differences (range) between DLST 1-18 isolates from the same patient when analysed with 
the standard and adapted methodology, by mapping against PA14 and PacBio references, when applying a 
mapping quality (MQ) value of 20 or 60, and when using a minimum of 20 or 10 reads to consider a SNP 
site. 
DLST 1-18 
Isolates 
Standard 
methodology 
Adapted methodology 
PA14 PacBio PA14 PacBio 
  20 MQ 60 MQ 20 MQ 60 MQ 
  20 reads 10 reads 20 reads 10 reads 20 reads 10 reads 20 reads 10 reads 
Patient 1  
(2 isolates) 
48 12 14 14 11 11 13 13 12 12 
Patient 4  
(6 isolates) 
31-73 0-6 2-9 3-9 0-6 0-7 0-8 0-8 0-7 0-7 
Patient 23  
(3 isolates) 
81-121 2-5 8-11 10-13 2-5 2-5 2-5 2-5 0-2 0-2 
 
 Phylogeny of DLST 1-18 acquired with the adapted methodology demonstrated 
that isolates from Patient 1 were distantly related to the remaining collection, although 
with a slightly lower number of SNPs (91-101) (Figure 15 and 16). Several subclades were 
still observed (Figure 16), nonetheless most of the isolates shared only less than 10 SNPs 
except for one isolate belonging to Patient 16 (<13 SNPs). Five of six isolates from Patient 
4 were present on the same subclade but all were closely related (<10 SNPs), 
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Patient 19_R | 13.03.2012 | ICU3 
Env. 1 | 10.10.2011 | ICU3 
Patient 17_R | 18.02.2012 | ICU3 
Patient 17_R | 01.02.2012 | ICU3 
Env. 7 | 23.03.2012 | ICU3 
Patient 4 | 03.04.2011 | ICU3 
Patient 9 | 18.05.2011 | ICU3 
Patient 8 | 13.03.2011 | ICU3 
Patient 20 | 16.03.2012 | ICU3 
Patient 13_R | 14.07.2011 | ICU3 
Env. 2 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 9 | 17.07.2012 | ICU3 
Patient 3_R | 28.08.2010 | ICU3 
Patient 3 | 15.08.2010 | ICU3 
Patient 6_R | 30.01.2011 | ICU3 
Patient 23 | 18.10.2012 | ICU3 
Env. 11 | 24.10.2012 | ICU3 
Patient 20 | 04.03.2012 | ICU3 
Patient 9 | 01.07.2011 | ICU3 
Patient 13_R | 26.07.2011 | ICU3 
Patient 9 | 08.06.2011 | ICU3 
Patient 23 | 25.10.2012 | ICU3 
Patient 16 | 08.12.2012 | ICU3 
Patient 19_R | 27.02.2012 | ICU3 
Env. 6 | 23.03.2012 | ICU3 
Patient 16 | 07.12.2011 | ICU3 
Patient 16 | 01.02.2012 | ICU3 
Patient 16 | 15.02.2012 | ICU3 
Patient 16 | 01.03.2012 | ICU3 
Env. 5 | 23.03.2012 | ICU3 
Patient 18_R | 03.01.2012 | ICU3 
Patient 24 | 04.12.2012 | ICU3 
Patient 4 | 10.05.2011 | ICU3 
Patient 12_R | 26.06.2011 | ICU4 
Patient 4 | 18.04.2011 | ICU3 
Patient 11_R | 06.06.2011 | ICU4 
Patient 4 | 01.03.2011 | ICU3 
Patient 11 | 11.06.2011 | ICU4 
Patient 4 | 13.04.2011 | ICU3 
Env. 10 | 27.07.2012 | ICU 4/5 
Patient 12_R | 25.07.2011 | ICU4 
Patient 21_R  | 25.04.2012 | ICU4 
Patient 21_R  | 03.05.2012 | ICU4 
Patient 21_R  | 22.04.2012 | ICU4 
Env. 8 | 27.04.2012 | ICU4 
Patient 8 | 28.02.2011 | ICU3 
Patient 20 | 22.03.2012 | ICU3 
Patient 20 | 13.04.2012 | ICU3 
Patient 20 | 18.03.2012 | ICU3 
Env. 12 | 25.01.2013 | ICU3 
Patient 9 | 21.03.2011 | ICU3 
Env. 17 | 25.01.2013 | ICU3 
Patient 14 | 10.10.2011 | ICU ped 
Env. 16_R | 25.01.2013 | ICU3 
Env. 15 | 25.01.2013 | ICU3 
Env. 14 | 25.01.2013 | ICU3 
Patient 5_R | 24.01.2011 | ICU3 
Env. 13 | 25.01.2013 | ICU3 
Env. 18 | 25.01.2013 | ICU3 
Patient 15_R | 16.10.2011 | ICU3 
Patient 17_R | 11.12.2011 | ICU3 
Patient 4 | 13.01.2011 | ICU3 
Patient 23_RR | 18.10.2012 | ICU3 
Patient 2_R | 28.05.2010 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Patient 10_R | 02.05.2011 | ICU3 
Patient 8_R | 22.02.2011 | ICU3 
Patient 7 | 01.02.2011 | ICU1 
Patient 22_R | 25.06.2012 | ICU3 
Patient 9 | 04.04.2011 | ICU3 
Patient 16 | 30.01.2012 | ICU3 
Patient 1_R | 24.04.2010 | ICU5 
Patient 1_R | 31.03.2010 | ICU5 
Figure 15. DLST 1-18 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. aeruginosa PA14 with 
mapping quality of 60 and minimum of 10 reads to consider a SNP site. Number of SNP differences between pairs of isolates are displayed in each square. 
Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 1 (first isolate) to Patient 19 (last isolate). Different colors 
represent different SNP differences’ limits:10, 20, 50, 100, and 150. The frequency of each number of SNP differences is pictured by a white line on the color 
legend plot.  
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Figure 16. DLST 1-18 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against P. 
aeruginosa PA14 with mapping quality of 60 and minimum of 10 reads to consider a SNP site. Non-outbreak isolates belonging to Patient 1 are 
highlighted in grey, and clustered apart from the remaining isolates. Isolates from Patient 4 and 23 are highlighted in pink and blue, respectively. 
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(B) 
 
(C) 
 
 
Figure 17. Frequency of number of SNP differences obtained with the adapted methodology, mapping 
against P. aeruginosa PA14 with mapping quality of 60 and minimum of 10 reads to consider a SNP site, 
for (A) DLST 1-18, (B) DLST 1-21, and (C) DLST 6-7. 
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Patient 23 isolates were separated in different subclades with 2 to five SNPs between 
them, and the long branch associated with a Patient 23 isolate (25 October 2012) was no 
longer observed. As clearly depicted on the graph of number of SNP differences frequency 
(Figure 17) minimum of 0 SNPs and a maximum of 101 SNPs (<13 SNPs excluding Patient 
1) was found between DLST 1-18 isolates when analysed with the second pipeline. 
 Regarding DLST 1-21, no major differences were found between both 
methodologies (Figure 18 and 19). The small change in SNP differences obtained with the 
adapted methodology are listed in Table 3. 
 
 
 DLST 1-21 
Isolate 
Standard 
methodology 
Adapted methodology 
PA14 PacBio PA14 PacBio 
   20 MQ 60 MQ 20 MQ 60 MQ 
    20 reads 10 reads 20 reads 10 reads 20 reads 10 reads 20 reads 10 reads 
ICU2 link  
(3 isolates)  
0  1-3  0-1 0-1 0 0  0-1 0-1 0-1 1 
Patient 5 and 12  
(2 isolates) 
9  6  5 5 4 4  6 6 6 6 
Environmental 
isolates 10 years 
apart (3 isolates) 
12-15  12-13 11-14 11-15 11-13 11-14  11-13 11-14 11-13 11-14  
Subclade ICU3  
(8 isolates) 
<15  <12  <17 <17 <11 <11  <11 <11 <11 <11  
Same patient 4-5  1-3  1-4  1-4 2-4 2-4  1-4 1-4 2-4 0-4  
 
 
Table 3. SNP differences (range) between specific DLST 1-21 isolates when analysed with the standard and 
adapted methodology, by mapping against PA14 and PacBio references, when applying a mapping quality 
(MQ) value of 20 or 60, and when using a minimum of 20 or 10 reads to consider a SNP site. 
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Figure 18. DLST 1-21 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against 
P. aeruginosa PA14 with mapping quality of 60 and minimum of 10 reads to consider a SNP site. Three environmental isolates retrieved 
between 2004 and 2013 are highlighted in orange; isolates from two patients and an environmental sample collected from ICU2 are 
highlighted in blue; subclade of environmental isolates from the burn unit are highlighted in green.  
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Env. 5 | 02.04.2012 | ICU2 
Patient 11 | 10.04.2012 | ICU2 
Patient 10 | 31.03.2012 | ICU2 
Patient 16 | 01.09.2014 | ICU5 
Patient 12 | 07.11.2012 | ICU4 
Patient 5 | 27.10.2010 | ICU2 
Patient 4 | 02.09.2010 | ICU4 
Patient 1 | 08.01.2010 | ICU5 
Patient 3 | 18.05.2010 | ICU1 
Patient 13 | 04.12.2012 | ICU1 
Patient 6  | 31.12.2011 | ICU5 
Patient 6  | 28.02.2011 | ICU5 
Patient 14 | 02.02.2013 | ICU ped 
Patient 7 | 03.04.2011 | ICU2 
Env. 6 | 27.04.2012 | ICU5 
Patient 9 | 13.03.2012 | ICU5 
Patient 2 | 03.05.2010 | ICU5 
Patient 2 | 29.04.2010 | ICU5 
Patient 15 | 08.08.2014 | ICU5 
Env. 2_R | 23.12.2004 | ICU ped 
Env. 12 | 07.03.2013 | ICU5 
Env. 1_R | 18.05.2004 | ICU ped 
Env. 11 | 25.01.2013 | ICU3 
Env. 10 | 25.01.2013 | ICU3 
Env. 9 | 25.01.2013 | ICU3 
Env. 8 | 07.12.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 7 | 13.11.2012 | ICU3 
Env. 13 | 29.05.2013 | ICU3 
Patient 8 | 08.12.2011 | ICU ped 
Figure 19. DLST 1-21 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. aeruginosa PA14 
with mapping quality of 60 and minimum of 10 reads to consider a SNP site. Number of SNP differences between pairs of isolates are displayed in each 
square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 8 (first isolate) to Env. 5 (last isolate). 
Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. The frequency of each number of SNP differences is pictured by a 
white line on the color legend plot.  
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 Similarly to DLST 1-18, the number of SNPs between DLST 6-7 isolates also 
decreased greatly with the adapted methodology (Table 4). Patient 22 did not cluster 
apart from the remaining isolates although it still shared a high number of SNPs with them 
(70-279 SNPs) (Figure 20 and 21). Isolates retrieved from the burn unit suspected to be 
epidemiologically linked were genetically similar with less than 10 SNP differences. 
Environmental isolates retrieved from the burn unit and ICU2 which clustered with the 
burn unit subclade were 22 to 32 SNPs apart. A subclade composed of Patient 11 and 
environmental samples from ICU2 showed less than 14 SNPs as opposed to more than 50 
SNPs acquired with the standard pipeline. The number of SNPs also decreased drastically 
between isolates from the same patient (7-30 SNPs). Patient 2 isolates (Figure 21, in 
orange) differed only by 7 to 12 SNPs. Figure 17 shows that most of DLST 6-7 patients 
were distantly related with 50 to 150 SNPs, with a minimum of 2 SNPs between isolates 
and a maximum of 429 SNPs. 
Table 4. SNP differences (range) between specific DLST 6-7 isolates when analysed with the standard and 
adapted methodology, by mapping against PA14 and PacBio references, when applying a mapping quality 
(MQ) value of 20 or 60, and when using a minimum of 20 or 10 reads to consider a SNP site. 
 
 DLST 6-7 
Isolate 
Standard 
methodology 
Adapted methodology 
PA14 PacBio PA14 PacBio 
  20 MQ 60 MQ 20 MQ 60 MQ 
  20 reads 10 reads 20 reads 10 reads 20 reads 10 reads 20 reads 10 reads 
Burn unit subclade 
(11 isolates) 
62-227 0-17 3-24 4-26 2-22 2-23 0-13 0-13 0-13 0-13 
Subclade ICU2 
(7 isolates) 
81-135 2-14 1-12 1-12 3-14 3-14 0-9 0-9 0-7 0-7 
Same patient 78-93 0-8 7-24 7-24 7-20 7-20 1-6 1-6 1-6 1-6 
Patient 12 
(3 isolates) 
85-124 0-1 7-11 7-11 7-12 7-12 1-2 1-2 1-2 1-2 
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Patient 11 | 18.11.2011 | ICU2 
Env 9 | 30.07.2012 | ICU2 
Patient 11 | 06.12.2011 | ICU2 
Patient 11 | 07.11.2011 | ICU2 
Env 10 | 07.11.2012 | ICU2 
Env 3 | 02.04.2012 | ICU2 
Env 14 | 20.03.2013 | ICU2 
Patient 20 | 26.04.2014 | ICU2 
Env 15 | 04.03.2014 | ICU2 
Patient 21 | 13.10.2014 | ICU2 
Patient 12 | 15.04.2012 | ICU1 
Patient 12 | 21.03.2013 | ICU1 
Patient 12 | 09.04.2013 | ICU1 
Patient 10 | 26.08.2011 | ICU1 
Patient 16 | 17.05.2013 | ICU3  
Patient 14 | 26.09.2012 | ICU1 
Patient 14 | 07.10.2012 | ICU1 
Patient 18 | 11.10.2013 | Not ICU - Ped 
Patient 7 | 19.04.2011 | ICU1 
Patient 7 | 21.05.2011 | ICU1 
Patient 13 | 04.05.2012 | ICU5 
Patient 7 | 04.05.2011 | ICU1 
Patient 9 | 30.07.2011 | ICU4 
Patient 19 | 10.01.2014 | ICU2 
Patient 17 | 30.05.2013 | ICU1 
Patient 8 | 21.07.2011 | ICU ped 
Patient 6 | 16.09.2010 | ICU2 
Patient 15 | 12.12.2012 | ICU ped 
Patient 22 | 15.10.2014 | ICU5 
Env 6 | 27.04.2012 | ICU4 
Env 13 | 11.12.2012 | ICU3 
Env 7 | 17.07.2012 | ICU3  
Patient 4 | 30.08.2010 | ICU3  
Patient 2 | 20.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 02.06.2010 | ICU3  
Patient 3 | 25.07.2010 | ICU3  
Patient 5 | 10.09.2010 | ICU3  
Patient 2 | 10.07.2010 | ICU3  
Patient 4 | 03.08.2010 | ICU3  
Patient 5 | 15.08.2010 | ICU3  
Patient 1 | 06.04.2010 | ICU3  
Env 5 | 27.04.2012 | ICU4 
Env 4 | 03.04.2012 | ICU4 
Env 8 | 17.07.2012 | ICU3  
Env 2 | 10.10.2011 | ICU3  
Env 12 | 08.11.2012 | ICU4 
Env 11 | 07.11.2012 | ICU2 
Env 1 | 10.10.2011 | ICU2 
Figure 20. DLST 6-7 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. aeruginosa PA14 
with mapping quality of 60 and minimum of 10 reads to consider a SNP site. Number of SNP differences between pairs of isolates are displayed in each 
square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Env. 1 (first isolate) to Patient 11 (last isolate). 
Different colors represent different SNP differences’ limits:10, 20, 50, 100,150, 200, 400, and 600. The frequency of each number of SNP differences is 
pictured by a white line on the color legend plot.  
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Figure 21. DLST 6-7 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against 
P. aeruginosa PA14 with mapping quality of 60 and minimum of 10 reads to consider a SNP site. A subclade of isolates from the burn 
unit suspected to be epidemiologically linked are highlighted in green. Another subclade, in blue, is composed of isolates from Patient 
11 and environmental isolates retrieved from ICU2. An example of isolates belonging to the same patient, Patient 12, is highlighted in 
green. Two long branches belonging to Env. 1 and Env. 11 are highlighted in red. 
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2.3.5. Standard methodology with mapping against the PacBio reference 
 At the start of this study, only available complete genomes were published 
belonging to ST253 (DLST 1-21), and not for the other two ST found in our isolate 
collection: ST1076 (DLST 1-18) and ST17 (DLST 6-7). Thus, we decided to use the well-
known reference genome from P. aeruginosa PA14 (ST253) for the mapping step in both 
tested bioinformatic pipelines. However, it is known that the use of a closely related 
reference genome to the isolate collection can overcame challenges during the analysis 
and help to determine with more accuracy outbreak and non-outbreak isolates (2). 
Considering the weight of the reference in the analysis we decided to construct a 
reference genome from the index case of each DLST cluster, as described in Section 3.6. 
Here we present the results of WGS analysis with the standard methodology using the 
corrected PacBio references instead of P. aeruginosa PA14, also summarized in Tables 2 
to 4. 
 
 Interestingly, the use of a closely related reference genome decreased greatly the 
number of SNPs between DLST 1-18 isolates, as it was observed when using the stricter 
adapted methodology (Table 2). Isolates from Patient 1 were considered again genetically 
distant from the remaining isolates (105-118 SNPs) (Figure 22). Although the tree 
topology was similar to the ones observed in previous results (Figure 22), the number of 
SNPs between most of the isolates was less than ten, with only a minority having less than 
15 SNP differences between them. Once again, five out of six isolates from Patient 4 
clustered together with less then 13 SNP differences. Patient 23 isolates were separated 
on the phylogenetic tree although only by 2 to 5 SNPs, and no long branch associated with 
one of the isolates was observed. The minimum number of SNPs between DLST 1-18 
isolates was zero and maximum was 118 (Figure 24), with the rest of the isolates being 
genetically similar with less then 13 SNPs apart. 
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Env. 1 | 10.10.2011 | ICU3 
Patient 18_R | 03.01.2012 | ICU3 
Patient 4 | 03.04.2011 | ICU3 
Patient 9 | 01.07.2011 | ICU3 
Patient 13_R | 26.07.2011 | ICU3 
Patient 9 | 08.06.2011 | ICU3 
Patient 15_R | 16.10.2011 | ICU3 
Patient 17_R | 11.12.2011 | ICU3 
Patient 17_R | 01.02.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 2 | 23.03.2012 | ICU3 
Env. 9 | 17.07.2012 | ICU3 
Patient 3 | 15.08.2010 | ICU3 
Patient 6_R | 30.01.2011 | ICU3 
Patient 3_R | 28.08.2010 | ICU3 
Patient 19_R | 13.03.2012 | ICU3 
Env. 7 | 23.03.2012 | ICU3 
Patient 8 | 13.03.2011 | ICU3 
Patient 20 | 16.03.2012 | ICU3 
Env. 11 | 24.10.2012 | ICU3 
Patient 23 | 18.10.2012 | ICU3 
Patient 22_R | 25.06.2012 | ICU3 
Patient 8 | 28.02.2011 | ICU3 
Patient 20 | 04.03.2012 | ICU3 
Patient 23 | 25.10.2012 | ICU3 
Patient 16 | 01.03.2012 | ICU3 
Patient 16 | 01.02.2012 | ICU3 
Patient 19_R | 27.02.2012 | ICU3 
Env. 6 | 23.03.2012 | ICU3 
Patient 16 | 07.12.2011 | ICU3 
Patient 16 | 08.12.2012 | ICU3 
Env. 5 | 23.03.2012 | ICU3 
Patient 24 | 04.12.2012 | ICU3 
Patient 17_R | 18.02.2012 | ICU3 
Patient 21_R  | 25.04.2012 | ICU4 
Env. 8 | 27.04.2012 | ICU4 
Patient 21_R  | 22.04.2012 | ICU4 
Patient 21_R  | 03.05.2012 | ICU4 
Patient 20 | 22.03.2012 | ICU3 
Patient 20 | 18.03.2012 | ICU3 
Patient 20 | 13.04.2012 | ICU3 
Patient 12_R | 26.06.2011 | ICU4 
Patient 11_R | 06.06.2011 | ICU4 
Patient 11 | 11.06.2011 | ICU4 
Patient 4 | 13.04.2011 | ICU3 
Patient 4 | 01.03.2011 | ICU3 
Patient 4 | 10.05.2011 | ICU3 
Patient 4 | 18.04.2011 | ICU3 
Patient 12_R | 25.07.2011 | ICU4 
Env. 10 | 27.07.2012 | ICU 4/5 
Patient 16 | 30.01.2012 | ICU3 
Patient 16 | 15.02.2012 | ICU3 
Patient 5_R | 24.01.2011 | ICU3 
Patient 14 | 10.10.2011 | ICU ped 
Patient 9 | 21.03.2011 | ICU3 
Env. 12 | 25.01.2013 | ICU3 
Env. 13 | 25.01.2013 | ICU3 
Env. 14 | 25.01.2013 | ICU3 
Env. 15 | 25.01.2013 | ICU3 
Env. 16_R | 25.01.2013 | ICU3 
Env. 17 | 25.01.2013 | ICU3 
Env. 18 | 25.01.2013 | ICU3 
Patient 7 | 01.02.2011 | ICU1 
Patient 10_R | 02.05.2011 | ICU3 
Patient 9 | 18.05.2011 | ICU3 
Patient 13_R | 14.07.2011 | ICU3 
Patient 4 | 13.01.2011 | ICU3 
Patient 23_RR | 18.10.2012 | ICU3 
Patient 2_R | 28.05.2010 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Patient 9 | 04.04.2011 | ICU3 
Patient 8_R | 22.02.2011 | ICU3 
Patient 1_R | 24.04.2010 | ICU5 
Patient 1_R | 31.03.2010 | ICU5 
Figure 22. DLST 1-18 color heatmap showing pairwise genomic distances obtained with the standard methodology, mapping against the PaCBio 
reference. Number of SNP differences between pairs of isolates are displayed in each square. Each line corresponds to an isolate. Isolate’s identification 
on the columns from left to right: Patient 1 (first isolate) to Env.1 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, 
and 150. The frequency of each number of SNP differences is pictured by a white line on the color legend plot.  
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Figure 23. DLST 1-18 maximum likelihood tree based on the SNPs alignment obtained with the standard methodology, 
mapping against the PacBio reference. Non-outbreak isolates belonging to Patient 1 are highlighted in grey, and clustered 
apart from the remaining isolates. Isolates from Patient 4 and 23 are highlighted in pink and blue, respectively. 
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Figure 24. Frequency of number of SNP differences obtained with the standard methodology, mapping 
against the PacBio reference, for (A) DLST 1-18, (B) DLST 1-21, and (C) DLST 6-7. 
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For DLST 1-21, applying the original methodology with mapping against the 
PacBio reference gave similar results to when both methodologies were performed with 
P. aeruginosa PA14 (Figure 25 and 26). However, one difference was in the number of 
SNPs between isolates suspected to be epidemiologically linked which instead of zero, 
showed 1-3 SNPs differences. Additional minor changes in SNPs are present in Table 3.  
 This methodology also lead to a lower number of SNPs between DLST 6-7 isolates 
(Figure 27 and 28). Results were very similar to the ones achieved with the adapted 
methodology using PA14, except for environmental sample 1 being genetically distant 
from the remaining isolates and not considered just a long branch as before. Other slight 
SNPs differences in the results are present in Table 4, as no additional clear change was 
detected. 
 
2.3.6. Adapted methodology with mapping against the PacBio reference 
As was done for the previous bioinformatic schemes, the SNP differences of specific 
isolates discussed in the results are summarized in Table 2 to 4. Patient 1clustered far 
apart from the remaining isolates with a maximum of 120 SNPs between a pair of isolates 
(Figure 29 and 30). Several subclades were identified comprising both clinical and 
environmental isolates, however most of the outbreak isolates were closely related with 
less than 10 SNP differences. Isolates retrieved from the same patient, although some 
were separated on the phylogenetic tree, were genetically different by only less then 10 
SNPs differences, e.g. Patient 4 (<7 SNPs) and Patient 23 (0-2 SNPs). The number of SNP 
differences count (Figure 31) demonstrated that the maximum of differences observed 
between a pair of isolates is 16 and the minimum is zero, except for isolates belonging to 
Patient 1 (120 SNPs). 
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Patient 11 | 10.04.2012 | ICU2 
Env. 5 | 02.04.2012 | ICU2 
Patient 10 | 31.03.2012 | ICU2 
Patient 12 | 07.11.2012 | ICU4 
Patient 5 | 27.10.2010 | ICU2 
Patient 4 | 02.09.2010 | ICU4 
Env. 2_R | 23.12.2004 | ICU ped 
Env. 1_R | 18.05.2004 | ICU ped 
Env. 12 | 07.03.2013 | ICU5 
Patient 16 | 01.09.2014 | ICU5 
Patient 13 | 04.12.2012 | ICU1 
Patient 1 | 08.01.2010 | ICU5 
Patient 3 | 18.05.2010 | ICU1 
Patient 6  | 31.12.2011 | ICU5 
Patient 6  | 28.02.2011 | ICU5 
Patient 9 | 13.03.2012 | ICU5 
Patient 15 | 08.08.2014 | ICU5 
Env. 6 | 27.04.2012 | ICU5 
Patient 7 | 03.04.2011 | ICU2 
Patient 14 | 02.02.2013 | ICU ped 
Patient 2 | 29.04.2010 | ICU5 
Patient 2 | 03.05.2010 | ICU5 
Env. 11 | 25.01.2013 | ICU3 
Env. 9 | 25.01.2013 | ICU3 
Env. 8 | 07.12.2012 | ICU3 
Env. 10 | 25.01.2013 | ICU3 
Env. 7 | 13.11.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 13 | 29.05.2013 | ICU3 
Patient 8 | 08.12.2011 | ICU ped 
Figure 25. DLST 1-21 color heatmap showing pairwise genomic distances obtained with the standard methodology, mapping against the PaCBio reference. Number of 
SNP differences between pairs of isolates are displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right:  
Patient 8 (first isolate) to Patient 11 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. The frequency of each number of 
SNP differences is pictured by a white line on the color legend plot.  
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Figure 26. DLST 1-21 maximum likelihood tree based on the SNPs alignment obtained with the standard methodology, mapping against the 
PacBio reference. Three environmental isolates retrieved between 2004 and 2013 are highlighted in orange; isolates from two patients and 
an environmental sample collected from ICU2 are highlighted in blue; subclade of environmental isolates from the burn unit are highlighted 
in green.  
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Env 3 | 02.04.2012 | ICU2 
Env 9 | 30.07.2012 | ICU2 
Patient 11 | 07.11.2011 | ICU2 
Env 14 | 20.03.2013 | ICU2 
Patient 11 | 18.11.2011 | ICU2 
Patient 11 | 06.12.2011 | ICU2 
Env 10 | 07.11.2012 | ICU2 
Patient 20 | 26.04.2014 | ICU2 
Env 15 | 04.03.2014 | ICU2 
Patient 21 | 13.10.2014 | ICU2 
Patient 12 | 15.04.2012 | ICU1 
Patient 12 | 09.04.2013 | ICU1 
Patient 12 | 21.03.2013 | ICU1 
Patient 7 | 21.05.2011 | ICU1 
Patient 7 | 19.04.2011 | ICU1 
Patient 7 | 04.05.2011 | ICU1 
Patient 13 | 04.05.2012 | ICU5 
Patient 10 | 26.08.2011 | ICU1 
Patient 16 | 17.05.2013 | ICU3  
Patient 9 | 30.07.2011 | ICU4 
Patient 14 | 07.10.2012 | ICU1 
Patient 14 | 26.09.2012 | ICU1 
Patient 18 | 11.10.2013 | Not ICU - Ped 
Patient 4 | 30.08.2010 | ICU3  
Patient 5 | 10.09.2010 | ICU3  
Patient 3 | 25.07.2010 | ICU3  
Patient 2 | 10.07.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 20.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 02.06.2010 | ICU3  
Patient 5 | 15.08.2010 | ICU3  
Patient 4 | 03.08.2010 | ICU3  
Patient 1 | 06.04.2010 | ICU3  
Env 8 | 17.07.2012 | ICU3  
Env 2 | 10.10.2011 | ICU3  
Env 4 | 03.04.2012 | ICU4 
Env 12 | 08.11.2012 | ICU4 
Env 5 | 27.04.2012 | ICU4 
Env 6 | 27.04.2012 | ICU4 
Patient 8 | 21.07.2011 | ICU ped 
Patient 15 | 12.12.2012 | ICU ped 
Patient 6 | 16.09.2010 | ICU2 
Patient 17 | 30.05.2013 | ICU1 
Patient 19 | 10.01.2014 | ICU2 
Patient 22 | 15.10.2014 | ICU5 
Env 13 | 11.12.2012 | ICU3 
Env 7 | 17.07.2012 | ICU3  
Env 1 | 10.10.2011 | ICU2 
Env 11 | 07.11.2012 | ICU2 
Figure 27. DLST 6-7 color heatmap showing pairwise genomic distances obtained with the standard methodology, mapping against the PaCBio reference. Number of SNP 
differences between pairs of isolates are displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Env 11 
(first isolate) to Env 3 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, 150,200, 400, and 600. The frequency of each number of 
SNP differences is pictured by a white line on the color legend plot. 
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Figure 28. DLST 6-7 maximum likelihood tree based on the SNPs alignment obtained with the standard methodology, mapping against the 
PacBio reference. A subclade of isolates from the burn unit suspected to be epidemiologically linked are highlighted in green. Another 
subclade, in blue, is composed of isolates from Patient 11 and environmental isolates retrieved from ICU2. An example of isolates belonging 
to the same patient, Patient 12, is highlighted in green. Two long branches belonging to Env. 1 and Env. 11 are highlighted in red. 
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Patient 3 | 15.08.2010 | ICU3 
Patient 23_RR | 18.10.2012 | ICU3 
Patient 14 | 10.10.2011 | ICU ped 
Env. 4 | 23.03.2012 | ICU3 
Env. 7 | 23.03.2012 | ICU3 
Patient 15_R | 16.10.2011 | ICU3 
Patient 8 | 13.03.2011 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 17 | 25.01.2013 | ICU3 
Patient 9 | 18.05.2011 | ICU3 
Env. 2 | 23.03.2012 | ICU3 
Patient 13_R | 14.07.2011 | ICU3 
Env. 9 | 17.07.2012 | ICU3 
Patient 2_R | 28.05.2010 | ICU3 
Patient 9 | 04.04.2011 | ICU3 
Patient 23 | 18.10.2012 | ICU3 
Env. 14 | 25.01.2013 | ICU3 
Patient 4 | 13.01.2011 | ICU3 
Env. 18 | 25.01.2013 | ICU3 
Patient 9 | 21.03.2011 | ICU3 
Env. 12 | 25.01.2013 | ICU3 
Patient 6_R | 30.01.2011 | ICU3 
Patient 8_R | 22.02.2011 | ICU3 
Patient 10_R | 02.05.2011 | ICU3 
Env. 15 | 25.01.2013 | ICU3 
Patient 22_R | 25.06.2012 | ICU3 
Env. 16_R | 25.01.2013 | ICU3 
Patient 17_R | 11.12.2011 | ICU3 
Patient 5_R | 24.01.2011 | ICU3 
Env. 13 | 25.01.2013 | ICU3 
Patient 20 | 16.03.2012 | ICU3 
Patient 3_R | 28.08.2010 | ICU3 
Patient 7 | 01.02.2011 | ICU1 
Env. 11 | 24.10.2012 | ICU3 
Patient 17_R | 01.02.2012 | ICU3 
Patient 17_R | 18.02.2012 | ICU3 
Patient 19_R | 13.03.2012 | ICU3 
Patient 21_R  | 25.04.2012 | ICU4 
Patient 21_R  | 22.04.2012 | ICU4 
Env. 8 | 27.04.2012 | ICU4 
Patient 21_R  | 03.05.2012 | ICU4 
Patient 8 | 28.02.2011 | ICU3 
Patient 20 | 04.03.2012 | ICU3 
Patient 20 | 18.03.2012 | ICU3 
Patient 20 | 13.04.2012 | ICU3 
Patient 20 | 22.03.2012 | ICU3 
Patient 18_R | 03.01.2012 | ICU3 
Patient 24 | 04.12.2012 | ICU3 
Env. 5 | 23.03.2012 | ICU3 
Env. 1 | 10.10.2011 | ICU3 
Patient 4 | 03.04.2011 | ICU3 
Patient 9 | 01.07.2011 | ICU3 
Patient 13_R | 26.07.2011 | ICU3 
Patient 9 | 08.06.2011 | ICU3 
Patient 23 | 25.10.2012 | ICU3 
Patient 16 | 08.12.2012 | ICU3 
Patient 19_R | 27.02.2012 | ICU3 
Env. 6 | 23.03.2012 | ICU3 
Patient 16 | 07.12.2011 | ICU3 
Patient 16 | 01.02.2012 | ICU3 
Patient 16 | 01.03.2012 | ICU3 
Patient 16 | 15.02.2012 | ICU3 
Patient 12_R | 26.06.2011 | ICU4 
Patient 11_R | 06.06.2011 | ICU4 
Patient 11 | 11.06.2011 | ICU4 
Patient 4 | 13.04.2011 | ICU3 
Patient 4 | 18.04.2011 | ICU3 
Patient 4 | 01.03.2011 | ICU3 
Patient 4 | 10.05.2011 | ICU3 
Patient 12_R | 25.07.2011 | ICU4 
Env. 10 | 27.07.2012 | ICU 4/5 
Patient 16 | 30.01.2012 | ICU3 
Patient 1_R | 24.04.2010 | ICU5 
Patient 1_R | 31.03.2010 | ICU5 
Figure 29. DLST 1-18 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the PaCBio reference with a 
mapping quality of 60 and with a minimum of 10 reads to consider a SNP site. Number of SNP differences between pairs of isolates are displayed in each square. 
Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 1 (first isolate) to Patient 3 (last isolate). Different colors 
represent different SNP differences’ limits:10, 20, 50, 100, and 150. The frequency of each number of SNP differences is pictured by a white line on the color legend 
plot.  
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Figure 30. DLST 1-18 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, 
mapping against the PacBio reference. Non-outbreak isolates belonging to Patient 1 are highlighted in grey, and clustered 
apart from the remaining isolates. Isolates from Patient 4 and 23 are highlighted in pink and blue, respectively. 
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Figure 31. Frequency of number of SNP differences obtained with the adapted methodology, mapping 
against the PacBio reference, for (A) DLST 1-18, (B) DLST 1-21, and (C) DLST 6-7. 
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For DLST 1-21, two isolates from two patients (zero SNPs) and one isolate from 
the environment (Figure 32 and Figure 33, in blue,) showed one SNP difference between 
them. Only six SNP differences were found between two isolates of two patients 
hospitalized in different ICUs (ICU2 and ICU4), retrieved two years apart. A low number 
of SNPs (<14 SNPs) was observed between environmental isolates retrieved ten years 
apart (highlighted in orange). Environmental isolates retrieved from different sink traps 
in the burn unit (ICU3) clustered together with less than 11 SNP differences. Isolates 
belonging to the same patient were closely related with a maximum of 4 SNPs between 
them. SNPs count for this DLST cluster demonstrated a high variability of the number of 
SNPs found, ranging from zero to 116 SNPs between a pair of isolates (Figure 31). 
Figure 35 representing DLST 6-7 cluster phylogeny showed several clades and 
subclades with high number of SNP differences (Figure 34). One subclade (Figure 35, in 
green) was composed by isolates retrieved in the burn unit with less than 13 SNPs 
differences. These isolates belonged to patients for which epidemiological links were 
suspected. Four environmental isolates retrieved from both the burn unit and ICU4 were 
closely related to the burn unit cluster (10-19 SNPS). A adapted subclade was constituted 
by closely related isolates from Patient 11 sampled in ICU2 and environmental isolates 
from the same ICU (0-7 SNPs). All isolates recovered from the same patient clustered 
together with only a few SNPs differences (1-6), e.g. Patient 12 (1-2 SNPs) (Figure 35, in 
yellow). Long branches with more than 200 SNPs associated with two isolates from the 
environment (Env 1, 11) were detected. Most isolates had 50 to 150 SNP differences 
between them, with a maximum of 429 SNPs and a minimum of 2 SNPs (Figure 31).  
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Patient 11 | 10.04.2012 | ICU2 
Patient 10 | 31.03.2012 | ICU2 
Env. 5 | 02.04.2012 | ICU2 
Patient 16 | 01.09.2014 | ICU5 
Patient 12 | 07.11.2012 | ICU4 
Patient 5 | 27.10.2010 | ICU2 
Patient 4 | 02.09.2010 | ICU4 
Patient 1 | 08.01.2010 | ICU5 
Patient 3 | 18.05.2010 | ICU1 
Patient 13 | 04.12.2012 | ICU1 
Patient 6  | 31.12.2011 | ICU5 
Patient 6  | 28.02.2011 | ICU5 
Env. 6 | 27.04.2012 | ICU5 
Patient 9 | 13.03.2012 | ICU5 
Patient 15 | 08.08.2014 | ICU5 
Patient 2 | 03.05.2010 | ICU5 
Patient 2 | 29.04.2010 | ICU5 
Patient 14 | 02.02.2013 | ICU ped 
Patient 7 | 03.04.2011 | ICU2 
Env. 11 | 25.01.2013 | ICU3 
Env. 10 | 25.01.2013 | ICU3 
Env. 9 | 25.01.2013 | ICU3 
Env. 8 | 07.12.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 7 | 13.11.2012 | ICU3 
Env. 13 | 29.05.2013 | ICU3 
Env. 2_R | 23.12.2004 | ICU ped 
Env. 12 | 07.03.2013 | ICU5 
Env. 1_R | 18.05.2004 | ICU ped 
Patient 8 | 08.12.2011 | ICU ped 
Figure 32. DLST 1-21 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the PaCBio reference with a 
mapping quality of 60 and with a minimum of 10 reads to consider a SNP site. Number of SNP differences between pairs of isolates are displayed in each square. 
Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 8 (first isolate) to Patient 11 (last isolate). Different colors 
represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the color legend plot pictures the frequency of each number of SNP differences.  
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Figure 33. DLST 1-21 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against the PaCBio reference with a 
mapping quality of 60 and with a minimum of 10 reads to consider a SNP site. Three environmental isolates retrieved between 2004 and 2013 are highlighted in orange; 
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Patient 7 | 04.05.2011 | ICU1 
Patient 7 | 19.04.2011 | ICU1 
Patient 7 | 21.05.2011 | ICU1 
Patient 13 | 04.05.2012 | ICU5 
Patient 9 | 30.07.2011 | ICU4 
Patient 10 | 26.08.2011 | ICU1 
Patient 16 | 17.05.2013 | ICU3  
Patient 12 | 09.04.2013 | ICU1 
Patient 12 | 21.03.2013 | ICU1 
Patient 12 | 15.04.2012 | ICU1 
Patient 14 | 07.10.2012 | ICU1 
Patient 14 | 26.09.2012 | ICU1 
Patient 18 | 11.10.2013 | Not ICU - Ped 
Env 14 | 20.03.2013 | ICU2 
Env 3 | 02.04.2012 | ICU2 
Env 9 | 30.07.2012 | ICU2 
Patient 11 | 18.11.2011 | ICU2 
Env 10 | 07.11.2012 | ICU2 
Patient 11 | 06.12.2011 | ICU2 
Patient 11 | 07.11.2011 | ICU2 
Patient 20 | 26.04.2014 | ICU2 
Env 15 | 04.03.2014 | ICU2 
Patient 21 | 13.10.2014 | ICU2 
Patient 5 | 10.09.2010 | ICU3  
Patient 4 | 30.08.2010 | ICU3  
Patient 3 | 25.07.2010 | ICU3  
Patient 2 | 10.07.2010 | ICU3  
Patient 2 | 20.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 02.06.2010 | ICU3  
Env 5 | 27.04.2012 | ICU4 
Env 4 | 03.04.2012 | ICU4 
Env 2 | 10.10.2011 | ICU3  
Env 8 | 17.07.2012 | ICU3  
Patient 5 | 15.08.2010 | ICU3  
Patient 4 | 03.08.2010 | ICU3  
Patient 1 | 06.04.2010 | ICU3  
Env 12 | 08.11.2012 | ICU4 
Env 6 | 27.04.2012 | ICU4 
Patient 6 | 16.09.2010 | ICU2 
Patient 15 | 12.12.2012 | ICU ped 
Patient 17 | 30.05.2013 | ICU1 
Patient 8 | 21.07.2011 | ICU ped 
Patient 19 | 10.01.2014 | ICU2 
Patient 22 | 15.10.2014 | ICU5 
Env 13 | 11.12.2012 | ICU3 
Env 7 | 17.07.2012 | ICU3  
Env 11 | 07.11.2012 | ICU2 
Env 1 | 10.10.2011 | ICU2 
Figure 34. DLST 6-7 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the PaCBio reference with a 
mapping quality of 60 and with a minimum of 10 reads to consider a SNP site. Number of SNP differences between pairs of isolates are displayed in each square. Each 
line corresponds to an isolate. Isolate’s identification on the columns from left to right: Env. 1 (first isolate) to Patient 7 (last isolate). Different colors represent 
different SNP differences’ limits:10, 20, 50, 100, 150, 200, 400, and 600. The frequency of each number of SNP differences is pictured by a white line on the color 
legend plot. 
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Figure 35. DLST 6-7 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against the PaCBio reference with a 
mapping quality of 60 and with a minimum of 10 reads to consider a SNP site. A subclade of isolates from the burn unit suspected to be epidemiologically linked are 
highlighted in green. Another subclade, in blue, is composed of isolates from Patient 11 and environmental isolates retrieved from ICU2. An example of isolates belonging 
to the same patient, Patient 12, is highlighted in green. Two long branches belonging to Env. 1 and Env. 11 are highlighted in red. 
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2.3.7. Adapted methodology: different parameters 
2.3.7.1. Variant calling using a lower mapping quality threshold 
 Minimum mapping quality is an important parameter used to exclude low-
confidence alignments. It is a probabilistic value that determines the confidence of the 
read to be correctly mapped to the genomic coordinates of the reference genome. When 
developing the second bioinformatic scheme, thresholds were defined according to the 
default parameters in the standard methodology. FreeBayes, the program used for variant 
calling in both methodologies, is implemented in Snippy (standard methodology) with a 
minimum mapping quality of 60, which was used for all the analysis thus far. To evaluate 
the weight of this parameter on our genome collection when using different references 
genomes, we decided to decrease the minimum mapping quality value to 20. This value 
was only tested in the adapted methodology. 
 
 The number of SNP differences resulting from this analysis are listed for all DLST 
types in Table 2 to 4. In general, no major differences were observed by decreasing the 
minimum mapping quality threshold. For DLST 1-18, the number of SNPs obtained by 
mapping against the PacBio reference with the minimum mapping quality as 60 was 
similar to when the value was 20. However, using PA14 as the reference genome with 
minimum mapping quality 20 increased slightly the number of SNPs between isolates of 
the same patient. Phylogenetic trees showed also an identical topology, specially for the 
isolates selected for the comparison (Chapter 7. Supplementary figures). DLST 1-21 
isolates were unaltered by a lower minimum mapping quality value as the phylogenetic 
tree topologies and number of SNPs were very similar between analysis (Chapter 7. 
Supplementary figures). Interestingly, only changes in genetically distant isolates were 
detected for DLST 6-7 isolates from 60 to 20 as minimum mapping qualities for mapping 
performed with both references (Chapter 7. Supplementary figures). 
CHAPTER 2. Use of open-access bioinformatic tools to investigate P. aeruginosa 
 
67 
 
2.3.7.2. Filtering using a lower number of reads per allele to detect a SNP 
 Another parameter utilized to avoid errors in variant detection is the minimum 
number of reads per allele to report a SNP. Incorrectly aligned reads can lead to poorly 
supported genome SNP sites (2). On the adapted methodology, this parameter was part 
of the filtering applied to the VCF file using an in-house script and the threshold used was 
10: a minimum of 10 reads per allele to consider a SNP position. To verify to which extent 
a stricter value would affect the number of detected SNP differences, we changed the 
threshold of this parameter to 20. 
 Only minor decrease in the SNP number was identified when considering sites 
supported by a minimum of 20 as opposed to 10 reads (Table 2 to 4). Nevertheless, this 
happened only for genetically distant isolates (Chapter 7. Supplementary figures). 
 
2.4. Discussion 
 In this study we give insight to the epidemiology of P. aeruginosa in the ICUs of the 
University Hospital of Lausanne by combining a molecular typing method with WGS. 
While doing so, we also emphasize the importance of defining a bioinformatic pipeline for 
WGS data analysis suitable for P. aeruginosa and the dataset being studied. 
 
 MLST results acquired from the isolates’ raw reads divided the dataset in three 
different STs; ST 1076, ST253, and ST17. This division was exactly concordant with the 
attribution of types performed with DLST; DLST 1-8, DLST 1-21, and DLST 6-7, 
respectively. Such findings confirmed the previously documented similar discriminatory 
power of both methods (20). ST253 belongs to the clinical and international well 
described clonal complex (CC) PA14, and ST17 was previously reported as part of the 
clonal complex C, both CCs being the worldwide most abundant clonal complexes in the 
P. aeruginosa population (41). No complete published genomes were available at the start 
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of this study for ST1076 and ST17, although a few investigations have reported these STs 
(149, 150). Knowing the isolates ST helped to choose the P. aeruginosa PA14 as the 
reference genome for the mapping step of both methodologies. However, this choice was 
not ideal as only DLST 1-21 isolates were closely related to the chosen reference. 
 Applying the standard methodology for WGS analysis, using P. aeruginosa PA14 as 
a reference, lead to an unexpected high number of SNPs between isolates for which 
epidemiological links were suspected. This happened as well for isolates clustering 
together in the phylogenetic tree and/or between isolates from the same patient retrieved 
less than one week apart. These odd results were observed for DLST 1-18 and 6-7. On the 
other hand, the number of SNPs and the phylogenetic tree topology for DLST cluster 1-21 
isolates seemed to be concordant with epidemiological data. 
 To understand if the SNP problem we encountered was due to an inadequate 
choice of bioinformatic tools and/or parameters to analyse the WGS data, we adapted the 
original methodology to a stricter quality approach. A first step of subsampling the reads 
was added to introduce comparability in coverage which in turn would facilitate the 
subsequent analysis (147). In addition, more specific recombination and quality filtering 
was applied. The addition of these analysis steps resulted in a significant decrease of SNP 
distances between isolates from DLST 1-18 and 6-7. While most of the SNP differences for 
DLST 1-18 isolates acquired with the standard methodology were between 20 to 100, and 
81-121 between isolates of the same patient, the adapted procedure resulted in 0 to 10 
between most of the isolates and less than 10 SNPs between isolates of the same patient. 
The SNP differences between most of the isolates decreased (from 100-200, to 50 to 150), 
nonetheless it was still in concordance with the sporadic occurrence demonstrated by 
epidemiological data. The number of SNP differences between isolates of the same patient 
was now from 7 to 20, instead of 78 to 93. Phylogenetic tree topologies were not majorly 
changed between approaches as the isolates clustered in an identical manner in both 
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approaches. No major differences were observed for DLST 1-21 which can be explained 
by the reference used being from the same ST as this DLST type, and therefore closely 
related to DLST 1-21 genomes. 
 SNP analyses is known to give a very high resolution, but a reference genome 
closely related to the sequenced isolates must be used in order to reduce chances of 
mismapping and increase regions in the reference genome to which the reads can map 
against (2). Taking this into consideration, and the results of the previous analyses, we 
decided to construct a reference genome from the index case of each DLST type and map 
the reads against it with both methodologies. Interestingly, results of the standard 
methodology when using the PacBio reference were very similar to the ones obtained 
when a stricter and more adapted filtering was applied with the P. aeruginosa PA14 
reference. The decrease in SNP differences was even more evident when the adapted 
analysis was performed using the PacbBio reference, which produced the lowest number 
of SNP differences between isolates. Isolates that were distantly related in all 
methodologies were more affected by the variations in SNP differences. Such findings 
suggest that the stricter filtering in the adapted methodology is overcoming the problems, 
i.e. mismapping of reads or lower coverage of certain regions, of mapping against a 
distantly related reference genome. 
 Stemming from the premise that filtering options can overcome an inaccurate 
number of SNP when using a reference not related to the dataset, different parameter 
thresholds related to the mapping step and site coverage where tested. Changing the 
mapping qualities to a lower value (MQ 20) resulted in slight changes in SNP differences 
for DLST 1-18 when analysed with the adapted methodology and P. aeruginosa PA14 
reference. No significant alterations were detected for the other two DLST types. 
Similarly, when altering the number of reads from 20 to 10 to consider a site, no major 
differences in the SNP differences were observed. This implies other parameters or 
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thresholds are responsible for the differences in results obtained with both 
methodologies, which need to be further investigated. Standard methodology with other 
thresholds was not tested so far, but the results could aid in understanding exactly in 
which parameter does this SNP problem lie. Defining a reliable bioinformatic analysis 
pipeline adapted to the pathogen and dataset in being studied are important aspects to 
take in consideration before implementing WGS as a routine epidemiological typing tool 
(151). Several recent studies on SNP calling bias due to different sequencing and 
bioinformatic analysis approaches have been published (151, 152). Their findings state 
the importance for SNP analysis of choosing a close reference strain, as well as departing 
from good quality raw data, and applying the adequate thresholds, which is comparable 
to what is reported in this study. As results were equivalent when performing the stricter 
adapted methodology, this approach was chosen with mapping the reads against the 
PacBio reference, a MQ of 60, and a minimum number of 10 reads to consider a SNP site, 
for the subsequent investigation of P. aeruginosa epidemiology. 
 
The three investigated DLST types sowed different epidemiological behaviours 
during this study period. Most of DLST cluster 1-18 patients were hospitalized in the burn 
unit during overlapping periods of time. As P. aeruginosa is capable to survive on wet 
surfaces such as sinks, sink traps, pipes, and hydrotherapy equipment; several nosocomial 
outbreaks have been associated with these specific reservoirs (153). DLST 1-18 
environmental isolates retrieved from shower mattresses and sink traps from the 
hydrotherapy room support the assumption of an environmental source of infection. The 
high number of epidemiological links between patients, along with the wide presence of 
this DLST type in the environment of the burn unit, helped to previously determine this 
cluster as responsible for an outbreak with an environmental source (112). Of interest, 
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the first patient detected was considered as part of the outbreak based on DLST typing, 
despite no epidemiological links were found to other patients or the environment. 
 In 2010, DLST type 6-7 was responsible for a small outbreak in the burn unit 
comprising five patients. From 2011, both DLST 1-21 and 6-7 occurred sporadically 
throughout the rest of the study period with only one suspected epidemiological link 
found for DLST 1-21 isolates (between patients and environment). This behaviour may 
be explained by a major role of this types’ prevalence in our ICUs environment, which lead 
to sporadic patient infection. Nonetheless, one limitation of this study relies on the 
insufficient environmental sampling information until 2012. A more frequent and regular 
sampling throughout the four years study would have helped to discover probable 
epidemiological links between infected patients and environmental sources.  
 
 By combining DLST and epidemiological data it was possible to determine three 
genotypes with different behaviours in our ICUs. However, DLST was not discriminatory 
enough to confirm possible cases of transmission between patients and between patients 
and the environment, or to define a probable source of infection. WGS helped to group the 
DLST 1-18 outbreak isolates with less than 10 SNP differences between them, while 
excluding Patient 1 as part of the outbreak, which was inferred by epidemiological data 
but not by DLST typing. Environmental isolates retrieved from sink traps and shower 
mattresses on the hydrotherapy room clustered with the outbreak isolates (<10 SNPs) 
which can indicate them as possible sources of infection.  
Analysis of DLST 1-21 WGS data confirmed the suspected epidemiological link 
between isolates retrieved from ICU2. In addition, it considered as closely related, isolates 
for which no epidemiological links were suspected. For instance, isolates sampled from 
the burn unit were related with less than 11 SNPs; environmental isolates sampled 10 
years apart were related with 11 to 14 SNPs; two isolates from two patients collected 12 
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years apart had six SNP differences. These values are lower than expected when 
considering the long time between isolate sampling, and considering that isolates 
retrieved from the same patient, weeks apart, had close number of SNP differences (0-4 
SNPs). One explanation can be the slower evolution of P. aeruginosa isolates in the 
environment of ICUs which then lead to patients being infected with genetically identical 
strains.  
 Lastly, a small DLST 6-7 outbreak between patients hospitalized in the burn unit 
in 2010 was confirmed by WGS (0-13 SNP differences). A subclade of ICU2 clinical and 
environmental isolates with zero to seven SNP differences suggests a possible 
transmission between patient and the environment that was not questioned with the 
epidemiological data. Interestingly, two environmental isolates were associated with long 
branches. One reason for the occurrence of these long branches is the long branch 
attraction phenomenon(phylogenetic artefact when distantly related lineages are 
considered closely related by error because they have both undergone a large amount of 
molecular change) (154). Another reason could be that these are hypermutator isolates 
as a response to environmental selection (155). A way to assess the latter would be to 
investigate the presence of genes coding for the methyl-directed mismatch repair (MMR) 
system proteins in this DLST type genome.  
 Although WGS costs are decreasing, its implementation as a routine surveillance 
method for P. aeruginosa still comes at a higher price per isolate than the currently used 
DLST. Additionally, analyses of WGS data requires a certain level of bioinformatic 
expertise that is not always available in all epidemiology laboratories(156). Thus, 
recurring to DLST as a first-line molecular typing tool in combination with the 
discriminatory power of WGS would culminate in an efficient typing strategy for outbreak 
investigation or surveillance of P. aeruginosa infections. 
 
CHAPTER 3. High-Quality Complete Genome Sequences of Three Pseudomonas aeruginosa Isolates 
 
73 
 
 
 
 
CHAPTER 3. 
High-Quality Complete Genome Sequences 
of Three Pseudomonas aeruginosa 
Isolates Retrieved from Patients 
Hospitalized in Intensive Care Units 
(Microbiology Resource Announcements, from the American Society for Microbiology 
journal. In Press.) 
 
Bárbara Magalhães,a Laurence Senn,a and Dominique S. Blanca# 
 
aService of Hospital Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland 
 
Abstract 
Pseudomonas aeruginosa is one of the major Gram-negative pathogens responsible for hospital-
acquired infections. Here, we present the high-quality genome sequences of three P. aeruginosa 
genotypes retrieved from patients hospitalized in intensive care units. PacBio reads were 
assembled into a single contig, which was afterwards corrected using Illumina HiSeq reads.  
 
Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen which is identified as one 
of the most frequent microorganisms in Intensive Care Units (ICUs) (1, 2).  
Following an unexplained increase in P. aeruginosa incidence in the ICUs of the University 
Hospital of Lausanne, all clinical and environmental isolates from 2010 to 2014 were typed. Most 
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patients harbored three sequence types (STs): ST1076, ST253, and ST17. To further investigate 
the epidemiology of this pathogen in the ICUs with short read whole genome sequencing, a 
complete reference genome was constructed for each ST. The first clinical isolate collected from 
each of the three STs was selected for that purpose:  H25883 (ST1076), H26023 (ST253), and 
H26027 (ST17). 
 
Single colonies were inoculated in 5ml of Lysogeny broth (LB) and incubated for four hours to 
reach an early exponential phase. Extraction of the genomic DNA was performed on 1.5 mL 
cultures using the GenElute bacterial genomic DNA kit (SIGMA-ALDRICH, St. Louis, MO, USA). The 
genomic DNA (gDNA) was subsequently used for library preparation according to the PacBio 
standard protocol with the BluePippin size-selection system (Sage Science). The finished libraries 
were sequenced on a PacBio RSII instrument using P6-C4 chemistry, for 360-min movies, and 
yielded 100,236 to 103,875 reads with an average size of 19,375 to 19,604 base pairs (bp). 
Hierarchical Genome Assembly Process (HGAP3) v. 2.3.0 (3) from the SMRT Analysis Software 
suite (PacBio) was used to assemble the PacBio reads with a minimum seed read length of 6kb. 
All genomes were manually circularized using the Minimus pipeline (4) included in AMOS (5), 
merging the overlapping extremities of the main contig. A single circular contig was produced for 
isolates H25883, H26023, and H26027, with the following genome size and coverage: 6,706,793 
(223x), 6,729,215 (217x), and 7,079,586 (228x), respectively. 
 
The extracted gDNA was also used for library preparation with the Nextera DNA Library 
Preparation Kit (Illumina, Inc., San Diego, CA, USA) for a 100-bp paired-end sequencing on 
Illumina HiSeq 2500, aiming for a 100-fold coverage. Illumina HiSeq reads were mapped against 
the assembled PacBio contigs with BWA-MEM, and single nucleotide polymorphisms (SNPs) and 
indels were identified and corrected using Pilon v.1.22 (6) with  a minimum size for unclosed gaps 
of 10. The genotype, final genome size, and G+C content of the three final corrected circular 
genomes is represented in Table 5.  
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A total of 6,400 to 6,806 genes was predicted with Prokaryotic Genome Annotation Pipeline 
(PGAP) (7), and 6,216 to 6,629 coding sequences (CDSs) annotated, together with 63 to 64 tRNAS 
and 4 rRNA operons. 
 
Accession number(s). The complete genome sequences for the three Pseudomonas aeruginosa 
isolates have been deposited in DDBJ/ENA/NCBI, and the PacBio and Illumina reads are available 
in the NCBI Sequence Read Archive. The respective accession numbers are listed in Table 5. 
  
Table 5. Metadata of the three complete corrected genomes of each genotype. 
Isolate no.  Genotype 
N50 read 
length 
(bp) 
Genbank 
accession 
no. 
SRA accession no. 
Genome 
size (bp) 
G+C 
content 
(%) 
CDS 
        Illumna reads PacBio reads       
H25883 ST1076 26,667 CP033686 SRX5329115 SRX5322128 6,706,800 66.15 6,216 
H26023 ST253 26,676 CP033685 SRX5329116 SRX5322127 6,729,216 66.21 6,246 
H26027 ST17 27,385 CP033684 SRX5329117 SRX5322129 7,079,598 66.07 6,629 
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CHAPTER 4. 
 
Comparison of different bioinformatic 
approaches for routine analyses of 
WGS data 
4.1. Objectives  
 Whole genome sequencing (WGS) has proven to be a very effective subtyping tool 
for various nosocomial pathogens. An array of approaches to analyse WGS data have been 
applied for epidemiologic and infection control purposes. The genomic data can be 
exploited essentially by single nucleotide polymorphisms (SNPs) or gene-by-gene 
methods. Only a few studies were published to date on the comparison of these different 
analysis approaches, leaving out several important pathogens. A previously published 
ST228 Methicillin-resistant Staphylococcus aureus (MRSA) dataset from a large outbreak 
in a University hospital (1) will be used to assess and compare the performance of 
different genomic methods for outbreak investigation. This data set was investigated 
through mapping against a reference and posterior SNP calling and showed the outbreak 
clonality with a diversification through time of seven different branches. With this project, 
the same dataset will be analysed with Whole Genome SNPs (wgSNPs) and Whole Genome 
Multi-Locus Sequence Typing (wgMLST), both implemented in BioNumerics v.7.6.3 
CHAPTER 4. Comparison of different bioinformatic approaches for routine analyses of WGS data 
 
77 
 
(Applied-Maths). Ultimately, the comparison of these methodologies will help to evaluate 
their implementation in routine diagnostic of S. aureus.   
 
4.2. Material and Methods  
4.2.1. Bacterial isolates  
 All MRSA ST 228 isolates (one per patient) recovered in 2008, and one consecutive 
patient out of 10 from 2009 to 2012, were included in the study.  
 
4.2.2. Whole genome SNPs analysis 
 Reads of 235 MRSA sequence type 228 (ST 228) isolates were imported into 
BioNumerics. Staphylococcus aureus subsp. aureus N315 reference strain was used as the 
reference sequence for mapping against the raw reads. Base differences against the 
reference sequence were obtained by the wgSNPs tool using the “Strict SNP filtering 
(closed SNP set)” option. This option removes positions with at least one unreliable base 
(N), ambiguous base (non-ATCG), gaps and non-discriminatory positions between the 
entries. Each SNP position should had at least 5x coverage, was covered once in forward 
or reverse direction, and the minimum inter-SNP distance was 12. A maximum likelihood 
tree cannot be obtained with BioNumerics as it considers nucleotides as characters. Thus, 
the filtered SNPs matrix was exported to the comparison window where a maximum 
spanning tree (MST) was constructed. 
 
4.2.3. Whole genome MLST analysis  
 Whole genome MLST analysis was done by using the default parameters suggested 
for S. aureus. The wgMLST pan-genome scheme for S. aureus includes a total of 3897 loci, 
from which 1861 are considered in the core genome, and 2036 as accessory loci. Three 
jobs were submitted to the calculation engine of Amazon: de novo assembly, assembly-
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free calls, and assembly-based calls. Alleles were identified by combining the assembly-
free k-mer based approach from raw reads and the assembly-based BLAST approach of 
Velvet optimizer assembled genomes. New alleles were automatically submitted to the 
allele nomenclature server. A maximum spanning tree (MST) was constructed for the 
wgMLST and cgMLST allelic profile.  
  
4.3. Results 
4.3.1. Whole genome SNPs results 
 Figure 36 shows the maximum likelihood tree previously published by SNPs 
analysis with all MRSA ST 228 isolates. The isolates’ phylogeny based on the SNP variable 
sites illustrated the diversification of seven major branches during the 52-month study 
period. Isolates considered not part of the outbreak were distantly related to the outbreak 
isolates. In addition, isolate number 188 (group b) was distantly related to the other 
members of the group and was represented by a long branch.  
Whole genome SNPs analysis in BioNumerics resulted in a total of 879 SNPs 
between the 235 MRSA isolates. In general, isolates belonging to a specific branch group 
(a to g) tended to cluster together with few SNP differences, with the exception of some 
isolates belonging to group b, d, and g, in red, pink and dark blue, respectively (Figure 37). 
Isolate 188 was closely related to the remaining members of its group (group b). Isolates 
not related to the outbreak were distantly related from the remaining isolates, with high 
number of SNPs between them (>38 SNPs). Isolate 233, previously considered the most 
distant isolate, showed the highest number of SNP differences (87 SNPs) with the 
remaining isolates. 
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4.3.2. Whole genome MLST results 
 Results were not in congruence with the SNPs analysis approach (Figure 38). First, 
isolates obtained before the outbreak clustered within the outbreak isolates. Second, the 
clustering of the isolates in the seven branches (a to g groups) was not observed; they 
were mixed in different clusters. Third, isolate 233, which was considered as the more 
distant with the SNPs analysis, was found to cluster with the remaining isolates. In 
addition, isolate 188 was closely related to other isolates and not located at the end of a 
long branch. In turn, isolate 108 showed high allele differences from the remaining 
isolates (2623 alleles), as well as isolates 223 and 221 (2565 alleles).   
Figure 36. Maximum likelihood tree based on SNP variable sites of all S. aureus ST 228 
isolates over a 52-month period. Seven different branches are highlighted in different 
colors and numerated from a to g (1). 
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Figure 37. Minimum spanning tree based on S. aureus ST 228 isolates’ SNP differences acquired with wgSNPs. SNPs differences are 
discriminated on the branches of tree. Isolates belonging to the seven previously reported clusters are highlighted in different colors 
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Figure 38. Minimum spanning tree based on S. aureus ST 228 isolates’ allele differences acquired with wgMLST. Isolates belonging to the seven previously reported 
clusters are highlighted in different colors 
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4.3.3. Whole genome MLST results after bug fix 
 While trying to decipher why discrepancies in the results were obtained with 
wgSNPs and wgMLST, we discovered that low quality alleles were being marked as 
tentative, i.e. does not meet the quality criteria set by the curator of the database and are 
not part of the search data for the allele calling algorithms. However, these alleles were 
being included in the search data by the allele calling algorithms. After discussion with the 
BioNumerics support team on this matter, we realized the problem relied on the 
corruption of the database with low quality alleles as users were submitting alleles with 
very low similarity thresholds and the program did not check the start, stop, and internal 
stop was performed. Consequently, some loci fragments were being considered as allele. 
To overcome this problem, BioNumerics team removed all tentative alleles from the 
search data. Although they are still in the allele nomenclature database, they are no longer 
used as input for allele calling algorithms. 
 
 wgMLST was repeated only for a subset of MRSA ST228 isolates. From the original 
235 isolates, 131 were selected to be analysed by the corrected version of wgMLST. Figure 
39 shows the concordance between new wgMLST results and the ones obtained with 
wgSNPs and the original SNPs analysis. Clustering of isolates according to the previously 
described groups was more accurate than the one obtained with wgSNPs. Isolates from 
group f (in brown) evolved from the ancestor group of isolates in green but some were 
disposed separately on the MST tree. Isolates 233 and 221 were part of the non-outbreak 
group in white whit 82 and 15 allele differences,
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(A) (B) 
Figure 39. Minimum spanning tree based ona subset of 131 S. aureus ST 228 isolates’ allele differences acquired with wgMLST after the 
bug fix. Two MST trees are illustrated: (A) with isolate number and (B) with allele differences between isolates. Isolates belonging to the 
seven previously reported clusters are highlighted in different colors 
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respectively. Isolate 188 clustered with isolates from group b (in blue) with 25 allele 
differences and isolate 108 belonged to group e (in dark green) with seven allele 
differences. 
 
4.4. Discussion 
 A great concern with WGS in a clinical routine microbiology laboratory is 
still data analysis, as it normally requires specific bioinformatic expertise. SNP and gene-
by-gene comparisons are the primary approaches for WGS data analyses for purposes of 
bacterial strain typing and epidemiological investigations (2). However, due to the 
availability of these two approaches in user-friendly software packages, WGS data 
analysis for diagnostic purposes is possible with little bioinformatics knowledge (25). 
This project aimed to compare SNP analysis and gene-by-gene approaches for WGS data 
analysis in routine investigation of  S. aureus.  
 Whole genome SNPs analysis performed with BioNumerics was able to cluster the 
isolates similarly to what was observed in the original published results, with only some 
exceptions. The number of SNP positions was lower than the one previously published 
(879 vs1565 SNP positions), which can maybe be explained by the application of a stricter 
filtering of SNPs. After the bug fix, wgMLST results were concordant with both SNP 
analysis methods. The subset of 131 isolates clustered accordingly to the seven branches 
almost identically to the original phylogenetic tree. Similar distances between isolates 
were found between wgSNPs and wgMLST, e.g. Patient 233 was the farthest from the 
outbreak isolates with 87 SNPs and 82 allele differences, respectively. Unfortunately, the 
complete dataset was not included in the repetition of wgMLST since BioNumerics 
requires the payment of credits to perform the analysis with wgMLST tools. Although the 
concordance in SNP and allele differences between methods seems evident, other S. 
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aureus datasets should be tested in order to validate BioNumerics tools for outbreak 
investigation of this pathogen. 
 Important aspects of these two approaches need to be considered when deciding 
which method to apply to the dataset in question. SNP analysis has high resolution but a 
closely related genome reference to the isolates is crucial for correct calling of variant 
sites and that is not always possible for real-time outbreak investigation. Another 
limitation of this approach is the reproducibility between different studies where 
different references and thresholds are being applied. Whole genome MLST is able to 
surpass these obstacles as the mapping step is not performed, hence there is no need to 
choose a closely related reference. In addition, the assignment of alleles in comparison to 
a curated set of predefined genes gives it interlaboratory reproducibility (2). 
In general, both BioNumerics WGS tools were very easy to use, in relatively short 
amount of time. No knowledge on bioinformatics was needed to perform these 
BioNumerics analyses, as it could be easily followed by the software tutorials. However, 
such knowledge is greatly needed in the investigation of discrepancies between these 
methods. For instance, P. aeruginosa is not a clonal pathogen as opposed to S. aureus, and 
the default parameters applied to one pathogen may not work best for another. 
Understanding the microorganism in question, which parameters and thresholds should 
be altered, is still crucial for a reliable application of such software to diagnostics. 
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CHAPTER 5. 
Conclusions and Future Perspectives 
 
The main objective of this thesis was to evaluate the implementation of WGS for 
epidemiological investigation of nosocomial pathogens. To accomplish that, several WGS 
analysis methodologies tested using datasets from two important nosocomial pathogens, 
P. aeruginosa and MRSA.  
 DLST grouping of the isolates in three types, DLST 1-18, DLST 1-21, and DLST 6-7, 
was identical to ST identification: ST1076, ST253, and ST17, respectively. Applying a 
standard methodology with default parameters, while using a reference distantly related 
to the isolate collection, lead to an unexpected high number of SNP differences between 
epidemiologically linked isolates. A stricter quality filtering helped to overcome this 
problem. When using a closely related reference, the results were very similar to the ones 
obtained with stricter quality thresholds. This indicates that mapping against a distant 
reference creates variant artefacts due to the low quality of the alignment. However, when 
parameters related to alignment quality were changed, no significant changes in the 
number of SNPs were observed. Using more discrepant thresholds or evaluating other 
important parameters could aid in understanding where the odd SNPs number problem 
resides. Additionally, the changed thresholds need to be tested with the standard 
methodology as well.  
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 After choosing the methodology that seemed more reliable in results and in 
principle for P. aeruginosa investigation, the obtained WGS data were highly concordant 
with the epidemiological information. WGS confirmed the occurrence of a long DLST 1-18 
outbreak, and a DLST 6-7 smaller one, in the burn unit. It successfully identified 
genetically related isolates for which epidemiological links were observed. In turn, WGS 
considered closely related isolates that were not epidemiologically linked, suggesting that 
the environment could play an important role in the sporadic infection of patients, as well 
as the source of nosocomial outbreaks.  
 Due to the costs and need of bioinformatic expertise when using WGS routinely in 
epidemiology laboratories, combining DLST as a first screening method and 
complementing it with the discriminatory power of WGS to resolve specific cases looks 
like a very efficient and reliable typing approach.  
 
 One of this project’s tasks was to genetically characterize each DLST type; however 
this was not accomplished so far. Preliminary results on virulence and resistance genes 
have shown that DLST 1-18 and DLST 6-7 have comparable virulence and resistance. 
Although DLST 1-21 resistance does not differ from the other types, its virulence arsenal 
appears to be bigger. Comparison of the PacBio references of each DLST type will further 
elucidate on the genetic composition of each genotype.  
It is known that a single reference genome is not sufficient to fully represent the 
entire genetic diversity of a given species (161). Thus, the analysis of these P. aeruginosa 
isolates’ pangenome will be performed in order to determined its core and 
variable/accessory/dispensable gene content.  
 
 The second project aimed to compare different approaches for WGS data analysis, 
using both open-access and commercially available bioinformatic tools. Only the wgSNPs 
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and wgMLST tools incorporated in BioNumerics program were tested thus far. These 
tools showed high concordance in tree topology and genetic distances with the SNPs 
analysis previously performed. In addition, wgMLST showed great potential to be used as 
an alternative approach to SNP analysis for routine molecular typing of nosocomial 
pathogens. However, adaptability of the analysis to the pathogen and dataset being 
studied is not easily performed with these commercial programs since the parameters are 
limited.  
In order to validate wgMLST for its implementation in epidemiology laboratories, 
other MRSA datasets and pathogens needed to be tested and the results evaluated. 
Investigation of other wgMLST-based tools, such as SeqSphere+ (162), whole genome 
sequence analysis (WGSA) (https://pathogen.watch/), and PHYLOViZ (163), would 
greatly complement this comparison study and put in evidence the reproducibility of WGS 
analysis.  
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DLST 1-18 pairwise distance matrix  
Adapted methodology: PA14 reference, MQ 20, 10 reads  
 
 
 
 
  
Figure 40. DLST 1-18 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. aeruginosa 
PA14 with mapping quality of 20 and minimum of 10 reads to consider a SNP site. Number of SNP differences between pairs of isolates are displayed 
in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 1 (first isolate) to Env. 8 (last 
isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the color legend plot pictures the 
frequency of each number of SNP differences. 
Env. 8 | 27.04.2012 | ICU4 
Patient 21_R  | 03.05.2012 | ICU4 
Patient 20 | 18.03.2012 | ICU3 
Patient 20 | 22.03.2012 | ICU3 
Patient 21_R  | 25.04.2012 | ICU4 
Patient 21_R  | 22.04.2012 | ICU4 
Patient 20 | 13.04.2012 | ICU3 
Patient 8 | 28.02.2011 | ICU3 
Patient 24 | 04.12.2012 | ICU3 
Patient 13_R | 26.07.2011 | ICU3 
Patient 17_R | 01.02.2012 | ICU3 
Patient 17_R | 18.02.2012 | ICU3 
Patient 6_R | 30.01.2011 | ICU3 
Patient 20 | 16.03.2012 | ICU3 
Patient 18_R | 03.01.2012 | ICU3 
Patient 12_R | 25.07.2011 | ICU4 
Patient 4 | 13.04.2011 | ICU3 
Patient 4 | 10.05.2011 | ICU3 
Patient 4 | 18.04.2011 | ICU3 
Patient 11 | 11.06.2011 | ICU4 
Patient 12_R | 26.06.2011 | ICU4 
Patient 11_R | 06.06.2011 | ICU4 
Patient 4 | 01.03.2011 | ICU3 
Env. 10 | 27.07.2012 | ICU 4/5 
Patient 16 | 30.01.2012 | ICU3 
Patient 16 | 01.03.2012 | ICU3 
Patient 16 | 15.02.2012 | ICU3 
Patient 16 | 07.12.2011 | ICU3 
Env. 5 | 23.03.2012 | ICU3 
Patient 23 | 25.10.2012 | ICU3 
Patient 23 | 18.10.2012 | ICU3 
Patient 19_R | 13.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Patient 3 | 15.08.2010 | ICU3 
Env. 7 | 23.03.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Patient 4 | 03.04.2011 | ICU3 
Patient 3_R | 28.08.2010 | ICU3 
Patient 17_R | 11.12.2011 | ICU3 
Patient 9 | 18.05.2011 | ICU3 
Patient 13_R | 14.07.2011 | ICU3 
Env. 9 | 17.07.2012 | ICU3 
Patient 15_R | 16.10.2011 | ICU3 
Patient 8_R | 22.02.2011 | ICU3 
Patient 9 | 08.06.2011 | ICU3 
Patient 9 | 01.07.2011 | ICU3 
Env. 1 | 10.10.2011 | ICU3 
Patient 7 | 01.02.2011 | ICU1 
Patient 20 | 04.03.2012 | ICU3 
Env. 6 | 23.03.2012 | ICU3 
Patient 16 | 08.12.2012 | ICU3 
Patient 16 | 01.02.2012 | ICU3 
Patient 19_R | 27.02.2012 | ICU3 
Patient 9 | 04.04.2011 | ICU3 
Patient 10_R | 02.05.2011 | ICU3 
Env. 15 | 25.01.2013 | ICU3 
Env. 16_R | 25.01.2013 | ICU3 
Env. 18 | 25.01.2013 | ICU3 
Patient 5_R | 24.01.2011 | ICU3 
Patient 23_RR | 18.10.2012 | ICU3 
Env. 14 | 25.01.2013 | ICU3 
Patient 4 | 13.01.2011 | ICU3 
Patient 9 | 21.03.2011 | ICU3 
Env. 12 | 25.01.2013 | ICU3 
Env. 11 | 24.10.2012 | ICU3 
Patient 22_R | 25.06.2012 | ICU3 
Patient 8 | 13.03.2011 | ICU3 
Env. 2 | 23.03.2012 | ICU3 
Env. 13 | 25.01.2013 | ICU3 
Patient 14 | 10.10.2011 | ICU ped 
Patient 2_R | 28.05.2010 | ICU3 
Env. 17 | 25.01.2013 | ICU3 
Patient 1_R | 24.04.2010 | ICU5 
Patient 1_R | 31.03.2010 | ICU5 
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DLST 1-18 phylogeny 
Adapted methodology: PA14 reference, MQ 20, 10 reads 
  
Figure 41. DLST 1-18 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology 
mapping against P. aeruginosa PA14 with mapping quality of 20 and minimum of 10 reads to consider a SNP site. Non-
outbreak isolates belonging to Patient 1 are highlighted in grey. Isolates from Patient 4 and 23 are highlighted in pink and 
blue, respectively. 
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DLST 1-21 pairwise distance matrix  
Adapted methodology: PA14 reference, MQ 20, 10 reads 
 
 
 
 
 
  
Figure 42. DLST 1-21 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. aeruginosa 
PA14 with mapping quality of 20 and minimum of 10 reads to consider a SNP site. Number of SNP differences between pairs of isolates are displayed in 
each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 8 (first isolate) to Patient 10 (last 
isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the color legend plot pictures the frequency 
of each number of SNP differences. 
Patient 10 | 31.03.2012 | ICU2 
Env. 5 | 02.04.2012 | ICU2 
Patient 11 | 10.04.2012 | ICU2 
Patient 16 | 01.09.2014 | ICU5 
Patient 12 | 07.11.2012 | ICU4 
Patient 5 | 27.10.2010 | ICU2 
Patient 4 | 02.09.2010 | ICU4 
Patient 1 | 08.01.2010 | ICU5 
Patient 3 | 18.05.2010 | ICU1 
Patient 13 | 04.12.2012 | ICU1 
Patient 6  | 31.12.2011 | ICU5 
Patient 6  | 28.02.2011 | ICU5 
Env. 6 | 27.04.2012 | ICU5 
Patient 9 | 13.03.2012 | ICU5 
Patient 15 | 08.08.2014 | ICU5 
Patient 2 | 03.05.2010 | ICU5 
Patient 2 | 29.04.2010 | ICU5 
Patient 14 | 02.02.2013 | ICU ped 
Patient 7 | 03.04.2011 | ICU2 
Env. 2_R | 23.12.2004 | ICU ped 
Env. 12 | 07.03.2013 | ICU5 
Env. 1_R | 18.05.2004 | ICU ped 
Env. 8 | 07.12.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 9 | 25.01.2013 | ICU3 
Env. 7 | 13.11.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Env. 11 | 25.01.2013 | ICU3 
Env. 10 | 25.01.2013 | ICU3 
Env. 13 | 29.05.2013 | ICU3 
Patient 8 | 08.12.2011 | ICU ped 
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DLST 1-21 phylogeny 
Adapted methodology: PA14 reference, MQ 20, 10 reads 
  
Figure 43. DLST 1-21 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against 
the P. aeruginosa PA14 with a mapping quality of 20 and with a minimum of 10 reads to consider a SNP site. Three environmental isolates 
retrieved between 2004 and 2013 are highlighted in orange; isolates from two patients and an environmental sample collected from ICU2 
are highlighted in blue; subclade of environmental isolates from the burn unit are highlighted in green.  
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DLST 6-7 pairwise distance matrix  
Adapted methodology: PA14 reference, MQ 20, 10 reads 
 
 
 
 
 
  
Figure 44. DLST 6-7 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. aeruginosa 
PA14 with mapping quality of 20 and minimum of 10 reads to consider a SNP site.. Number of SNP differences between pairs of isolates are 
displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Env. 1 (first isolate) to Env. 9 
(last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, 150, 200, and 300. A white line on the color legend plot 
pictures the frequency of each number of SNP differences. 
Env 9 | 30.07.2012 | ICU2 
Env 10 | 07.11.2012 | ICU2 
Env 14 | 20.03.2013 | ICU2 
Env 3 | 02.04.2012 | ICU2 
Patient 11 | 06.12.2011 | ICU2 
Patient 11 | 07.11.2011 | ICU2 
Patient 11 | 18.11.2011 | ICU2 
Patient 20 | 26.04.2014 | ICU2 
Env 15 | 04.03.2014 | ICU2 
Patient 12 | 09.04.2013 | ICU1 
Patient 12 | 21.03.2013 | ICU1 
Patient 12 | 15.04.2012 | ICU1 
Patient 16 | 17.05.2013 | ICU3  
Patient 7 | 19.04.2011 | ICU1 
Patient 7 | 21.05.2011 | ICU1 
Patient 13 | 04.05.2012 | ICU5 
Patient 7 | 04.05.2011 | ICU1 
Patient 10 | 26.08.2011 | ICU1 
Patient 9 | 30.07.2011 | ICU4 
Patient 14 | 26.09.2012 | ICU1 
Patient 14 | 07.10.2012 | ICU1 
Patient 21 | 13.10.2014 | ICU2 
Patient 18 | 11.10.2013 | Not ICU - Ped 
Patient 22 | 15.10.2014 | ICU5 
Patient 17 | 30.05.2013 | ICU1 
Patient 19 | 10.01.2014 | ICU2 
Patient 8 | 21.07.2011 | ICU ped 
Patient 15 | 12.12.2012 | ICU ped 
Patient 6 | 16.09.2010 | ICU2 
Env 6 | 27.04.2012 | ICU4 
Env 13 | 11.12.2012 | ICU3 
Env 7 | 17.07.2012 | ICU3  
Patient 4 | 30.08.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 20.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 02.06.2010 | ICU3  
Patient 5 | 10.09.2010 | ICU3  
Patient 3 | 25.07.2010 | ICU3  
Patient 2 | 10.07.2010 | ICU3  
Patient 5 | 15.08.2010 | ICU3  
Patient 1 | 06.04.2010 | ICU3  
Patient 4 | 03.08.2010 | ICU3  
Env 5 | 27.04.2012 | ICU4 
Env 4 | 03.04.2012 | ICU4 
Env 12 | 08.11.2012 | ICU4 
Env 8 | 17.07.2012 | ICU3  
Env 2 | 10.10.2011 | ICU3  
Env 11 | 07.11.2012 | ICU2 
Env 1 | 10.10.2011 | ICU2 
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DLST 1-21 phylogeny 
Adapted methodology: PA14 reference, MQ 20, 10 reads 
Figure 45. DLST 6-7 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against 
P. aeruginosa PA14 with a mapping quality of 20 and with a minimum of 10 reads to consider a SNP site. A subclade of isolates from 
the burn unit suspected to be epidemiologically linked are highlighted in green. Another subclade, in blue, is composed of isolates 
from Patient 11 and environmental isolates retrieved from ICU2. An example of isolates belonging to the same patient, Patient 12, is 
highlighted in green. Two long branches belonging to Env. 1 and Env. 11 are highlighted in red 
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(A) 
 
(B) 
 
(C) 
 
 
Figure 46. Frequency of number of SNP differences obtained with the adapted methodology, mapping 
against P. aeruginosa PA14 with mapping quality of 20 and minimum of 10 reads to consider a SNP site, 
for (A) DLST 1-18, (B) DLST 1-21, and (C) DLST 6-7. 
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DLST 1-18 pairwise distance matrix  
Adapted methodology: PA14 reference, MQ 20, 20 reads 
 
 
 
 
 
  
Figure 47 
Figure 48. DLST 1-18 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. aeruginosa 
PA14 with mapping quality of 20 and minimum of 20 reads to consider a SNP site. Number of SNP differences between pairs of isolates are displayed 
in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 1 (first isolate) to Env. 6 (last 
isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the color legend plot pictures the 
frequency of each number of SNP differences. 
Env. 6 | 23.03.2012 | ICU3 
Patient 16 | 08.12.2012 | ICU3 
Patient 16 | 01.02.2012 | ICU3 
Patient 16 | 07.12.2011 | ICU3 
Patient 16 | 15.02.2012 | ICU3 
Patient 19_R | 27.02.2012 | ICU3 
Patient 17_R | 01.02.2012 | ICU3 
Patient 17_R | 18.02.2012 | ICU3 
Patient 9 | 08.06.2011 | ICU3 
Env. 1 | 10.10.2011 | ICU3 
Patient 3_R | 28.08.2010 | ICU3 
Env. 9 | 17.07.2012 | ICU3 
Patient 15_R | 16.10.2011 | ICU3 
Patient 17_R | 11.12.2011 | ICU3 
Patient 13_R | 26.07.2011 | ICU3 
Patient 24 | 04.12.2012 | ICU3 
Patient 20 | 16.03.2012 | ICU3 
Patient 8 | 28.02.2011 | ICU3 
Patient 21_R  | 25.04.2012 | ICU4 
Patient 21_R  | 22.04.2012 | ICU4 
Patient 20 | 13.04.2012 | ICU3 
Patient 18_R | 03.01.2012 | ICU3 
Patient 23 | 18.10.2012 | ICU3 
Env. 8 | 27.04.2012 | ICU4 
Patient 21_R  | 03.05.2012 | ICU4 
Patient 20 | 18.03.2012 | ICU3 
Patient 20 | 22.03.2012 | ICU3 
Patient 12_R | 25.07.2011 | ICU4 
Patient 4 | 13.04.2011 | ICU3 
Patient 4 | 10.05.2011 | ICU3 
Patient 4 | 18.04.2011 | ICU3 
Patient 11 | 11.06.2011 | ICU4 
Patient 11_R | 06.06.2011 | ICU4 
Patient 12_R | 26.06.2011 | ICU4 
Patient 4 | 01.03.2011 | ICU3 
Env. 10 | 27.07.2012 | ICU 4/5 
Patient 23 | 25.10.2012 | ICU3 
Env. 5 | 23.03.2012 | ICU3 
Patient 16 | 30.01.2012 | ICU3 
Patient 16 | 01.03.2012 | ICU3 
Patient 19_R | 13.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Patient 3 | 15.08.2010 | ICU3 
Patient 4 | 03.04.2011 | ICU3 
Patient 9 | 18.05.2011 | ICU3 
Patient 13_R | 14.07.2011 | ICU3 
Patient 9 | 01.07.2011 | ICU3 
Env. 7 | 23.03.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Patient 8_R | 22.02.2011 | ICU3 
Patient 7 | 01.02.2011 | ICU1 
Patient 20 | 04.03.2012 | ICU3 
Env. 11 | 24.10.2012 | ICU3 
Patient 22_R | 25.06.2012 | ICU3 
Patient 10_R | 02.05.2011 | ICU3 
Patient 9 | 04.04.2011 | ICU3 
Env. 15 | 25.01.2013 | ICU3 
Env. 16_R | 25.01.2013 | ICU3 
Env. 18 | 25.01.2013 | ICU3 
Patient 5_R | 24.01.2011 | ICU3 
Patient 23_RR | 18.10.2012 | ICU3 
Env. 14 | 25.01.2013 | ICU3 
Patient 4 | 13.01.2011 | ICU3 
Patient 9 | 21.03.2011 | ICU3 
Env. 12 | 25.01.2013 | ICU3 
Patient 14 | 10.10.2011 | ICU ped 
Patient 2_R | 28.05.2010 | ICU3 
Env. 17 | 25.01.2013 | ICU3 
Patient 8 | 13.03.2011 | ICU3 
Env. 13 | 25.01.2013 | ICU3 
Patient 6_R | 30.01.2011 | ICU3 
Env. 2 | 23.03.2012 | ICU3 
Patient 1_R | 24.04.2010 | ICU5 
Patient 1_R | 31.03.2010 | ICU5 
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DLST 1-18 phylogeny  
Adapted methodology: PA14 reference, MQ 20, 20 reads 
  
Figure 49. DLST 1-18 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology mapping 
against P. aeruginosa PA14 with mapping quality of 20 and minimum of 20 reads to consider a SNP site. Non-outbreak isolates 
belonging to Patient 1 are highlighted in grey. Isolates from Patient 4 and 23 are highlighted in pink and blue, respectively. 
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DLST 1-21 pairwise distance matrix  
Adapted methodology: PA14 reference, MQ 20, 20 reads 
 
 
 
 
 
  
Figure 50. DLST 1-21 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. aeruginosa PA14 with 
mapping quality of 20 and minimum of 20 reads to consider a SNP site. Number of SNP differences between pairs of isolates are displayed in each square. Each 
line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 8 (first isolate) to Patient 12 (last isolate). Different colors 
represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the color legend plot pictures the frequency of each number of SNP 
differences. 
 
Patient 12 | 07.11.2012 | ICU4 
Patient 5 | 27.10.2010 | ICU2 
Patient 4 | 02.09.2010 | ICU4 
Patient 1 | 08.01.2010 | ICU5 
Patient 10 | 31.03.2012 | ICU2 
Env. 5 | 02.04.2012 | ICU2 
Patient 11 | 10.04.2012 | ICU2 
Patient 16 | 01.09.2014 | ICU5 
Patient 3 | 18.05.2010 | ICU1 
Patient 13 | 04.12.2012 | ICU1 
Patient 6  | 31.12.2011 | ICU5 
Patient 6  | 28.02.2011 | ICU5 
Env. 6 | 27.04.2012 | ICU5 
Patient 15 | 08.08.2014 | ICU5 
Patient 9 | 13.03.2012 | ICU5 
Patient 2 | 03.05.2010 | ICU5 
Patient 2 | 29.04.2010 | ICU5 
Patient 14 | 02.02.2013 | ICU ped 
Patient 7 | 03.04.2011 | ICU2 
Env. 2_R | 23.12.2004 | ICU ped 
Env. 12 | 07.03.2013 | ICU5 
Env. 1_R | 18.05.2004 | ICU ped 
Env. 8 | 07.12.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 9 | 25.01.2013 | ICU3 
Env. 7 | 13.11.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Env. 11 | 25.01.2013 | ICU3 
Env. 10 | 25.01.2013 | ICU3 
Env. 13 | 29.05.2013 | ICU3 
Patient 8 | 08.12.2011 | ICU ped 
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DLST 1-21 phylogeny  
Adapted methodology: PA14 reference, MQ 20, 20reads 
 
 
  
Figure 51. DLST 1-21 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, 
mapping against the P. aeruginosa PA14 with a mapping quality of 20 and with a minimum of 20 reads to consider a SNP 
site. Three environmental isolates retrieved between 2004 and 2013 are highlighted in orange; isolates from two patients 
and an environmental sample collected from ICU2 are highlighted in blue; subclade of environmental isolates from the burn 
unit are highlighted in green.  
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DLST 6-7 pairwise distance matrix  
Adapted methodology: PA14 reference, MQ 20, 20 reads 
 
 
 
 
 
  
Figure 52. DLST 6-7 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. aeruginosa 
PA14 with mapping quality of 20 and minimum of 20 reads to consider a SNP site.. Number of SNP differences between pairs of isolates are 
displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Env. 1 (first isolate) to Env.9 
(last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, 150, 200, and 300. A white line on the color legend plot 
pictures the frequency of each number of SNP differences. 
 
Env 9 | 30.07.2012 | ICU2 
Env 14 | 20.03.2013 | ICU2 
Env 3 | 02.04.2012 | ICU2 
Env 10 | 07.11.2012 | ICU2 
Patient 11 | 06.12.2011 | ICU2 
Patient 11 | 18.11.2011 | ICU2 
Patient 11 | 07.11.2011 | ICU2 
Patient 20 | 26.04.2014 | ICU2 
Env 15 | 04.03.2014 | ICU2 
Patient 21 | 13.10.2014 | ICU2 
Patient 12 | 09.04.2013 | ICU1 
Patient 12 | 21.03.2013 | ICU1 
Patient 12 | 15.04.2012 | ICU1 
Patient 10 | 26.08.2011 | ICU1 
Patient 16 | 17.05.2013 | ICU3  
Patient 7 | 19.04.2011 | ICU1 
Patient 7 | 21.05.2011 | ICU1 
Patient 13 | 04.05.2012 | ICU5 
Patient 9 | 30.07.2011 | ICU4 
Patient 7 | 04.05.2011 | ICU1 
Patient 14 | 26.09.2012 | ICU1 
Patient 14 | 07.10.2012 | ICU1 
Patient 18 | 11.10.2013 | Not ICU - Ped 
Patient 17 | 30.05.2013 | ICU1 
Patient 19 | 10.01.2014 | ICU2 
Patient 22 | 15.10.2014 | ICU5 
Patient 6 | 16.09.2010 | ICU2 
Patient 8 | 21.07.2011 | ICU ped 
Patient 15 | 12.12.2012 | ICU ped 
Env 6 | 27.04.2012 | ICU4 
Env 13 | 11.12.2012 | ICU3 
Env 7 | 17.07.2012 | ICU3  
Patient 4 | 30.08.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 20.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 02.06.2010 | ICU3  
Patient 5 | 10.09.2010 | ICU3  
Patient 3 | 25.07.2010 | ICU3  
Patient 2 | 10.07.2010 | ICU3  
Patient 5 | 15.08.2010 | ICU3  
Patient 1 | 06.04.2010 | ICU3  
Patient 4 | 03.08.2010 | ICU3  
Env 12 | 08.11.2012 | ICU4 
Env 4 | 03.04.2012 | ICU4 
Env 5 | 27.04.2012 | ICU4 
Env 8 | 17.07.2012 | ICU3  
Env 2 | 10.10.2011 | ICU3  
Env 11 | 07.11.2012 | ICU2 
Env 1 | 10.10.2011 | ICU2 
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DLST 6-7 phylogeny  
Adapted methodology: PA14 reference, MQ 20, 20reads 
Figure 53. DLST 6-7 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against P. 
aeruginosa PA14 with a mapping quality of 20 and with a minimum of 20 reads to consider a SNP site. A subclade of isolates from the burn 
unit suspected to be epidemiologically linked are highlighted in green. Another subclade, in blue, is composed of isolates from Patient 11 and 
environmental isolates retrieved from ICU2. An example of isolates belonging to the same patient, Patient 12, is highlighted in green. Two 
long branches belonging to Env. 1 and Env. 11 are highlighted in red 
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(A) 
 
(B) 
 
(C) 
 
Figure 54. Frequency of number of SNP differences obtained with the adapted methodology, mapping 
against P. aeruginosa PA14 with mapping quality of 20 and minimum of 20 reads to consider a SNP site, 
for (A) DLST 1-18, (B) DLST 1-21, and (C) DLST 6-7. 
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DLST 1-18 pairwise distance matrix  
Adapted methodology: PA14 reference, MQ 60, 20 reads 
 
 
 
 
  
Figure 55. DLST 1-18 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. aeruginosa 
PA14 with mapping quality of 60 and minimum of 20 reads to consider a SNP site. Number of SNP differences between pairs of isolates are 
displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 1 (first isolate) to 
Patient 19 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, and 100. A white line on the color legend plot 
pictures the frequency of each number of SNP differences. 
 
Patient 19_R | 13.03.2012 | ICU3 
Env. 1 | 10.10.2011 | ICU3 
Patient 17_R | 18.02.2012 | ICU3 
Patient 17_R | 01.02.2012 | ICU3 
Env. 7 | 23.03.2012 | ICU3 
Patient 4 | 03.04.2011 | ICU3 
Patient 9 | 18.05.2011 | ICU3 
Patient 8 | 13.03.2011 | ICU3 
Patient 20 | 16.03.2012 | ICU3 
Patient 13_R | 14.07.2011 | ICU3 
Env. 2 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 9 | 17.07.2012 | ICU3 
Patient 3_R | 28.08.2010 | ICU3 
Patient 3 | 15.08.2010 | ICU3 
Patient 6_R | 30.01.2011 | ICU3 
Patient 9 | 01.07.2011 | ICU3 
Patient 13_R | 26.07.2011 | ICU3 
Patient 9 | 08.06.2011 | ICU3 
Env. 12 | 25.01.2013 | ICU3 
Patient 9 | 21.03.2011 | ICU3 
Env. 17 | 25.01.2013 | ICU3 
Patient 14 | 10.10.2011 | ICU ped 
Env. 16_R | 25.01.2013 | ICU3 
Env. 15 | 25.01.2013 | ICU3 
Env. 14 | 25.01.2013 | ICU3 
Patient 5_R | 24.01.2011 | ICU3 
Env. 13 | 25.01.2013 | ICU3 
Env. 18 | 25.01.2013 | ICU3 
Patient 15_R | 16.10.2011 | ICU3 
Patient 17_R | 11.12.2011 | ICU3 
Patient 4 | 13.01.2011 | ICU3 
Patient 23_RR | 18.10.2012 | ICU3 
Patient 2_R | 28.05.2010 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Patient 10_R | 02.05.2011 | ICU3 
Patient 8_R | 22.02.2011 | ICU3 
Patient 7 | 01.02.2011 | ICU1 
Patient 22_R | 25.06.2012 | ICU3 
Patient 9 | 04.04.2011 | ICU3 
Patient 23 | 18.10.2012 | ICU3 
Env. 11 | 24.10.2012 | ICU3 
Patient 20 | 04.03.2012 | ICU3 
Patient 21_R  | 25.04.2012 | ICU4 
Patient 21_R  | 03.05.2012 | ICU4 
Patient 21_R  | 22.04.2012 | ICU4 
Env. 8 | 27.04.2012 | ICU4 
Patient 8 | 28.02.2011 | ICU3 
Patient 20 | 22.03.2012 | ICU3 
Patient 20 | 13.04.2012 | ICU3 
Patient 20 | 18.03.2012 | ICU3 
Patient 23 | 25.10.2012 | ICU3 
Env. 5 | 23.03.2012 | ICU3 
Patient 18_R | 03.01.2012 | ICU3 
Patient 24 | 04.12.2012 | ICU3 
Patient 16 | 08.12.2012 | ICU3 
Patient 19_R | 27.02.2012 | ICU3 
Env. 6 | 23.03.2012 | ICU3 
Patient 16 | 07.12.2011 | ICU3 
Patient 16 | 01.02.2012 | ICU3 
Patient 16 | 15.02.2012 | ICU3 
Patient 16 | 01.03.2012 | ICU3 
Patient 4 | 10.05.2011 | ICU3 
Patient 12_R | 26.06.2011 | ICU4 
Patient 4 | 18.04.2011 | ICU3 
Patient 11_R | 06.06.2011 | ICU4 
Patient 4 | 01.03.2011 | ICU3 
Patient 11 | 11.06.2011 | ICU4 
Patient 4 | 13.04.2011 | ICU3 
Env. 10 | 27.07.2012 | ICU 4/5 
Patient 12_R | 25.07.2011 | ICU4 
Patient 16 | 30.01.2012 | ICU3 
Patient 1_R | 24.04.2010 | ICU5 
Patient 1_R | 31.03.2010 | ICU5 
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DLST 1-18 phylogeny  
Adapted methodology: PA14 reference, MQ 60, 20 reads 
 
  
  
Figure 56. DLST 1-18 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology mapping against 
P. aeruginosa PA14 with mapping quality of 60 and minimum of 20 reads to consider a SNP site. Non-outbreak isolates belonging to 
Patient 1 are highlighted in grey. Isolates from Patient 4 and 23 are highlighted in pink and blue, respectively. 
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DLST 1-21 pairwise distance matrix  
Adapted methodology: PA14 reference, MQ 60, 20 reads 
 
 
 
  
Figure 57. DLST 1-21 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. 
aeruginosa PA14 with mapping quality of 60 and minimum of 20 reads to consider a SNP site. Number of SNP differences between pairs of 
isolates are displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from: left to right: Patient 8 
(first isolate) to Env. 5 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the color 
legend plot pictures the frequency of each number of SNP differences. 
 
Env. 5 | 02.04.2012 | ICU2 
Patient 11 | 10.04.2012 | ICU2 
Patient 10 | 31.03.2012 | ICU2 
Patient 16 | 01.09.2014 | ICU5 
Patient 12 | 07.11.2012 | ICU4 
Patient 5 | 27.10.2010 | ICU2 
Patient 4 | 02.09.2010 | ICU4 
Patient 1 | 08.01.2010 | ICU5 
Patient 3 | 18.05.2010 | ICU1 
Patient 13 | 04.12.2012 | ICU1 
Patient 6  | 31.12.2011 | ICU5 
Patient 6  | 28.02.2011 | ICU5 
Env. 6 | 27.04.2012 | ICU5 
Patient 15 | 08.08.2014 | ICU5 
Patient 9 | 13.03.2012 | ICU5 
Patient 2 | 03.05.2010 | ICU5 
Patient 2 | 29.04.2010 | ICU5 
Patient 14 | 02.02.2013 | ICU ped 
Patient 7 | 03.04.2011 | ICU2 
Env. 2_R | 23.12.2004 | ICU ped 
Env. 12 | 07.03.2013 | ICU5 
Env. 1_R | 18.05.2004 | ICU ped 
Env. 11 | 25.01.2013 | ICU3 
Env. 10 | 25.01.2013 | ICU3 
Env. 9 | 25.01.2013 | ICU3 
Env. 8 | 07.12.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 7 | 13.11.2012 | ICU3 
Env. 13 | 29.05.2013 | ICU3 
Patient 8 | 08.12.2011 | ICU ped 
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DLST 1-21 phylogeny  
Adapted methodology: PA14 reference, MQ 60, 20 reads 
  
Figure 58. DLST 1-21 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping 
against the P. aeruginosa PA14 with a mapping quality of 60 and with a minimum of 20 reads to consider a SNP site. Three 
environmental isolates retrieved between 2004 and 2013 are highlighted in orange; isolates from two patients and an environmental 
sample collected from ICU2 are highlighted in blue; subclade of environmental isolates from the burn unit are highlighted in green.  
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DLST 6-7 pairwise distance matrix  
Adapted methodology: PA14 reference, MQ 60, 20 reads 
 
 
 
 
  
Figure 59. DLST 6-7 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against P. 
aeruginosa PA14 with mapping quality of 60 and minimum of 20 reads to consider a SNP site. Number of SNP differences between pairs of 
isolates are displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Env. 1 (first 
isolate) to Patient 11 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, 150, 200, and 400. A white line on 
the color legend plot pictures the frequency of each number of SNP differences. 
Patient 11 | 18.11.2011 | ICU2 
Env 9 | 30.07.2012 | ICU2 
Patient 11 | 06.12.2011 | ICU2 
Patient 11 | 07.11.2011 | ICU2 
Env 10 | 07.11.2012 | ICU2 
Env 3 | 02.04.2012 | ICU2 
Env 14 | 20.03.2013 | ICU2 
Patient 21 | 13.10.2014 | ICU2 
Patient 12 | 15.04.2012 | ICU1 
Patient 12 | 21.03.2013 | ICU1 
Patient 12 | 09.04.2013 | ICU1 
Patient 20 | 26.04.2014 | ICU2 
Env 15 | 04.03.2014 | ICU2 
Patient 14 | 26.09.2012 | ICU1 
Patient 14 | 07.10.2012 | ICU1 
Patient 18 | 11.10.2013 | Not ICU - Ped 
Patient 7 | 19.04.2011 | ICU1 
Patient 7 | 21.05.2011 | ICU1 
Patient 13 | 04.05.2012 | ICU5 
Patient 7 | 04.05.2011 | ICU1 
Patient 10 | 26.08.2011 | ICU1 
Patient 16 | 17.05.2013 | ICU3  
Patient 9 | 30.07.2011 | ICU4 
Patient 19 | 10.01.2014 | ICU2 
Patient 17 | 30.05.2013 | ICU1 
Patient 8 | 21.07.2011 | ICU ped 
Patient 22 | 15.10.2014 | ICU5 
Patient 6 | 16.09.2010 | ICU2 
Patient 15 | 12.12.2012 | ICU ped 
Env 6 | 27.04.2012 | ICU4 
Env 13 | 11.12.2012 | ICU3 
Env 7 | 17.07.2012 | ICU3  
Patient 4 | 30.08.2010 | ICU3  
Patient 2 | 20.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 02.06.2010 | ICU3  
Patient 3 | 25.07.2010 | ICU3  
Patient 5 | 10.09.2010 | ICU3  
Patient 2 | 10.07.2010 | ICU3  
Patient 4 | 03.08.2010 | ICU3  
Patient 5 | 15.08.2010 | ICU3  
Patient 1 | 06.04.2010 | ICU3  
Env 5 | 27.04.2012 | ICU4 
Env 4 | 03.04.2012 | ICU4 
Env 12 | 08.11.2012 | ICU4 
Env 8 | 17.07.2012 | ICU3  
Env 2 | 10.10.2011 | ICU3  
Env 11 | 07.11.2012 | ICU2 
Env 1 | 10.10.2011 | ICU2 
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DLST 6-7 phylogeny  
Adapted methodology: PA14 reference, MQ 60, 20 reads 
Figure 60. DLST 6-7 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against P. 
aeruginosa PA14 with a mapping quality of 60 and with a minimum of 20 reads to consider a SNP site. A subclade of isolates from the burn 
unit suspected to be epidemiologically linked are highlighted in green. Another subclade, in blue, is composed of isolates from Patient 11 
and environmental isolates retrieved from ICU2. An example of isolates belonging to the same patient, Patient 12, is highlighted in green. 
Two long branches belonging to Env. 1 and Env. 11 are highlighted in red 
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(A) 
 
(B) 
 
(C) 
 
Figure 61. Frequency of number of SNP differences obtained with the adapted methodology, mapping 
against P. aeruginosa PA14 with mapping quality of 60 and minimum of 20 reads to consider a SNP site, 
for (A) DLST 1-18, (B) DLST 1-21, and (C) DLST 6-7. 
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DLST 1-18 pairwise distance matrix  
Adapted methodology: PacBio reference, MQ 20, 10 reads 
 
 
 
 
  
Figure 62. DLST 1-18 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the 
PacBio reference with mapping quality of 20 and minimum of 10 reads to consider a SNP site. Number of SNP differences between pairs of 
isolates are displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 1 
(first isolate) to Env. 1 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the 
color legend plot pictures the frequency of each number of SNP differences. 
Env. 1 | 10.10.2011 | ICU3 
Patient 18_R | 03.01.2012 | ICU3 
Patient 4 | 03.04.2011 | ICU3 
Patient 17_R | 18.02.2012 | ICU3 
Patient 17_R | 01.02.2012 | ICU3 
Env. 2 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 9 | 17.07.2012 | ICU3 
Patient 6_R | 30.01.2011 | ICU3 
Patient 3_R | 28.08.2010 | ICU3 
Patient 20 | 16.03.2012 | ICU3 
Patient 8 | 13.03.2011 | ICU3 
Patient 13_R | 14.07.2011 | ICU3 
Patient 9 | 18.05.2011 | ICU3 
Patient 19_R | 13.03.2012 | ICU3 
Env. 7 | 23.03.2012 | ICU3 
Patient 3 | 15.08.2010 | ICU3 
Patient 13_R | 26.07.2011 | ICU3 
Patient 9 | 01.07.2011 | ICU3 
Patient 9 | 08.06.2011 | ICU3 
Patient 21_R  | 03.05.2012 | ICU4 
Env. 8 | 27.04.2012 | ICU4 
Patient 21_R  | 25.04.2012 | ICU4 
Patient 21_R  | 22.04.2012 | ICU4 
Patient 8 | 28.02.2011 | ICU3 
Patient 20 | 22.03.2012 | ICU3 
Patient 20 | 13.04.2012 | ICU3 
Patient 20 | 18.03.2012 | ICU3 
Patient 23 | 25.10.2012 | ICU3 
Patient 16 | 07.12.2011 | ICU3 
Patient 19_R | 27.02.2012 | ICU3 
Env. 6 | 23.03.2012 | ICU3 
Patient 16 | 08.12.2012 | ICU3 
Patient 16 | 01.02.2012 | ICU3 
Patient 16 | 01.03.2012 | ICU3 
Patient 16 | 15.02.2012 | ICU3 
Env. 5 | 23.03.2012 | ICU3 
Patient 24 | 04.12.2012 | ICU3 
Patient 5_R | 24.01.2011 | ICU3 
Env. 13 | 25.01.2013 | ICU3 
Patient 9 | 21.03.2011 | ICU3 
Env. 18 | 25.01.2013 | ICU3 
Env. 14 | 25.01.2013 | ICU3 
Env. 16_R | 25.01.2013 | ICU3 
Env. 15 | 25.01.2013 | ICU3 
Patient 14 | 10.10.2011 | ICU ped 
Env. 12 | 25.01.2013 | ICU3 
Env. 17 | 25.01.2013 | ICU3 
Patient 15_R | 16.10.2011 | ICU3 
Patient 17_R | 11.12.2011 | ICU3 
Patient 4 | 13.01.2011 | ICU3 
Patient 23_RR | 18.10.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Patient 2_R | 28.05.2010 | ICU3 
Patient 8_R | 22.02.2011 | ICU3 
Patient 22_R | 25.06.2012 | ICU3 
Patient 7 | 01.02.2011 | ICU1 
Patient 10_R | 02.05.2011 | ICU3 
Patient 9 | 04.04.2011 | ICU3 
Patient 23 | 18.10.2012 | ICU3 
Env. 11 | 24.10.2012 | ICU3 
Patient 20 | 04.03.2012 | ICU3 
Patient 12_R | 25.07.2011 | ICU4 
Patient 12_R | 26.06.2011 | ICU4 
Env. 10 | 27.07.2012 | ICU 4/5 
Patient 11 | 11.06.2011 | ICU4 
Patient 11_R | 06.06.2011 | ICU4 
Patient 4 | 13.04.2011 | ICU3 
Patient 4 | 18.04.2011 | ICU3 
Patient 4 | 10.05.2011 | ICU3 
Patient 4 | 01.03.2011 | ICU3 
Patient 16 | 30.01.2012 | ICU3 
Patient 1_R | 24.04.2010 | ICU5 
Patient 1_R | 31.03.2010 | ICU5 
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DLST 1-18 phylogeny  
Adapted methodology: PacBio reference, MQ 20, 10 reads 
 
  
  
Figure 63. DLST 1-18 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology mapping 
against the PacBio reference with mapping quality of 20 and minimum of 10 reads to consider a SNP site. Non-outbreak isolates 
belonging to Patient 1 are highlighted in grey. Isolates from Patient 4 and 23 are highlighted in pink and blue, respectively. 
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DLST 1-21 pairwise distance matrix  
Adapted methodology: PacBio reference, MQ 20, 10 reads 
 
 
 
 
  
Figure 64. DLST 1-21 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the PacBio 
reference with mapping quality of 20 and minimum of 10 reads to consider a SNP site. Number of SNP differences between pairs of isolates are 
displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 8 (first isolate) to 
Patient 11 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the color legend plot 
pictures the frequency of each number of SNP differences. 
 
Patient 11 | 10.04.2012 | ICU2 
Patient 10 | 31.03.2012 | ICU2 
Env. 5 | 02.04.2012 | ICU2 
Patient 16 | 01.09.2014 | ICU5 
Patient 12 | 07.11.2012 | ICU4 
Patient 5 | 27.10.2010 | ICU2 
Patient 4 | 02.09.2010 | ICU4 
Patient 1 | 08.01.2010 | ICU5 
Patient 3 | 18.05.2010 | ICU1 
Patient 13 | 04.12.2012 | ICU1 
Patient 6  | 31.12.2011 | ICU5 
Patient 6  | 28.02.2011 | ICU5 
Patient 9 | 13.03.2012 | ICU5 
Env. 6 | 27.04.2012 | ICU5 
Patient 15 | 08.08.2014 | ICU5 
Patient 2 | 03.05.2010 | ICU5 
Patient 2 | 29.04.2010 | ICU5 
Patient 14 | 02.02.2013 | ICU ped 
Patient 7 | 03.04.2011 | ICU2 
Env. 9 | 25.01.2013 | ICU3 
Env. 11 | 25.01.2013 | ICU3 
Env. 10 | 25.01.2013 | ICU3 
Env. 8 | 07.12.2012 | ICU3 
Env. 7 | 13.11.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 13 | 29.05.2013 | ICU3 
Env. 2_R | 23.12.2004 | ICU ped 
Env. 12 | 07.03.2013 | ICU5 
Env. 1_R | 18.05.2004 | ICU ped 
Patient 8 | 08.12.2011 | ICU ped 
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DLST 1-21 phylogeny  
Adapted methodology: PacBio reference, MQ 20, 10 reads 
 
  
Figure 65. DLST 1-21 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against 
the PacBio reference with a mapping quality of 20 and with a minimum of 10 reads to consider a SNP site. Three environmental isolates 
retrieved between 2004 and 2013 are highlighted in orange; isolates from two patients and an environmental sample collected from 
ICU2 are highlighted in blue; subclade of environmental isolates from the burn unit are highlighted in green.  
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DLST 6-7 pairwise distance matrix  
Adapted methodology: PacBio reference, MQ 20, 10 reads 
 
 
 
 
 
  
Figure 66. DLST 6-7 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the PacBio 
reference with mapping quality of 20 and minimum of 10 reads to consider a SNP site. Number of SNP differences between pairs of isolates are 
displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Env. 1 (first isolate) to Env. 
9 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, 150, 200, and 300. A white line on the color legend plot 
pictures the frequency of each number of SNP differences. 
Env 9 | 30.07.2012 | ICU2 
Env 3 | 02.04.2012 | ICU2 
Env 14 | 20.03.2013 | ICU2 
Env 10 | 07.11.2012 | ICU2 
Patient 11 | 18.11.2011 | ICU2 
Patient 11 | 06.12.2011 | ICU2 
Patient 11 | 07.11.2011 | ICU2 
Patient 20 | 26.04.2014 | ICU2 
Env 15 | 04.03.2014 | ICU2 
Patient 7 | 04.05.2011 | ICU1 
Patient 7 | 19.04.2011 | ICU1 
Patient 7 | 21.05.2011 | ICU1 
Patient 13 | 04.05.2012 | ICU5 
Patient 12 | 15.04.2012 | ICU1 
Patient 12 | 09.04.2013 | ICU1 
Patient 12 | 21.03.2013 | ICU1 
Patient 16 | 17.05.2013 | ICU3  
Patient 18 | 11.10.2013 | Not ICU - Ped 
Patient 21 | 13.10.2014 | ICU2 
Patient 14 | 07.10.2012 | ICU1 
Patient 14 | 26.09.2012 | ICU1 
Patient 10 | 26.08.2011 | ICU1 
Patient 9 | 30.07.2011 | ICU4 
Patient 4 | 30.08.2010 | ICU3  
Patient 5 | 10.09.2010 | ICU3  
Patient 3 | 25.07.2010 | ICU3  
Patient 2 | 10.07.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 20.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 02.06.2010 | ICU3  
Env 8 | 17.07.2012 | ICU3  
Env 2 | 10.10.2011 | ICU3  
Env 4 | 03.04.2012 | ICU4 
Env 5 | 27.04.2012 | ICU4 
Patient 5 | 15.08.2010 | ICU3  
Patient 4 | 03.08.2010 | ICU3  
Patient 1 | 06.04.2010 | ICU3  
Env 12 | 08.11.2012 | ICU4 
Patient 17 | 30.05.2013 | ICU1 
Patient 8 | 21.07.2011 | ICU ped 
Patient 19 | 10.01.2014 | ICU2 
Patient 15 | 12.12.2012 | ICU ped 
Env 6 | 27.04.2012 | ICU4 
Patient 22 | 15.10.2014 | ICU5 
Patient 6 | 16.09.2010 | ICU2 
Env 13 | 11.12.2012 | ICU3 
Env 7 | 17.07.2012 | ICU3  
Env 11 | 07.11.2012 | ICU2 
Env 1 | 10.10.2011 | ICU2 
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DLST 6-7 phylogeny  
Adapted methodology: PacBio reference, MQ 20, 10 reads 
 
 
Figure 67. DLST 6-7 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against the 
PacbBio reference with a mapping quality of 20 and with a minimum of 10 reads to consider a SNP site. A subclade of isolates from the 
burn unit suspected to be epidemiologically linked are highlighted in green. Another subclade, in blue, is composed of isolates from Patient 
11 and environmental isolates retrieved from ICU2. An example of isolates belonging to the same patient, Patient 12, is highlighted in 
green. Two long branches belonging to Env. 1 and Env. 11 are highlighted in red 
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(A) 
 
(B) 
 
(C) 
 
Figure 68. Frequency of number of SNP differences obtained with the adapted methodology, mapping 
against the PacBio reference with mapping quality of 20 and minimum of 10 reads to consider a SNP site, 
for (A) DLST 1-18, (B) DLST 1-21, and (C) DLST 6-7. 
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DLST 1-18 pairwise distance matrix  
Adapted methodology: PacBio reference, MQ 20, 20 reads 
 
 
 
 
 
  
Figure 69. DLST 1-18 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the PacBio 
reference with mapping quality of 20 and minimum of 20 reads to consider a SNP site. Number of SNP differences between pairs of isolates are 
displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 1 (first isolate) to 
Env. 1 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the color legend plot 
pictures the frequency of each number of SNP differences. 
Env. 1 | 10.10.2011 | ICU3 
Patient 18_R | 03.01.2012 | ICU3 
Patient 4 | 03.04.2011 | ICU3 
Patient 17_R | 18.02.2012 | ICU3 
Patient 17_R | 01.02.2012 | ICU3 
Env. 2 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 9 | 17.07.2012 | ICU3 
Patient 6_R | 30.01.2011 | ICU3 
Patient 3_R | 28.08.2010 | ICU3 
Patient 20 | 16.03.2012 | ICU3 
Patient 8 | 13.03.2011 | ICU3 
Patient 13_R | 14.07.2011 | ICU3 
Patient 9 | 18.05.2011 | ICU3 
Patient 19_R | 13.03.2012 | ICU3 
Env. 7 | 23.03.2012 | ICU3 
Patient 3 | 15.08.2010 | ICU3 
Patient 13_R | 26.07.2011 | ICU3 
Patient 9 | 01.07.2011 | ICU3 
Patient 9 | 08.06.2011 | ICU3 
Patient 21_R  | 03.05.2012 | ICU4 
Env. 8 | 27.04.2012 | ICU4 
Patient 21_R  | 25.04.2012 | ICU4 
Patient 21_R  | 22.04.2012 | ICU4 
Patient 8 | 28.02.2011 | ICU3 
Patient 20 | 22.03.2012 | ICU3 
Patient 20 | 13.04.2012 | ICU3 
Patient 20 | 18.03.2012 | ICU3 
Patient 23 | 25.10.2012 | ICU3 
Patient 16 | 07.12.2011 | ICU3 
Patient 19_R | 27.02.2012 | ICU3 
Env. 6 | 23.03.2012 | ICU3 
Patient 16 | 08.12.2012 | ICU3 
Patient 16 | 01.02.2012 | ICU3 
Patient 16 | 01.03.2012 | ICU3 
Patient 16 | 15.02.2012 | ICU3 
Env. 5 | 23.03.2012 | ICU3 
Patient 24 | 04.12.2012 | ICU3 
Patient 5_R | 24.01.2011 | ICU3 
Env. 13 | 25.01.2013 | ICU3 
Patient 9 | 21.03.2011 | ICU3 
Env. 18 | 25.01.2013 | ICU3 
Env. 14 | 25.01.2013 | ICU3 
Env. 16_R | 25.01.2013 | ICU3 
Env. 15 | 25.01.2013 | ICU3 
Patient 14 | 10.10.2011 | ICU ped 
Env. 12 | 25.01.2013 | ICU3 
Env. 17 | 25.01.2013 | ICU3 
Patient 15_R | 16.10.2011 | ICU3 
Patient 17_R | 11.12.2011 | ICU3 
Patient 4 | 13.01.2011 | ICU3 
Patient 23_RR | 18.10.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Patient 2_R | 28.05.2010 | ICU3 
Patient 8_R | 22.02.2011 | ICU3 
Patient 22_R | 25.06.2012 | ICU3 
Patient 7 | 01.02.2011 | ICU1 
Patient 10_R | 02.05.2011 | ICU3 
Patient 9 | 04.04.2011 | ICU3 
Patient 23 | 18.10.2012 | ICU3 
Env. 11 | 24.10.2012 | ICU3 
Patient 20 | 04.03.2012 | ICU3 
Patient 12_R | 25.07.2011 | ICU4 
Patient 12_R | 26.06.2011 | ICU4 
Env. 10 | 27.07.2012 | ICU 4/5 
Patient 11 | 11.06.2011 | ICU4 
Patient 11_R | 06.06.2011 | ICU4 
Patient 4 | 13.04.2011 | ICU3 
Patient 4 | 18.04.2011 | ICU3 
Patient 4 | 10.05.2011 | ICU3 
Patient 4 | 01.03.2011 | ICU3 
Patient 16 | 30.01.2012 | ICU3 
Patient 1_R | 24.04.2010 | ICU5 
Patient 1_R | 31.03.2010 | ICU5 
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DLST 1-18 phylogeny  
Adapted methodology: PacBio reference, MQ 20, 20 reads 
  
Figure 70. DLST 1-18 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology mapping 
against the PacBio reference with mapping quality of 20 and minimum of 20 reads to consider a SNP site. Non-outbreak isolates 
belonging to Patient 1 are highlighted in grey. Isolates from Patient 4 and 23 are highlighted in pink and blue, respectively. 
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DLST 1-21 pairwise distance matrix  
Adapted methodology: PacBio reference, MQ 20, 20 reads 
 
 
 
 
  
Figure 71. DLST 1-21 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the PacBio 
reference with mapping quality of 20 and minimum of 20 reads to consider a SNP site. Number of SNP differences between pairs of isolates are 
displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 8 (first isolate) to 
Patient 12 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the color legend plot 
pictures the frequency of each number of SNP differences. 
 
Patient 12 | 07.11.2012 | ICU4 
Patient 5 | 27.10.2010 | ICU2 
Patient 4 | 02.09.2010 | ICU4 
Patient 1 | 08.01.2010 | ICU5 
Patient 11 | 10.04.2012 | ICU2 
Patient 10 | 31.03.2012 | ICU2 
Env. 5 | 02.04.2012 | ICU2 
Patient 16 | 01.09.2014 | ICU5 
Patient 3 | 18.05.2010 | ICU1 
Patient 13 | 04.12.2012 | ICU1 
Patient 6 | 31.12.2011 | ICU5 
Patient 6 | 28.02.2011 | ICU5 
Env. 6 | 27.04.2012 | ICU5 
Patient 15 | 08.08.2014 | ICU5 
Patient 9 | 13.03.2012 | ICU5 
Patient 7 | 03.04.2011 | ICU2 
Patient 2 | 03.05.2010 | ICU5 
Patient 2 | 29.04.2010 | ICU5 
Patient 14 | 02.02.2013 | ICU ped 
Env. 9 | 25.01.2013 | ICU3 
Env. 11 | 25.01.2013 | ICU3 
Env. 10 | 25.01.2013 | ICU3 
Env. 8 | 07.12.2012 | ICU3 
Env. 7 | 13.11.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 13 | 29.05.2013 | ICU3 
Env. 2_R | 23.12.2004 | ICU ped 
Env. 12 | 07.03.2013 | ICU5 
Env. 1_R | 18.05.2004 | ICU ped 
Patient 8 | 08.12.2011 | ICU ped 
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DLST 1-21 phylogeny  
Adapted methodology: PacBio reference, MQ 20, 20 reads 
  
Figure 72. DLST 1-21 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against 
the PacBio reference with a mapping quality of 20 and with a minimum of 20 reads to consider a SNP site. Three environmental 
isolates retrieved between 2004 and 2013 are highlighted in orange; isolates from two patients and an environmental sample collected 
from ICU2 are highlighted in blue; subclade of environmental isolates from the burn unit are highlighted in green.  
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DLST 6-7 pairwise distance matrix  
Adapted methodology: PacBio reference, MQ 20, 20 reads 
 
 
 
 
 
  
Figure 73. DLST 6-7 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the PacBio 
reference with mapping quality of 20 and minimum of 20 reads to consider a SNP site. Number of SNP differences between pairs of isolates are 
displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Env. 1 (first isolate) to 
Patient 4 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, 150, 200, and 300. A white line on the color 
legend plot pictures the frequency of each number of SNP differences. 
Patient 4 | 30.08.2010 | ICU3  
Patient 5 | 10.09.2010 | ICU3  
Patient 3 | 25.07.2010 | ICU3  
Patient 2 | 10.07.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 20.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 02.06.2010 | ICU3  
Env 8 | 17.07.2012 | ICU3  
Env 2 | 10.10.2011 | ICU3  
Env 4 | 03.04.2012 | ICU4 
Env 5 | 27.04.2012 | ICU4 
Env 12 | 08.11.2012 | ICU4 
Patient 5 | 15.08.2010 | ICU3  
Patient 4 | 03.08.2010 | ICU3  
Patient 1 | 06.04.2010 | ICU3  
Env 9 | 30.07.2012 | ICU2 
Env 3 | 02.04.2012 | ICU2 
Env 14 | 20.03.2013 | ICU2 
Env 10 | 07.11.2012 | ICU2 
Patient 11 | 18.11.2011 | ICU2 
Patient 11 | 06.12.2011 | ICU2 
Patient 11 | 07.11.2011 | ICU2 
Patient 21 | 13.10.2014 | ICU2 
Patient 20 | 26.04.2014 | ICU2 
Env 15 | 04.03.2014 | ICU2 
Patient 7 | 04.05.2011 | ICU1 
Patient 7 | 19.04.2011 | ICU1 
Patient 7 | 21.05.2011 | ICU1 
Patient 13 | 04.05.2012 | ICU5 
Patient 10 | 26.08.2011 | ICU1 
Patient 16 | 17.05.2013 | ICU3  
Patient 9 | 30.07.2011 | ICU4 
Patient 12 | 15.04.2012 | ICU1 
Patient 12 | 09.04.2013 | ICU1 
Patient 12 | 21.03.2013 | ICU1 
Patient 14 | 07.10.2012 | ICU1 
Patient 14 | 26.09.2012 | ICU1 
Patient 18 | 11.10.2013 | Not ICU - Ped 
Env 6 | 27.04.2012 | ICU4 
Patient 8 | 21.07.2011 | ICU ped 
Patient 6 | 16.09.2010 | ICU2 
Patient 15 | 12.12.2012 | ICU ped 
Patient 19 | 10.01.2014 | ICU2 
Patient 17 | 30.05.2013 | ICU1 
Patient 22 | 15.10.2014 | ICU5 
Env 13 | 11.12.2012 | ICU3 
Env 7 | 17.07.2012 | ICU3  
Patient 13 | 04.05.2012 | ICU5 
Env 1 | 10.10.2011 | ICU2 
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DLST 6-7 phylogeny  
Adapted methodology: PacBio reference, MQ 20, 20 reads  
 
 
Figure 74. DLST 6-7 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against the PacbBio 
reference with a mapping quality of 20 and with a minimum of 20 reads to consider a SNP site. A subclade of isolates from the burn unit suspected to 
be epidemiologically linked are highlighted in green. Another subclade, in blue, is composed of isolates from Patient 11 and environmental isolates 
retrieved from ICU2. An example of isolates belonging to the same patient, Patient 12, is highlighted in green. Two long branches belonging to Env. 1 
and Env. 11 are highlighted in red 
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(A) 
 
(B) 
 
(C) 
 
 
Figure 75. Frequency of number of SNP differences obtained with the adapted methodology, mapping 
against the PacBio reference with mapping quality of 20 and minimum of 20 reads to consider a SNP site, 
for (A) DLST 1-18, (B) DLST 1-21, and (C) DLST 6-7. 
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DLST 1-18 pairwise distance matrix  
Adapted methodology: PacBio reference, MQ 60, 20 reads 
 
 
 
 
  
Figure 76. DLST 1-18 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the PacBio 
reference with mapping quality of 60 and minimum of 20 reads to consider a SNP site. Number of SNP differences between pairs of isolates are 
displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 1 (first isolate) to 
Patient 3 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the color legend plot 
pictures the frequency of each number of SNP differences. 
Patient 3 | 15.08.2010 | ICU3 
Patient 23_RR | 18.10.2012 | ICU3 
Patient 14 | 10.10.2011 | ICU ped 
Env. 4 | 23.03.2012 | ICU3 
Env. 7 | 23.03.2012 | ICU3 
Patient 15_R | 16.10.2011 | ICU3 
Patient 8 | 13.03.2011 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 17 | 25.01.2013 | ICU3 
Patient 9 | 18.05.2011 | ICU3 
Env. 2 | 23.03.2012 | ICU3 
Patient 13_R | 14.07.2011 | ICU3 
Env. 9 | 17.07.2012 | ICU3 
Patient 2_R | 28.05.2010 | ICU3 
Patient 9 | 04.04.2011 | ICU3 
Patient 23 | 18.10.2012 | ICU3 
Env. 14 | 25.01.2013 | ICU3 
Patient 4 | 13.01.2011 | ICU3 
Env. 18 | 25.01.2013 | ICU3 
Patient 9 | 21.03.2011 | ICU3 
Env. 12 | 25.01.2013 | ICU3 
Patient 6_R | 30.01.2011 | ICU3 
Patient 8_R | 22.02.2011 | ICU3 
Patient 10_R | 02.05.2011 | ICU3 
Env. 15 | 25.01.2013 | ICU3 
Patient 22_R | 25.06.2012 | ICU3 
Env. 16_R | 25.01.2013 | ICU3 
Patient 17_R | 11.12.2011 | ICU3 
Patient 5_R | 24.01.2011 | ICU3 
Env. 13 | 25.01.2013 | ICU3 
Patient 20 | 16.03.2012 | ICU3 
Patient 3_R | 28.08.2010 | ICU3 
Patient 7 | 01.02.2011 | ICU1 
Env. 11 | 24.10.2012 | ICU3 
Patient 17_R | 01.02.2012 | ICU3 
Patient 17_R | 18.02.2012 | ICU3 
Patient 19_R | 13.03.2012 | ICU3 
Patient 9 | 01.07.2011 | ICU3 
Patient 13_R | 26.07.2011 | ICU3 
Patient 20 | 04.03.2012 | ICU3 
Patient 21_R  | 25.04.2012 | ICU4 
Patient 21_R  | 22.04.2012 | ICU4 
Env. 8 | 27.04.2012 | ICU4 
Patient 21_R  | 03.05.2012 | ICU4 
Patient 8 | 28.02.2011 | ICU3 
Patient 23 | 25.10.2012 | ICU3 
Patient 9 | 08.06.2011 | ICU3 
Patient 20 | 18.03.2012 | ICU3 
Patient 20 | 13.04.2012 | ICU3 
Patient 20 | 22.03.2012 | ICU3 
Patient 18_R | 03.01.2012 | ICU3 
Patient 24 | 04.12.2012 | ICU3 
Env. 5 | 23.03.2012 | ICU3 
Env. 1 | 10.10.2011 | ICU3 
Patient 4 | 03.04.2011 | ICU3 
Patient 16 | 08.12.2012 | ICU3 
Patient 19_R | 27.02.2012 | ICU3 
Env. 6 | 23.03.2012 | ICU3 
Patient 16 | 07.12.2011 | ICU3 
Patient 16 | 01.02.2012 | ICU3 
Patient 16 | 01.03.2012 | ICU3 
Patient 16 | 15.02.2012 | ICU3 
Patient 12_R | 26.06.2011 | ICU4 
Patient 11_R | 06.06.2011 | ICU4 
Patient 11 | 11.06.2011 | ICU4 
Patient 4 | 13.04.2011 | ICU3 
Patient 12_R | 25.07.2011 | ICU4 
Env. 10 | 27.07.2012 | ICU 4/5 
Patient 4 | 18.04.2011 | ICU3 
Patient 4 | 01.03.2011 | ICU3 
Patient 4 | 10.05.2011 | ICU3 
Patient 16 | 30.01.2012 | ICU3 
Patient 1_R | 24.04.2010 | ICU5 
Patient 1_R | 31.03.2010 | ICU5 
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DLST 1-18 phylogeny  
Adapted methodology: PacBio reference, MQ 60, 20 reads 
  
Figure 77. DLST 1-18 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology mapping against the 
PacBio reference with mapping quality of 60 and minimum of 20 reads to consider a SNP site. Non-outbreak isolates belonging to Patient 1 
are highlighted in grey. Isolates from Patient 4 and 23 are highlighted in pink and blue, respectively. 
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DLST 1-21 pairwise distance matrix  
Adapted methodology: PacBio reference, MQ 60, 20 reads 
 
 
 
 
  
Figure 78. DLST 1-21 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the PacBio 
reference with mapping quality of 60 and minimum of 20 reads to consider a SNP site. Number of SNP differences between pairs of isolates are 
displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 8 (first isolate) to 
Patient 11 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, and 150. A white line on the color legend plot 
pictures the frequency of each number of SNP differences. 
Patient 11 | 10.04.2012 | ICU2 
Patient 10 | 31.03.2012 | ICU2 
Env. 5 | 02.04.2012 | ICU2 
Patient 16 | 01.09.2014 | ICU5 
Patient 12 | 07.11.2012 | ICU4 
Patient 5 | 27.10.2010 | ICU2 
Patient 4 | 02.09.2010 | ICU4 
Patient 1 | 08.01.2010 | ICU5 
Patient 3 | 18.05.2010 | ICU1 
Patient 13 | 04.12.2012 | ICU1 
Patient 6  | 31.12.2011 | ICU5 
Patient 6  | 28.02.2011 | ICU5 
Env. 6 | 27.04.2012 | ICU5 
Patient 15 | 08.08.2014 | ICU5 
Patient 9 | 13.03.2012 | ICU5 
Patient 7 | 03.04.2011 | ICU2 
Patient 2 | 03.05.2010 | ICU5 
Patient 2 | 29.04.2010 | ICU5 
Patient 14 | 02.02.2013 | ICU ped 
Env. 11 | 25.01.2013 | ICU3 
Env. 10 | 25.01.2013 | ICU3 
Env. 9 | 25.01.2013 | ICU3 
Env. 8 | 07.12.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 7 | 13.11.2012 | ICU3 
Env. 13 | 29.05.2013 | ICU3 
Env. 2_R | 23.12.2004 | ICU ped 
Env. 12 | 07.03.2013 | ICU5 
Env. 1_R | 18.05.2004 | ICU ped 
Patient 8 | 08.12.2011 | ICU ped 
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DLST 1-21 phylogeny  
Adapted methodology: PacBio reference, MQ 60, 20 reads 
 
  
Figure 79. DLST 1-21 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against the 
PacBio reference with a mapping quality of 60 and with a minimum of 20 reads to consider a SNP site. Three environmental isolates 
retrieved between 2004 and 2013 are highlighted in orange; isolates from two patients and an environmental sample collected from ICU2 
are highlighted in blue; subclade of environmental isolates from the burn unit are highlighted in green.  
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DLST 6-7 pairwise distance matrix  
Adapted methodology: PacBio reference, MQ 60, 20 reads 
 
 
 
 
  
Figure 80. DLST 6-7 color heatmap showing pairwise genomic distances obtained with the adapted methodology, mapping against the PacBio 
reference with mapping quality of 60 and minimum of 20 reads to consider a SNP site. Number of SNP differences between pairs of isolates are 
displayed in each square. Each line corresponds to an isolate. Isolate’s identification on the columns from left to right: Env. 1 (first isolate) to 
Patient 7 (last isolate). Different colors represent different SNP differences’ limits:10, 20, 50, 100, 150, 200, and 400. A white line on the color 
legend plot pictures the frequency of each number of SNP differences. 
Patient 7 | 04.05.2011 | ICU1 
Patient 7 | 19.04.2011 | ICU1 
Patient 7 | 21.05.2011 | ICU1 
Patient 13 | 04.05.2012 | ICU5 
Patient 9 | 30.07.2011 | ICU4 
Patient 12 | 09.04.2013 | ICU1 
Patient 12 | 21.03.2013 | ICU1 
Patient 12 | 15.04.2012 | ICU1 
Patient 10 | 26.08.2011 | ICU1 
Patient 16 | 17.05.2013 | ICU3  
Patient 14 | 07.10.2012 | ICU1 
Patient 14 | 26.09.2012 | ICU1 
Patient 18 | 11.10.2013 | Not ICU - Ped 
Env 14 | 20.03.2013 | ICU2 
Env 3 | 02.04.2012 | ICU2 
Env 9 | 30.07.2012 | ICU2 
Patient 11 | 18.11.2011 | ICU2 
Env 10 | 07.11.2012 | ICU2 
Patient 11 | 06.12.2011 | ICU2 
Patient 11 | 07.11.2011 | ICU2 
Patient 20 | 26.04.2014 | ICU2 
Env 15 | 04.03.2014 | ICU2 
Patient 21 | 13.10.2014 | ICU2 
Patient 5 | 10.09.2010 | ICU3  
Patient 4 | 30.08.2010 | ICU3  
Patient 3 | 25.07.2010 | ICU3  
Patient 2 | 10.07.2010 | ICU3  
Patient 2 | 20.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 02.06.2010 | ICU3  
Env 5 | 27.04.2012 | ICU4 
Env 4 | 03.04.2012 | ICU4 
Env 12 | 08.11.2012 | ICU4 
Env 2 | 10.10.2011 | ICU3  
Env 8 | 17.07.2012 | ICU3  
Patient 5 | 15.08.2010 | ICU3  
Patient 4 | 03.08.2010 | ICU3  
Patient 1 | 06.04.2010 | ICU3  
Env 6 | 27.04.2012 | ICU4 
Patient 8 | 21.07.2011 | ICU ped 
Patient 6 | 16.09.2010 | ICU2 
Patient 15 | 12.12.2012 | ICU ped 
Patient 19 | 10.01.2014 | ICU2 
Patient 17 | 30.05.2013 | ICU1 
Patient 22 | 15.10.2014 | ICU5 
Env 13 | 11.12.2012 | ICU3 
Env 7 | 17.07.2012 | ICU3  
Env 11 | 07.11.2012 | ICU2 
Env 1 | 10.10.2011 | ICU2 
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DLST 6-7 phylogeny 
Adapted methodology: PacBio reference, MQ 60, 20 reads 
 
 
Figure 81. DLST 6-7 maximum likelihood tree based on the SNPs alignment obtained with the adapted methodology, mapping against the 
PacbBio reference with a mapping quality of 60 and with a minimum of 20 reads to consider a SNP site. A subclade of isolates from the burn 
unit suspected to be epidemiologically linked are highlighted in green. Another subclade, in blue, is composed of isolates from Patient 11 and 
environmental isolates retrieved from ICU2. An example of isolates belonging to the same patient, Patient 12, is highlighted in green. Two 
long branches belonging to Env. 1 and Env. 11 are highlighted in red 
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(A) 
 
(B) 
 
(C) 
 
Figure 82. Frequency of number of SNP differences obtained with the adapted methodology, mapping 
against the PacBio reference with mapping quality of 60 and minimum of 20 reads to consider a SNP site, 
for (A) DLST 1-18, (B) DLST 1-21, and (C) DLST 6-7. 
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1. Introduction 
 Pseudomonas aeruginosa is considered one of the main Gram-negative bacteria causing 
hospital acquired infections (1). In these settings, P. aeruginosa widely present in the environment 
and can be retrieved from different sources, like respiratory therapy equipment, antiseptics, soap, 
sinks, and hydrotherapy pools(2). This pathogen was also found to be part of the endogenous 
microbiota of 2.6 to 24% of the hospitalized patients (3, 4). Patients with compromised host 
defense mechanisms, such as neutropenia, severe burns, or cystic fibrosis, are particularly 
affected by this pathogen  whose infections lead to high morbidity and mortality (5, 6). P. 
aeruginosa has been previously described as the second most common organism responsible for 
infections acquired in intensive care units (ICUs) (7) 
P. aeruginosa population structure is consensually believed to be panmictic-epidemic (8-
10), i.e. a superficially clonal structure with frequent recombination that creates new strains with 
unique genetic characteristics, in which occasionally highly successful epidemic clones arise. In 
addition, clinical isolates are indistinguishable from environmental isolates; and there are no 
specific clones related to a specific habitat selection (10).  
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 Molecular epidemiological investigations have become indispensable for active 
surveillance of infection and detection of expanding disease outbreaks. P. aeruginosa possesses a 
very complex ecology and, for that reason, only powerful typing methods can give insight on the 
relatedness of strains, and consequently on the routes of colonization and/or infection (11). 
Pulsed-field gel electrophoresis (PFGE) has been considered the “gold standard” for DNA 
fingerprinting of P. aeruginosa (12-14). However, this method as several disadvantages, such as 
long analysis time, the use of expensive and specialized equipment, low intra- and inter-laboratory 
reproducibility and is labor-intensive, which make it not the optimal method to be used in a large 
investigation (14, 15). To overcome these limitations, alternative amplification-based molecular 
methods have been implemented as is the case of multi-locus sequence typing (MLST) which 
showed to be efficient in the study of the global population structure of P. aeruginosa (16). Another 
sequence-based method, double locus sequence typing (DLST), based on partial sequencing of two 
highly variable loci has been successfully used to investigate the epidemiology of Staphylococcus 
aureus and Pseudomonas aeruginosa (1, 17-19).More recent studies on the P. aeruginosa evolution 
and dissemination in hospital settings have been conducted by recurring to whole genome 
sequencing (WGS) (20-22). This method enables the analysis of the complete genome of bacterial 
isolates, distinguishing strains at the single nucleotide level. 
 An increase in P. aeruginosa incidence was observed in the ICUs of the Uiversity Hospital 
of Lausanne. Clinical and environmental isolates retrieved from 2010 to 2014 were typed using 
DLST (1). Three major DLST types, i.e. comprising the highest number of patients, where 
identified: DLST 1-18, DLST 1-21, and DLST 6-7. DLST 1-18 was previously reported as the cause 
of an outbreak in the burn unit (23). However, DLST 1-21 and DLST 6-7 showed sporadic 
occurrence with only few cases of possible transmission between patients. The discriminatory 
power of whole genome sequencing (WGS) was used to further investigate these three major 
DLST clusters. 
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2. Material and Methods  
Bacterial isolates and molecular typing. P. aeruginosa isolates were collected from 
patients hospitalized in the five ICUs of the University Hospital of Lausanne over a five-
year period. From 2010 to 2014, clinical and environmental isolates were typed by the 
double locus sequence typing (DLST) method (1) previously developed by our group. 
Three major DLST clusters, i.e. clusters with the highest number of patients, were further 
analysed in this study: DLST cluster 1-18 (24 patients), 6-7 (22 patients), and 1-21 (16 
patients). At least one isolate was selected per patient. If several isolates were collected 
from one patient, only isolates sampled 15 days apart were selected, unless they belonged 
from different sample types. All environmental isolates from the three DLST clusters 
(mainly from sink traps) were considered. A total of 74 DLST 1-18 isolates (55 clinical and 
19 environmental), 50 DLST 6-7 isolates (38 clinical and 12 environmental), and 31 DLST 
1-21 isolates (18 clinical and 13 environmental) were selected for whole genome 
sequencing. 
 
Epidemiological investigation. Epidemiological data (unit and room of hospitalization, 
dates of ICU admission and discharge, and clinical diagnosis) was retrieved from the 
hospital databases and used to construct epidemiological maps and annotate the 
phylogenetic trees. Epidemiological links between patients or environment were 
identified as: (i) patients hospitalized during overlapping periods in the same ICU, or (ii) 
patients showing an identical DLST type with an environmental sample isolated in the 
same unit during the period of the study. 
 
DNA extraction and whole genome sequencing. We extracted genomic DNA from a 5ml 
Lysogenic Broth (LB) culture, acquired from single colonies and incubated to reach an 
early exponential phase, using the GenElute bacterial genomic DNA kit (SIGMA-ALDRICH, 
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St. Louis, MO, USA). Whole genome sequencing was performed on 155 P. aeruginosa 
clinical and environmental isolates by the Lausanne Genomic Technologies Facility (GTF, 
University of Lausanne). The sequencing libraries were prepared using the Nextera DNA 
Library Preparation Kit (Illumina, Inc., San Diego, CA, USA) for 100-bp paired-end 
sequencing runs on Illumina HiSeq 2500, aiming for a 100-fold coverage. 
 
SNPs and phylogenetic analysis. Isolates’ sequence type (ST) was assigned from the 
short reads data by the Short Read Sequence Typing 2 (SRST2) software. A first step of 
subsampling the number of raw reads to reach the lower read depth observed (70x) was 
added to provide comparable accuracy in the posterior analysis, as well as to reduce 
mapping time. Complete reference genomes were created by sequencing the first 
collected clinical isolate of each ST with both PacBio and Illumnina HiSeq technologies. 
The subsampled reads were then mapped against their respective complete reference 
genome with BWA-MEM. Variant calling was performed with FreeBayes with a minimum 
mapping quality of 60. Putative phages found with PHASTER along with repeat regions 
and potential recombination regions detected with an in-house script, were excluded 
from the genome alignment.  
A maximum likelihood tree was constructed from the final core SNPs alignment using the 
PhyML algorithm implemented in Seaview version 4.6.1 (24). Tree visualization was done 
with FigTree version 1.4.3. Detailed methodology is present in Supplementary data 1. 
 
3. Results 
Different epidemiology of the three DLST clusters. To infer possible epidemiological 
links between patients of the same DLST cluster and/or between patients and 
environmental isolates, the hospitalization period, the ICU where the hospitalization 
occurred, and the ICUs environmental sampling of P. aeruginosa were investigated and 
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are schematically represented in Figures 2.23. DLST cluster 1-18 was previously 
considered responsible for an outbreak in the burn unit from 2010 to 2012 (23). From 
the 24 patients harbouring this DLST type, 18 were hospitalized in the burn unit (ICU 3), 
and six in other ICUs. Several epidemiological links were found between the patients 
hospitalized in the burn unit which shared the same hydrotherapy shower room, during 
overlapping hospitalization periods. The first patient observed harbouring this DLST type 
was hospitalized in ICUs 1 and 5 and was not epidemiologically linked to other patients 
infected with the same type. Links between environmental isolates, mainly from the 
shower room and sink traps, and patients hospitalized in the same ICU were also found. 
Only two epidemiological links were identified for DLST cluster 1-21; one between 
two patients hospitalized in the same ICU (ICU 2), and one between those patients and an 
environmental sample retrieved from a sink trap in the same ICU. The remaining patients 
were dispersed through the six ICUs during the study period, except in 2013 when no 
patient was found to be colonized or infected with this DLST type (Figure 1).  
Figure 1. Epidemiological maps of the three different DLST types. The first panel corresponds to patients 
harbouring DLST 1-18 (N=24), the second to DLST 1-21 (N=16), and the third to DLST 6-7 (N=22). Each 
line represents the hospitalization period of each patient from 2010 to 2014. Units where patients were 
hospitalized are differentiated by colors. Stars represent the first isolation of P. aeruginosa for each 
patient. 
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Such behaviour suggests DLST cluster 1-121 was not considered to be the cause of a P. 
aeruginosa outbreak.  
Three epidemiological links were found between DLST cluster 6-7 patients 
hospitalized in the burn unit, in 2010. From 2011 to 2014, no epidemiological links were 
suspected as patients were not hospitalized in the same ICU during overlapping periods 
of time. In addition, no epidemiological links between patients and environmental sources 
were observed. Similarly to DLST cluster 1-21, this DLST type occurred sporadically 
throughout the study period and was not responsible for an outbreak. 
 
Different DLST clusters belonged to different sequence types. Among the different 
genotyes, DLST cluster 1-18, 1-21, and 6-7 comprised the highest number of patients and 
were chosen for posterior analysis with WGS. Although DLST allows inter laboratory 
comparison of genotypes, the universal standard of multilocus sequence typing (MLST) is 
still widely used for strain comparison. Therefore, the Illumina HiSeq raw reads were 
used to identify the STs present in the isolate collection. MLST results defined DLST 1-18, 
1-21, and 6-7 isolates as STs 1076, 253, and 17, respectively, confirming the previously 
documented similar discriminatory power of both methods (25). 
 
WGS confirmed the outbreak caused by DLST cluster 1-18. Patient 1, which was not hospitalized 
in the burn unit and had no epidemiological link with the outbreak, clustered far apart from the 
remaining isolates with a maximum of 120 SNPs between a pair of isolates (Figure 2 and 3). 
Several subclades were identified comprising both clinical and environmental isolates, however 
most of the outbreak isolates were closely related with less than 10 SNP differences. Patient 4 
isolates from ICU3 and Patient 11,12, and environmental isolate 10 from ICU4 were integrated in 
the same subclade. These isolates acquired from ICU4 and an isolate from Patient 4 (date of 
collection: 13.04.2011) showed a slightly higher number of differences in relation to the 
remaining isolates (<16 SNPs). Isolates retrieved from the same patient, although some were 
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separated on the phylogenetic tree, were genetically different by only less then 10 SNPs 
differences, e.g. Patient 4 (<7 SNPs) and Patient 23 (0-2 SNPs). The number of SNP differences 
count (Figure 4) demonstrated that the maximum of differences observed between a pair of 
isolates is 16 and the minimum is zero, except for isolates belonging to Patient 1 (120 SNPs). 
 
DLST cluster 1-21 and 6-7 occurred sporadically in the ICUs. Two clades and several subclades 
with high SNP differences between them reinforce the premise that DLST 2-21 was not 
responsible for an outbreak. Two isolates from two patients (zero SNPs) and one isolate from the 
environment (Figure 5 and Figure 6, in blue,) showed one SNP difference between them, 
confirming the previously suspected epidemiological link. Only six SNP differences were 
found between two isolates of two patients hospitalized in different ICUs (ICU2 and ICU4), 
retrieved two years apart. A low number of SNPs (<14 SNPs) was observed between 
environmental isolates retrieved ten years apart (Figure 6, in orange). Environmental 
isolates retrieved from different sink traps in the burn unit (ICU3) clustered together with 
less than 11 SNP differences. Isolates belonging to the same patient were closely related 
with a maximum of 4 SNPs between them. SNPs count for this DLST cluster demonstrated 
a high variability of the number of SNPs found, ranging from zero to 116 SNPs between a 
pair of isolates (Figure 4). 
DLST 6-7 clades and subclades showed a high number of SNP differences (Figure 7). One 
subclade (Figure 8, in green) was composed by isolates retrieved in the burn unit with 
less than 13 SNPs differences. These isolates belonged to patients for which 
epidemiological links were suspected. Four environmental isolates retrieved from both 
the burn unit and ICU4 were closely related to the burn unit cluster (10-19 SNPS). A 
second subclade was constituted by closely related isolates from Patient 11 sampled in 
ICU2 and environmental isolates from the same ICU (0-7 SNPs). All isolates recovered 
from the same patient clustered together with only a few SNPs differences (1-6), e.g. 
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Patient 12 (1-2 SNPs) (Figure 8, in yellow). Long branches with more than 200 SNPs 
associated with two isolates from the environment (Env 1, 11) were detected. Most 
isolates had 50 to 150 SNP differences between them, with a maximum of 429 SNPs and 
a minimum of 2 SNPs (Figure 4). 
 
4. Discussion 
 In this study we give insight to the epidemiology of P. aeruginosa in the ICUs of the 
University Hospital of Lausanne by combining a molecular typing method with WGS. The 
three investigated DLST types sowed different epidemiological behaviours during this 
study period. Most of DLST cluster 1-18 patients were hospitalized in the burn unit during 
overlapping periods of time. As P. aeruginosa is capable to survive on wet surfaces such 
as sinks, sink traps, pipes, and hydrotherapy equipment; several nosocomial outbreaks 
have been associated with these specific reservoirs (26). DLST 1-18 environmental 
isolates retrieved from shower mattresses and sink traps from the hydrotherapy room 
support the assumption of an environmental source of infection. The high number of 
epidemiological links between patients, along with the wide presence of this DLST type in 
the environment of the burn unit, helped to previously determine this cluster as 
responsible for an outbreak with an environmental source (23). However, the first patient 
detected with DLST 1-18 (Patient 1) was not considered an outbreak patient as since it 
was not epidemiologically linked to the other patients. 
 In 2010, DLST type 6-7 was responsible for a small outbreak in the burn unit 
comprising five patients. From 2011, both DLST 1-21 and 6-7 occurred sporadically 
throughout the rest of the study period with only one suspected epidemiological link 
found for DLST 1-21 isolates (between patients and environment). This behaviour may 
be explained by a major role of this types’ prevalence in our ICUs environment which lead 
to sporadic patient infection. Nonetheless, one limitation of this study relies on the 
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insufficient environmental sampling information until 2012. A more frequent and regular 
sampling throughout the four years study would have helped to discover probable 
epidemiological links between infected patients and environmental sources.  
 MLST results acquired from the isolates’ raw reads divided the dataset in three 
different STs; ST 1076, ST253, and ST17. This division was exactly concordant with the 
attribution of types performed with DLST; DLST 1-8, DLST 1-21, and DLST 6-7, 
respectively. Such findings confirmed the previously documented similar discriminatory 
power of both methods (25). ST253 belongs to the clinical and international well 
described clonal complex (CC) PA14, and ST17 was previously reported as part of the 
clonal complex C, both CCs being the worldwide most abundant clonal complexes in the 
P. aeruginosa population (27). 
 
 By combining DLST and epidemiological data it was possible to determine three 
genotypes with different behaviours in our ICUs. However, DLST was not discriminatory 
enough to confirm possible cases of transmission between patients and between patients 
and the environment, or to define a probable source of infection. WGS helped to group the 
DLST 1-18 outbreak isolates with less than 10 SNP differences between them, while 
excluding Patient 1 as part of the outbreak, which was inferred by epidemiological data 
but not by DLST typing. Environmental isolates retrieved from sink traps and shower 
mattresses on the hydrotherapy room clustered with the outbreak isolates (<10 SNPs) 
which can indicate them as possible sources of infection.  
Analysis of DLST 1-21 WGS data confirmed the suspected epidemiological link 
between isolates retrieved from ICU2. In addition, it considered as closely related, isolates 
for which no epidemiological links were suspected. For instance, isolates sampled from 
the burn unit were related with less than 11 SNPs; environmental isolates sampled 10 
years apart were related with 11 to 14 SNPs; two isolates from two patients collected 12 
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years apart had six SNP differences. These values are lower than expected when 
considering the long time between isolate sampling, and considering that isolates 
retrieved from the same patient, weeks apart, had close number of SNP differences (0-4 
SNPs). One explanation can be the slower evolution of P. aeruginosa isolates in the 
environment of ICUs which then lead to patients being infected with genetically identical 
strains.  
 Lastly, a small DLST 6-7 outbreak between patients hospitalized in the burn unit 
in 2010 was confirmed by WGS (0-13 SNP differences). A subclade of ICU2 clinical and 
environmental isolates with zero to seven SNP differences suggests a possible 
transmission between patient and the environment that was not questioned with the 
epidemiological data. Interestingly, two environmental isolates were associated with long 
branches. One reason for the occurrence of these long branches is the long branch 
attraction phenomenon: phylogenetic artefact when distantly related lineages are 
erroneously considered closely related solely because they have both undergone a large 
amount of molecular change (28). Another reason could be that these are hypermutator 
isolates as a response to environmental selection (29). A way to assess the latter would 
be investigated the presence of genes coding for the methyl-directed mismatch repair 
(MMR) system proteins in this DLST type genome.  
 Although WGS costs are decreasing, its implementation as a routine surveillance 
method for P. aeruginosa still comes at a higher price per isolate than the currently used 
DLST. Additionally, analyses of WGS data requires a certain level of bioinformatic 
expertise that is not always available in all epidemiology laboratories (30). Thus, recurring 
to DLST as a first-line molecular typing tool for screening of cases important to be 
analysed with the discriminatory power of WGS would culminate in a accurate and cost-
efficient typing strategy.  
Patient 3 | 15.08.2010 | ICU3 
Patient 23_RR | 18.10.2012 | ICU3 
Patient 14 | 10.10.2011 | ICU ped 
Env. 4 | 23.03.2012 | ICU3 
Env. 7 | 23.03.2012 | ICU3 
Patient 15_R | 16.10.2011 | ICU3 
Patient 8 | 13.03.2011 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 17 | 25.01.2013 | ICU3 
Patient 9 | 18.05.2011 | ICU3 
Env. 2 | 23.03.2012 | ICU3 
Patient 13_R | 14.07.2011 | ICU3 
Env. 9 | 17.07.2012 | ICU3 
Patient 2_R | 28.05.2010 | ICU3 
Patient 9 | 04.04.2011 | ICU3 
Patient 23 | 18.10.2012 | ICU3 
Env. 14 | 25.01.2013 | ICU3 
Patient 4 | 13.01.2011 | ICU3 
Env. 18 | 25.01.2013 | ICU3 
Patient 9 | 21.03.2011 | ICU3 
Env. 12 | 25.01.2013 | ICU3 
Patient 6_R | 30.01.2011 | ICU3 
Patient 8_R | 22.02.2011 | ICU3 
Patient 10_R | 02.05.2011 | ICU3 
Env. 15 | 25.01.2013 | ICU3 
Patient 22_R | 25.06.2012 | ICU3 
Env. 16_R | 25.01.2013 | ICU3 
Patient 17_R | 11.12.2011 | ICU3 
Patient 5_R | 24.01.2011 | ICU3 
Env. 13 | 25.01.2013 | ICU3 
Patient 20 | 16.03.2012 | ICU3 
Patient 3_R | 28.08.2010 | ICU3 
Patient 7 | 01.02.2011 | ICU1 
Env. 11 | 24.10.2012 | ICU3 
Patient 17_R | 01.02.2012 | ICU3 
Patient 17_R | 18.02.2012 | ICU3 
Patient 19_R | 13.03.2012 | ICU3 
Patient 21_R  | 25.04.2012 | ICU4 
Patient 21_R  | 22.04.2012 | ICU4 
Env. 8 | 27.04.2012 | ICU4 
Patient 21_R  | 03.05.2012 | ICU4 
Patient 8 | 28.02.2011 | ICU3 
Patient 20 | 04.03.2012 | ICU3 
Patient 20 | 18.03.2012 | ICU3 
Patient 20 | 13.04.2012 | ICU3 
Patient 20 | 22.03.2012 | ICU3 
Patient 18_R | 03.01.2012 | ICU3 
Patient 24 | 04.12.2012 | ICU3 
Env. 5 | 23.03.2012 | ICU3 
Env. 1 | 10.10.2011 | ICU3 
Patient 4 | 03.04.2011 | ICU3 
Patient 9 | 01.07.2011 | ICU3 
Patient 13_R | 26.07.2011 | ICU3 
Patient 9 | 08.06.2011 | ICU3 
Patient 23 | 25.10.2012 | ICU3 
Patient 16 | 08.12.2012 | ICU3 
Patient 19_R | 27.02.2012 | ICU3 
Env. 6 | 23.03.2012 | ICU3 
Patient 16 | 07.12.2011 | ICU3 
Patient 16 | 01.02.2012 | ICU3 
Patient 16 | 01.03.2012 | ICU3 
Patient 16 | 15.02.2012 | ICU3 
Patient 12_R | 26.06.2011 | ICU4 
Patient 11_R | 06.06.2011 | ICU4 
Patient 11 | 11.06.2011 | ICU4 
Patient 4 | 13.04.2011 | ICU3 
Patient 4 | 18.04.2011 | ICU3 
Patient 4 | 01.03.2011 | ICU3 
Patient 4 | 10.05.2011 | ICU3 
Patient 12_R | 25.07.2011 | ICU4 
Env. 10 | 27.07.2012 | ICU 4/5 
Patient 16 | 30.01.2012 | ICU3 
Patient 1_R | 24.04.2010 | ICU5 
Patient 1_R | 31.03.2010 | ICU5 
Figure 2. DLST 1-18 color heatmap showing pairwise genomic. Number of SNP differences between pairs of isolates are displayed in each square. Each line 
corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 1 (first isolate) to Patient 3 (last isolate). Different colors represent 
different SNP differences’ limits:10, 20, 50, 100, and 150. The frequency of each number of SNP differences is pictured by a white line on the color legend plot.  
 
 Figure 3. DLST 1-18 maximum likelihood. Non-outbreak isolates belonging to Patient 1 are highlighted in grey, and 
clustered apart from the remaining isolates. Isolates from Patient 4 and 23 are highlighted in pink and blue, respectively. 
 
(A) 
 
(B) 
 
(C) 
 
Figure 4. Frequency of number of SNP differences for (A) DLST 1-18, (B) DLST 1-21, and (C) DLST 6-7. 
 
  
Patient 11 | 10.04.2012 | ICU2 
Patient 10 | 31.03.2012 | ICU2 
Env. 5 | 02.04.2012 | ICU2 
Patient 16 | 01.09.2014 | ICU5 
Patient 12 | 07.11.2012 | ICU4 
Patient 5 | 27.10.2010 | ICU2 
Patient 4 | 02.09.2010 | ICU4 
Patient 1 | 08.01.2010 | ICU5 
Patient 3 | 18.05.2010 | ICU1 
Patient 13 | 04.12.2012 | ICU1 
Patient 6  | 31.12.2011 | ICU5 
Patient 6  | 28.02.2011 | ICU5 
Env. 6 | 27.04.2012 | ICU5 
Patient 9 | 13.03.2012 | ICU5 
Patient 15 | 08.08.2014 | ICU5 
Patient 2 | 03.05.2010 | ICU5 
Patient 2 | 29.04.2010 | ICU5 
Patient 14 | 02.02.2013 | ICU ped 
Patient 7 | 03.04.2011 | ICU2 
Env. 11 | 25.01.2013 | ICU3 
Env. 10 | 25.01.2013 | ICU3 
Env. 9 | 25.01.2013 | ICU3 
Env. 8 | 07.12.2012 | ICU3 
Env. 4 | 23.03.2012 | ICU3 
Env. 3 | 23.03.2012 | ICU3 
Env. 7 | 13.11.2012 | ICU3 
Env. 13 | 29.05.2013 | ICU3 
Env. 2_R | 23.12.2004 | ICU ped 
Env. 12 | 07.03.2013 | ICU5 
Env. 1_R | 18.05.2004 | ICU ped 
Patient 8 | 08.12.2011 | ICU ped 
Figure 5. DLST 1-21 color heatmap showing pairwise genomic distances. Number of SNP differences between pairs of isolates are displayed in each square. Each line 
corresponds to an isolate. Isolate’s identification on the columns from left to right: Patient 8 (first isolate) to Patient 11 (last isolate). Different colors represent 
different SNP differences’ limits:10, 20, 50, 100, and 150. The frequency of each number of SNP differences is pictured by a white line on the color legend plot.  
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Figure 6. DLST 1-21 maximum likelihood tree. Three environmental isolates retrieved between 2004 and 2013 are highlighted in orange; isolates from two patients and 
an environmental sample collected from ICU2 are highlighted in blue; subclade of environmental isolates from the burn unit are highlighted in green.  
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Patient 7 | 04.05.2011 | ICU1 
Patient 7 | 19.04.2011 | ICU1 
Patient 7 | 21.05.2011 | ICU1 
Patient 13 | 04.05.2012 | ICU5 
Patient 9 | 30.07.2011 | ICU4 
Patient 10 | 26.08.2011 | ICU1 
Patient 16 | 17.05.2013 | ICU3  
Patient 12 | 09.04.2013 | ICU1 
Patient 12 | 21.03.2013 | ICU1 
Patient 12 | 15.04.2012 | ICU1 
Patient 14 | 07.10.2012 | ICU1 
Patient 14 | 26.09.2012 | ICU1 
Patient 18 | 11.10.2013 | Not ICU - Ped 
Env 14 | 20.03.2013 | ICU2 
Env 3 | 02.04.2012 | ICU2 
Env 9 | 30.07.2012 | ICU2 
Patient 11 | 18.11.2011 | ICU2 
Env 10 | 07.11.2012 | ICU2 
Patient 11 | 06.12.2011 | ICU2 
Patient 11 | 07.11.2011 | ICU2 
Patient 20 | 26.04.2014 | ICU2 
Env 15 | 04.03.2014 | ICU2 
Patient 21 | 13.10.2014 | ICU2 
Patient 5 | 10.09.2010 | ICU3  
Patient 4 | 30.08.2010 | ICU3  
Patient 3 | 25.07.2010 | ICU3  
Patient 2 | 10.07.2010 | ICU3  
Patient 2 | 20.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 18.06.2010 | ICU3  
Patient 2 | 02.06.2010 | ICU3  
Env 5 | 27.04.2012 | ICU4 
Env 4 | 03.04.2012 | ICU4 
Env 2 | 10.10.2011 | ICU3  
Env 8 | 17.07.2012 | ICU3  
Patient 5 | 15.08.2010 | ICU3  
Patient 4 | 03.08.2010 | ICU3  
Patient 1 | 06.04.2010 | ICU3  
Env 12 | 08.11.2012 | ICU4 
Env 6 | 27.04.2012 | ICU4 
Patient 6 | 16.09.2010 | ICU2 
Patient 15 | 12.12.2012 | ICU ped 
Patient 17 | 30.05.2013 | ICU1 
Patient 8 | 21.07.2011 | ICU ped 
Patient 19 | 10.01.2014 | ICU2 
Patient 22 | 15.10.2014 | ICU5 
Env 13 | 11.12.2012 | ICU3 
Env 7 | 17.07.2012 | ICU3  
Env 11 | 07.11.2012 | ICU2 
Env 1 | 10.10.2011 | ICU2 
Figure 7. DLST 6-7 color heatmap showing pairwise genomic distances. Number of SNP differences between pairs of isolates are displayed in each square. Each line 
corresponds to an isolate. Isolate’s identification on the columns from left to right: Env. 1 (first isolate) to Patient 7 (last isolate). Different colors represent different SNP 
differences’ limits:10, 20, 50, 100, and 150. The frequency of each number of SNP differences is pictured by a white line on the color legend plot. 
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Figure 8. DLST 6-7 maximum likelihood tree. A subclade of isolates from the burn unit suspected to be epidemiologically linked are highlighted in green. Another 
subclade, in blue, is composed of isolates from Patient 11 and environmental isolates retrieved from ICU2. An example of isolates belonging to the same patient, Patient 
12, is highlighted in green. Two long branches belonging to Env. 1 and Env. 11 are highlighted in red. 
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Figure 1. Schematic representation of the different steps included in the adapted methodology. 
 
A first step of subsampling the number of raw reads to reach the lower read depth 
observed (70x) was done to provide comparable accuracy in the posterior analysis, as 
well as to reduce mapping time. The subsampled reads were then mapped against their 
respective complete reference genome with BWA-MEM. Variant calling was performed 
with FreeBayes with a minimum mapping quality of 60 and a minimum proportion for 
variant evidence of 0.9. A series of other in-house scripts were applied to the variant call 
format (VCF) file (lists each position where a SNP is detected along with several 
characteristics associated with this SNP, such as the nucleotide change, quality value, or 
the applied filtering) acquired after SNP calling with FreeBayes An in-house script was 
used for identification of recombination regions: it determines a threshold for SNP 
density according to the data being analysed and lists the regions of high SNP density to 
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be masked above this threshold. A probability to remove regions of high SNP density of 
0.001 and a window size of 2000 was used for recombination detection. Additionally, an 
in-house script performed repeat region identification. Putative phages found with 
PHASTER, along with repeat regions and potential recombination regions were excluded 
from the genome alignment. The VCF file was then filtered with other in-house scripts 
applying the following parameter thresholds: minimum quality of base assignement of 
100 and a minimum read by allele to report a SNP of 20. A maximum likelihood tree was 
constructed from the final core SNPs alignment using the PhyML algorithm implemented 
in Seaview version 4.7 (24). Tree visualization was done with FigTree version 1.4.3.  
 
 
